matchedPattern,context,lineNumber,columnNumber,publicationName
p.T378P,...harbored the same previously unreported mutation (p.T378P) that we had identified in our latest pati...,98,294,Acta_Myol_2011_Oct_30(2)_96-102.txt
p.V600E,"...BRAF gene revealed one BRAF mutation (c.1799 T>A, p.V600E), in a melanoma. No HRAS or NRAS mutations...",81,801,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,9	MC	c.626 A>C (p.Gln209Pro)	wt	na	wt,92,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,10	MM	c.626 A>T (p.Gln209Leu)	wt	wt	na,93,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,13	MC	c.626 A>T (p.Gln209Leu)	wt	wt	na,96,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,15	MM	wt	c.1799 T>A (p.V600E)	na	wt,98,22,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"... with a BRAF point mutation (case 15; c.1799 T>A, p.V600E) might be a metastasis rather than a prima...",114,857,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Val600Lys,...d M Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 1...,152,84,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.V600E,...l S Cote JF Peschaud F Capper D Detection of BRAF p.V600E mutations in melanomas: comparison of four...,162,128,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Glu5845Glu,....13066delT; p.Tyr4356Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu	exon 86: frameshift mutation leading ...,39,365,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ser8193Ser,"...non-invasive ventilation.	No	ex175; c.24579G > A, p.Ser8193Ser ex119; c.18676C > T, p.Gln6226*	ex175...",50,383,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.V600E,BRAF:p.V600E mutations were detected in 7 of 16 (43%) g...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...1, RNF130, CLCN6, MKRN1 and GNAI1[17,19,21]. BRAF:p.V600E mutations occur in PXAs (~70%), gangliogli...",133,512,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.R132H,...rs presenting in childhood rarely contain an IDH1:p.R132H mutation. This mutation is regarded as a h...,133,1023,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...tures of a classic ganglioglioma, harbored a BRAF:p.V600E mutation. This mutation is the most common...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...tures of a classic ganglioglioma, harbored a BRAF:p.V600E mutation. This mutation is the most common...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.Phe91Ile,"...atients 1 and 2s had novel mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectivel...",118,194,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Y374X,...p.P525L mutation in the FUS gene and a truncating p.Y374X mutation in the TARDBP gene,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,aCase 6 also carried a previously described p.Y374X TARDBP mutation (cDNA position c.1119_1120...,49,45,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...l surviving angulated neurons (arrows) in case 5 (p.R521H). H&E. b Well circumscribed basophilic inc...,121,136,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...l surviving angulated neurons (arrows) in case 5 (p.R521H). H&E. b Well circumscribed basophilic inc...,121,136,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,"...the spinal cords in case 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale ...",121,776,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,"...the spinal cords in case 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale ...",121,776,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"... 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale Bar (a)-140 μm, (b) (c) ...",121,800,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ts of FUS immunopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exh...,124,159,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,... and anti-p62 in (e) inset. f The cord in case 1 (p.R495X) revealing very mild loss of myelin in the...,124,807,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) and inset...,126,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) and inset illustrates...,126,28,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) and inset illustrates...,126,28,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510M,...uffering from a locked-in state associated with a p.K510M mutation and abundant FUS pathology in the...,135,2417,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,...ed UMN pathology but this time in patients with a p.R521C mutation which is identical to our cases 3...,135,2612,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"...t, and slower progression (including 2 cases with p.R521C mutations). Our findings do not fit neatly...",135,3462,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...neuronal loss present in the cord. Case 6 (with a p.P525L mutation) also had moderate-large numbers ...,135,4214,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...s having a p.P525L mutation also had a truncating p.Y374X TARDBP mutation on chromosome 1. The patho...,135,4533,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.A31P,...s that were homozygous for the mutation had fHCM. p.A31P heterozygosity was not associated with a si...,10,360,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ar that most MC cats that develop fHCM due to the p.A31P mutation prior to the age of approximately ...,13,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ed significance. The clinical significance of the p.A31P cMyBP-C protein mutation was determined by ...,38,185,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...es. There was tendency to an increasing effect of p.A31P cMyBP-C homozygosity with age, though the t...",44,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...1, P = 0.09. There was only a low effect of being p.A31P cMyBP-C heterozygous, ρ = 0.09, P = 0.4. Bo...",44,391,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...he corresponding line of tendency. Blue indicates p.A31P cMyBP-C homozygous where and the correspond...,44,803,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value mutation negative vs,73,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,p.A31P cMyBP-C genotypin,132,1,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,p.A31P cMyBP-C genotypin,132,1,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... distribution for the entire cohort. The group of p.A31P cMyBP-C homozygous cats had an increased pr...,135,167,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The significance of the p.A31P cMyBP-C mutatio,139,25,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...f diastolic IVS and LVFW as a function of age and p.A31P cMyBP-C heterozygous or homozygous status. ...,157,116,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...f diastolic IVS and LVFW as a function of age and p.A31P cMyBP-C heterozygous or homozygous status. ...,157,116,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...examine the significance of being affected by the p.A31P cMyBP-C mutation in middle-aged cats. The s...,159,172,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cance of being heterozygous or homozygous for the p.A31P cMyBP-C mutation in a cohort of young MC ca...,162,87,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cance of being heterozygous or homozygous for the p.A31P cMyBP-C mutation in a cohort of young MC ca...,162,87,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...zygous. Again, no significant association between p.A31P cMyBP-C and fHCM was found in heterozygous ...",166,314,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...at those pedigrees with cats heterozygous for the p.A31P mutation and affected with fHCM may represe...,170,467,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...her yet undiscovered mutation is present with the p.A31P cMyBP-C mutation. Digenic or compound heter...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...her yet undiscovered mutation is present with the p.A31P cMyBP-C mutation. Digenic or compound heter...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... cats. Our results support the pathogenic role of p.A31P when two affected gene alleles are present ...,183,156,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.T185S,The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of the human TMEM106B ge...,66,31,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e disequilibrium with the coding rs3173615 SNP of p.T185S, is closely associated with FTLD-TDP in th...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.G130A,"...with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes this anoth...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A339A,"...Exon 5	Chr9: 125,834,603	n/a	c.1017C > G	1/97 (1)	p.A339A",127,52,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala242Thr,"...ed a heterozygous c.724G > A change, resulting in p.Ala242Thr. Though this is a conserved alanine re...",135,96,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala172Phe,"...drome caused by a heterozygous missense mutation, p.Ala172Phe, located in the IgII domain of FGFR2. ...",7,835,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Pro252Arg,"...011]. Occasionally, a specific mutation in FGFR1, p.Pro252Arg can cause Pfeiffer syndrome—phenotypic...",14,295,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Pro252Arg,"...011]. Occasionally, a specific mutation in FGFR1, p.Pro252Arg can cause Pfeiffer syndrome—phenotypic...",14,295,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...cutive nucleotides (c.514_515delGCinsTT, encoding p.Ala172Phe) and was previously known only from Pf...",16,795,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ted British family, has also been implicated. The p.Ala172Phe mutation, involving a double nucleotid...",40,462,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ons and direct receptor–receptor contacts. In the p.Ala172Phe mutation, substituting the small alani...",71,807,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.W299R,JC_0759	62	M	6/12	6/12	23.16	22.92	RGS9	p.W299R / p.R128X	MCW,93,41,Am_J_Ophthalmol_2015_Dec_160(6)_1269-1275_e1.txt
p.Ala349Ser,"...strated the deleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 i...",51,1428,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...s of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, processing ...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Y279N,...evealed a homozygous novel mutation c. 835 T > A (p.Y279N) in exon 6,37,129,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Arg438Cys,...that resulted in a change in the protein level of p.Arg438Cys (Fig. 2). Mutation analysis and clinic...,17,547,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.G296S,...S    A novel mutation KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface...,150,98,Appl_Clin_Genet_2012_Oct_18_5_97-104.txt
p.Gln4154Lys,"...ve studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with lipid, apoB...",3,1580,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...he role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Indian Punjabi...",28,74,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.D727E,"...stigated the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gene using the polymera...",3,1446,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ers in exon 10 of the TSHR gene that contains the p.D727E polymorphism and digested by theNlaIII (Hi...,3,1835,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,... of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion of the recep...,8,1225,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...igure 1 The PCR-based restriction analysis of the p.D727E polymorphisms of the TSHR gene shown on 2%...,37,52,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...igure 1 The PCR-based restriction analysis of the p.D727E polymorphisms of the TSHR gene shown on 2%...,37,52,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Arg488Ter,"...cal case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (http://genetics.emory.edu/egl/emvcla...",91,924,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.L849P,"...oint mutation Cav1.4 L860P [14,15] referred to as p.L849P in these publications and the truncation m...",33,78,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,...tion mutation Cav1.4 R1827X ([15]; referred to as p.R1816X therein) were introduced into the Cav1.4 ...,33,172,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,... mutation in C-terminus at position Arg1827 (also p.R1816X in [15]; Fig. 1a) was found in an 8-year ...,52,57,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.S34N,"...ported that local deficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, which is the gene en...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.S34N,"...ported that local deficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, which is the gene en...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.K601E, c.1801A>G	p.K601E	11 (5.9),192,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	11 (5.9),192,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1 (0.5),194,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	34 (18.2),196,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	7 (3.7),199,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	6 (3.2),200,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.181C>A	p.Q61H	1 (0.5),204,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K	1 (0.5),205,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	6,246,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.R196P,23	1	−	+ (76%)	Exon 6/p.R196P,58,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,24	2	+ (86%)	−	Exon 8/p.R273H,59,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R175H,26	2	+ (70%)	−	Exon 5/p.R175H,61,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,27	2	+ (94%)	−	Exon 8/p.R273H,62,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.P142R,30	2	+ (53%)	−	Exon 5/p.P142R and exon 6/m.P222 L,66,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.G12V,...hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland adenoma ...,7,900,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...ed a point mutation at exon 1, codon 12 (c.35G>T; p.G12V) and wildtype sequence at exon 2 in the pyl...",55,100,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12R,"...in, serotonin, somatostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,172,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...C1, p16), negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 1...",96,152,BMC_Cancer_2012_Dec_4_12_570.txt
p.Asp2213Asn,c.6637G>A	p.Asp2213Asn	rs529038,44,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Pro200Leu,c.599C>T	p.Pro200Leu	rs1050450,50,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Pro200Leu,c.599C>T	p.Pro200Leu	rs1050450,50,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Cys130Arg,c.388 T>C	p.Cys130Arg	rs429358,59,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp432Glu,c.1296 T>G	p.Asp432Glu	rs7041,62,13,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp432Glu,c.1296 T>G	p.Asp432Glu	rs7041,62,13,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Met1Thr,c.2 T>C	p.Met1Thr	rs2228570,68,10,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was also signifi...",265,47,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.R605Q,"... to have 851del4, IVS16ins3kb, 1638ins23, and the p.R605Q variant (creating a BsrDI restriction site...",47,242,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,"... to have 851del4, IVS16ins3kb, 1638ins23, and the p.R605Q variant (creating a BsrDI restriction site...",47,242,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.D19H,...ed from blood leukocytes. Genotype frequencies of p.D19H were established using MALDI-TOF mass spect...,7,494,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... Moreover, irrespective of phenotype, carriers of p.D19H displayed a significant lower absorption th...",10,620,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... with diminished cholesterol absorption. However, p.D19H is not responsible for the differences in s...",13,108,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...verweight simultaneous carriers of gallstones and p.D19H displayed a higher OR (OR = 3.2, P = 0.0430...",142,881,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...vidual): C = 75, GS = 14; Gc genotype (carrier of p.D19H): C = 18, GS = 11",162,680,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.Trp82Arg,...amyloid deposits in all cases and all carried the p.Trp82Arg ALys variant at a heterozygous state,7,633,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"...ge of the amino acid from tryptophan to arginine (p.Trp82Arg in the new nomenclature, corresponds to...",25,399,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"... the mature protein from tryptophane to arginine. p.Trp82Arg in the new nomenclature, wich was previ...",40,429,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.R163Q,"...etween Asia and all other populations, due to the p.R163Q (c.488 G>A) polymorphism. The least amount...",9,397,BMC_Genet_2008_Apr_10_9_31.txt
p.R163Q,"...etween Asia and all other populations, due to the p.R163Q (c.488 G>A) polymorphism. The least amount...",9,397,BMC_Genet_2008_Apr_10_9_31.txt
p.C35Y,p.C35Y	c.104 G>A	0	0	0	0	0	0.12	0	0,41,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V38M,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V38M,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L44V,p.L44V	c.130 C>G	0	0	0	0	0	0.06	0	0,43,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S47I,p.S47I	c.140 G>T	0	0.43	0	0	0	0	0	0,45,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S47I,p.S47I	c.140 G>T	0	0.43	0	0	0	0	0	0,45,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83L,p.S83L	c.248 C>T	0	0	0	0	0	0.06	0	0,51,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D84E,p.D84E	c.252 C>A	0	0	0	0	1.00	0.12	1.51	0,52,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D84E,p.D84E	c.252 C>A	0	0	0	0	1.00	0.12	1.51	0,52,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V92M,p.V92M	c.274 G>A	0.07	0	13.41	0.94	8.00	3.70	9.06	...,53,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T95M,p.T95M	c.284 C>T	0	0	0	0	0.08	0.12	0	0,54,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A103A,p.A103A	c.309 C>T	0	0.43	0	0	0	0	0	0,56,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I155T,p.I155T	c.464 T>C	0	0	0	0	0.23	0.48	1.51	0,66,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160Q,p.R160Q	c.479 G>A	0	0	0	0	0	0.06	0	5,68,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R163Q,p.R163Q	c.488 G>A	0.14	0	75.51	4.72	4.62	1.61	4.15...,69,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A166A,p.A166A	c.498 G>A	0	0	0	0	0	0	0	11.25,70,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V174I,p.V174I	c.520 G>A	0	0	0	0	0.08	0	0	0,73,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G220G,p.G220G	c.660 C>T	0	0	0	0	0	0.06	0	0,77,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q228Q,p.Q228Q	c.684 G>A	0	0	0	0	0	0.12	0	0,78,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A240A,p.A240A	c.720 T>C	0	0	0	0	0	0	0.19	0,82,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C273C,p.C273C	c.819 C>T	0	0.43	0	0	0	0	0	0,88,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F300F,p.F300F	c.900 C>T	0	2.99	0	0	0	0	0	0,92,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T308M,p.T308M	c.923 C>T	0	0	0	0	0	0.06	0	0,93,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T308M,p.T308M	c.923 C>T	0	0	0	0	0	0.06	0	0,93,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,"...the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in Britain/I...",171,673,BMC_Genet_2008_Apr_10_9_31.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.V320A,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0.48	90.82	1.63	7.05	0.00	...,62,30,BMC_Genet_2013_Feb_19_14_6.txt
p.R2937Q, 	 	c.8810 G > A (p.R2937Q)	3235	20.1	4	94	94.03	1.08	4.33	0.56	0	0,71,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R2937Q, 	 	c.8810 G > A (p.R2937Q)	3235	20.1	4	94	94.03	1.08	4.33	0.56	0	0,71,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H199R, 	 	c.596A > G (p.H199R)	11616	29.2	9	86	9.13	2.95	85.73	2.18	0.00...,74,17,BMC_Genet_2013_Feb_19_14_6.txt
p.H199R, 	 	c.596A > G (p.H199R)	11616	29.2	9	86	9.13	2.95	85.73	2.18	0.00...,74,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R223H, 	 	c.668 G > A (p.R223H)	10344	31.4	5	93	92.62	1.14	4.89	1.31	0.00...,75,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R223H, 	 	c.668 G > A (p.R223H)	10344	31.4	5	93	92.62	1.14	4.89	1.31	0.00...,75,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S601L, 	 	c.1802C > T (p.S601L)	6027	21.4	59	34	2.17	59.25	4.35	34.23	0.0...,85,18,BMC_Genet_2013_Feb_19_14_6.txt
p.D248N, 	 	c.742 G > A (p.D248N)	15664	32.8	62	35	35.28	0.5	61.78	2.43	0	0...,96,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T529M, 	 	c.1586C > T (p.T529M)	15938	25.7	16	78	2.41	16.18	3.38	78.02	0	...,98,18,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68	37.71	60.85	0.73	0....,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.L483P, 	 	c.1448 T > C (p.L483P)	3331	26.4	60	38	0.99	38.04	0.9	60.07	0	0,117,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H33Q,IDUA	NM_000203.3	c.99 T > G / p.H33Q	34	10.2	6	91	2.94	0.00	91.18	5.88	0.00	0.00...,132,31,BMC_Genet_2013_Feb_19_14_6.txt
p.R105Q, 	 	c.314 G > A (p.R105Q)	10809	28.7	62	34	33.71	1.86	62.39	2.01	0....,135,18,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50	1.18	59.99	1.33	0.0...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.T388T, 	 	c.1164 G > C (p.T388T)	3080	23.1	65	31	2.05	31.30	65.16	1.49	0.0...,143,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S246S, 	 	c.738C > T (p.S246S)	10356	27.9	76	24	0.3	75.69	0.32	23.68	0	0...,150,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R1005Q, 	 	c.3014 G > A (p.R1005Q)	3027	27	50	48	47.9	1.06	50.21	0.83	0	0,155,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R456H, 	 	c.1367 G > A (p.R456H)	8525	29.5	61	36	36.29	1.69	60.75	1.23	0	0...,165,19,BMC_Genet_2013_Feb_19_14_6.txt
p.V36A, 	 	c.107 T > C (p.V36A)	 	 	 	 	 	 	 	 	 	 ,167,18,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"...e nucleotide changes, such as ACADVL c.1504C > G (p.L502V), but also small deletions and insertion e...",237,941,BMC_Genet_2013_Feb_19_14_6.txt
p.L99P,"...gh differentiation, (ii) the fixation of the MC1R p.L99P mutation in (old and new) BBC, BBM and HF, ...",118,724,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.P19S,... retardation and a reduced lifespan in mice [17]. p.P19S is therefore a plausible candidate mutation...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...early embryonic lethality in eukaryotes [24]. The p.W317R-variant is predicted to be highly damaging...,130,354,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.V327I,"... in LOC783918 (rs384792959, Chr10: 26,948,606 bp, p.V327I). Thirty-eight (out of 263) sequenced anim...",141,828,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.V327I,"... in LOC783918 (rs384792959, Chr10: 26,948,606 bp, p.V327I). Thirty-eight (out of 263) sequenced anim...",141,828,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.Gln27Glu,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was determined b...,27,34,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.Gln27Glu,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was determined b...,27,34,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.G232R,...). One reported mutation was a missense mutation (p.G232R) and 2 were frameshift mutations: c.1082in...,12,1417,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,...). One reported mutation was a missense mutation (p.G232R) and 2 were frameshift mutations: c.1082in...,12,1417,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,...). One reported mutation was a missense mutation (p.G232R) and 2 were frameshift mutations: c.1082in...,12,1417,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	F	40	2.4	4.2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,A	F	45	2.5	2.3	450	11.77	893	+/+	c.670T>G/p.W224R,70,44,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,50,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,So	M	18	1.1	1.2	35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,D	18.12	54.19	c.670T>G/p.W224R,202,25,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...tamic acid residue to a valine residue in exon 3 (p.E34V). The other was a G to C substitution at nu...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...ity seems to be unprobable in these cases. In the p.E34V and p.W224G mutations the glutamic acid and...,240,640,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...aryotic PPOXs, revealed that mutations p.E34V and p.G332A affect residues that are conserved in mito...",242,114,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...aryotic PPOXs, revealed that mutations p.E34V and p.G332A affect residues that are conserved in mito...",242,114,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"The last missense mutation, p.W224G affects a residue which is absent in the c...",244,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R1607W,"...e c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W), inherited from the mother and father re...",50,209,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53T,"...sense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82...",54,134,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...sponsible heterozygous mutation of the OTOF gene, p.I515T, was first found in two affected children ...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.R702W,"...hich are specific to AJ individuals [28,29], with p.R702W, pG908R, and p.L1007fs accounting for 81% ...",158,726,BMC_Med_Genet_2011_May_6_12_63.txt
p.R2146Q,"...). Of these, three variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblin...",67,187,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,"...hree variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblings. The p.S347...",67,201,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,"..., and p.S3474G) were shared by both siblings. The p.S3474G variant was ruled out because it was repo...",67,245,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2140Q,"...s and their family. One variant, corresponding to p.R2140Q, was heterozygotic in the patient’s fathe...",67,545,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2140Q,"...s and their family. One variant, corresponding to p.R2140Q, was heterozygotic in the patient’s fathe...",67,545,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...s found to contain another MYO15A coding variant, p.G1220R, which was also shared by both affected s...",71,689,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...placed with a non-polar phenylalanine side-chain (p.S2161F). Both alterations are predicted by SIFT ...,74,887,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2124Q,"...the case of myosin XVA, it has been reported that p.R2124Q and p.P2073S mutations located in the MyT...",109,760,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2124Q,"...the case of myosin XVA, it has been reported that p.R2124Q and p.P2073S mutations located in the MyT...",109,760,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...present study, we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the My...",109,1036,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...present study, we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the My...",109,1036,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...FS and CEN [27]. Therefore, we speculate that the p.R2146Q mutation cripples the inter-MyTH4-FERM in...",109,1637,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...85, we identified two novel nonsynomous variants, p.G1220R and p.S2161F, in the MYO15A gene. Both of...",111,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...fied two novel nonsynomous variants, p.G1220R and p.S2161F, in the MYO15A gene. Both of these varian...",111,71,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,...for the hearing loss observed in this family: (1) p.G1220R contributes to the phenotype of the SR-28...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,...for the hearing loss observed in this family: (1) p.G1220R contributes to the phenotype of the SR-28...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...iblings. (B) In family SR-285, only one mutation, p.S2161F in MYO15A, is shared with the affected si...",134,224,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Pro240Leu,"...e two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, as well as one novel...",10,154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... and p.Glu1595Lys, as well as one novel mutation, p.Asn342Ser. The p.Pro240Leu mutation was found in...",10,215,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...as detected. SR-209 family carried two mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both var...",57,625,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...d p.Glu1595Lys, were identified. One heterozygous p.Pro240Leu mutation was confirmed in the father. ...",59,280,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... compound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, were carried by an affected sibling a...",59,401,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,c.G4783A	p.Glu1595Lys	36	EC15	DRE	DAMAGING/0	0.987	−1	SR-10...,77,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...g two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mutati...",85,97,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...o240Leu and p.Glu1595Lys, and one novel mutation, p.Asn342Ser (Table 2). The ConSeq server revealed ...",85,151,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...alcium affinity and impairs protein function like p.Glu1595Lys. The p.Pro240Leu mutation does not di...,85,1325,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...d impairs protein function like p.Glu1595Lys. The p.Pro240Leu mutation does not directly interfere w...,85,1343,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...is longer and more flexible (Figure 2). Thus, the p.Pro240Leu substitution may affect protein stabil...",85,1631,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...is longer and more flexible (Figure 2). Thus, the p.Pro240Leu substitution may affect protein stabil...",85,1631,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...re wild-type and those of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are as...,87,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-68)	2/128	rs18837629...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-68)	2/128	rs18837629...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ser496Asn,6	Chr10:73434906	14	c.G1487A	p.Ser496Asn	rs10999947	7	54/128	[5],104,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1335Ala,10	Chr10:73492032	31	c.T4004C	p.Val1335Ala	.	.	1/30	Novel,108,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1335Ala,10	Chr10:73492032	31	c.T4004C	p.Val1335Ala	.	.	1/30	Novel,108,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn1351Asp,11	Chr10:73492079	31	c.A4051G	p.Asn1351Asp	rs1227065	16	29/30	[5],109,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala1575Thr,14	Chr10:73501556	36	c.G4723A	p.Ala1575Thr	rs1227051	16	28/30	[5],112,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala1575Thr,14	Chr10:73501556	36	c.G4723A	p.Ala1575Thr	rs1227051	16	28/30	[5],112,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30	[5],113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30	[5],113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1804Gln,16	Chr10:73544086	40	c.G5411A	p.Arg1804Gln	rs3802711	10	16/30	[5],114,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp1806Glu,17	Chr10:73544093	40	c.C5418G	p.Asp1806Glu	rs74145660	3	6/30	[5],115,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Thr1999Ser,18	Chr10:73550117	44	c.C5996G	p.Thr1999Ser	rs11592462	6	8/30	[5],116,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2358Gln,21	Chr10:73558886	49	c.G7073A	p.Arg2358Gln	rs4747194	12	26/30	[5],119,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro2380Leu,22	Chr10:73558952	49	c.C7139T	p.Pro2380Leu	rs4747195	12	26/30	[5],120,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"We identified three CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (...",132,38,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"We identified three CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (15%) of 13 Ko...",132,51,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...e CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (15%) of 13 Korean families with...",132,69,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln1716Pro,"...e others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that occur at rela...",132,473,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"... one patient, respectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutatio...",132,718,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...atients were heterozygous for the mutation. Thus, p.Pro240Leu is the most common cause of CDH23-asso...",132,1303,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...atients were heterozygous for the mutation. Thus, p.Pro240Leu is the most common cause of CDH23-asso...",132,1303,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,... of CDH23-associated ARNSHL in Asian populations. p.Glu1595Lys was present in 1 of 93 patients. Astu...,132,1389,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...nd in the EC domain. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly cons...",134,677,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ification, and dimerization of CDH23 [15,16]. The p.Glu1595Lys mutation may disrupt a conserved LDRE...",134,913,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...dent interactions [16]. Molecular modeling of the p.Glu1595Lys mutation shows impairment of calcium ...,134,1147,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.A4704V,"...sequencing. Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in...",10,532,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,".... Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unr...",10,542,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,".... Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unr...",10,542,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"..., rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unrelated Kosovo ...",10,556,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V121I,"...r was a rare variant. The novel variant (c.G361A, p.V121I) is located in the Contactin 2 gene (CNTN2...",144,121,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R5205H,"...e non-synonymous variant (rs150188026, c.G15614A, p.R5205H, MAF 0.018) is located in the Hemicentin ...",144,293,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"...HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF ...",144,619,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"...HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF ...",144,619,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R928C,"c.2782C > T	p.R928C	Bethlem myopathy, #158810",107,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R928C,"c.2782C > T	p.R928C	Bethlem myopathy, #158810",107,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.Gly243Arg,...tilized to predict the functional consequences of p.Gly243Arg (c.727G > C). The Polyphen2 program pr...,72,150,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...ral factors pertinent to the identified mutation (p.Gly243Arg) support the suggestion that FBXO32 is...,91,100,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...ral factors pertinent to the identified mutation (p.Gly243Arg) support the suggestion that FBXO32 is...,91,100,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Phe174Ser,...sessed. We compared the two patients carrying the p.Phe174Ser variant and concluded that this varian...,8,449,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...CR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cys mutation has been repeatedly reported ...,40,87,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...CR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cys mutation has been repeatedly reported ...,40,87,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...lico programs showing the predicted effect of the p.Phe174Ser mutation on the DHCR7. SNP&GO, http://...",43,157,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...wo mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in the TM3 and TM5 domai...,48,550,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...differences between our case and the one with the p.Phe174Ser mutation that was previously reported....,48,1139,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...e observations, it is possible to assume that the p.Phe174Ser variant is associated with mild forms ...",48,1260,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...e observations, it is possible to assume that the p.Phe174Ser variant is associated with mild forms ...",48,1260,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.V522A,rs34605986	c.1565 T > C	p.V522A	0.10	0.00	0.10,82,25,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.V522A,rs34605986	c.1565 T > C	p.V522A	0.10	0.00	0.10,82,25,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Arg247Pro,... two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p...,7,450,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,...pound heterozygous for a novel missense mutation (p.Arg247Pro) and a well-known nonsense mutation (p...,35,202,BMC_Nephrol_2014_Mar_3_15_41.txt
p.G2019S,... the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequenci...,6,204,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...ntly sporadic PD. The LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of typical sporadic PD...",20,617,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...iously been found to carry the LRRK2 c.6055G > A; p.G2019S mutation (n = 11). This selection led to ...,25,1159,BMC_Neurol_2008_Jan_22_8_1.txt
p.E395X,...ed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of exon 9; beca...,45,607,BMC_Neurol_2008_Jan_22_8_1.txt
p.E395X,...ed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of exon 9; beca...,45,607,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...tients studied here, we did identify c.6055G > A; p.G2019S in 2 of 46 early-onset cases. One of thes...",76,281,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...amples previously found to carry the c.6055G > A; p.G2019S mutation we calculate that this mutation ...,76,688,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.Arg438His,... mutations were identified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in fa...,37,647,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q78X,...tion in exon 3 of CTNNB1 (NM_001098209): c.C232T; p.Q78X (Fig. 1B).Fig. 1 Filtering strategy used fo...,128,1591,BMC_Neurol_2016_Mar_12_16_35.txt
p.R416W,...rginine to tryptophan at amino acid position 416 (p.R416W). Her daughter’s genomic DNA showed the sa...,48,294,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,"...e matter lesion, periventricular rim	c. 274 T > G	p.V87G",81,124,BMC_Neurol_2016_Nov_4_16_211.txt
p.R88C,a<4	Frontal white matter abnormality	c.276C > T	p.R88C,83,49,BMC_Neurol_2016_Nov_4_16_211.txt
p.S398Y,... medulla oblongata and cervical cord	c. 1193C > A	p.S398Y,89,128,BMC_Neurol_2016_Nov_4_16_211.txt
p.P47L,c.154C > T	p.P47L,92,12,BMC_Neurol_2016_Nov_4_16_211.txt
p.Glu809X,...2425G > T) responsible of a premature stop codon (p.Glu809X),80,728,BMC_Psychiatry_2015_May_7_15_107.txt
p.Glu809X,...2425G > T) responsible of a premature stop codon (p.Glu809X),80,728,BMC_Psychiatry_2015_May_7_15_107.txt
p.Gly12Asp,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,23,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Val,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,41,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Val,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,41,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...ild-type; two labs reported a mutation in exon 12 p.Gly12Asp, and three labs were consistent with th...",92,125,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...ild-type; two labs reported a mutation in exon 12 p.Gly12Asp, and three labs were consistent with th...",92,125,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Leu1077Pro,The p.Leu1077Pro CFTR mutation was firstly described i...,4,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...tion collected in database CFTR2 lead to consider p.Leu1077Pro as a severe CF mutation. Although it ...,4,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...tion collected in database CFTR2 lead to consider p.Leu1077Pro as a severe CF mutation. Although it ...,4,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...atients. 4 patients who were heterozygous for the p.Leu1077Pro mutation were included in the study,7,106,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,We found that the p.Leu1077Pro CFTR mutation is associated with a cl...,12,19,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...CFTR2 database. The relatively high prevalence of p.Leu1077Pro associated with the severe clinical c...,12,169,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,... Bozon et al. [8] firstly found evidence that the p.Leu1077Pro was associated with a pancreatic suff...,23,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...range 7 – 20 years) who were heterozygous for the p.Leu1077Pro mutation were included in the study: ...,33,431,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,3	M	12	19.63 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,4	F	20	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ing is routinely performed in our laboratory. The p.Leu1077Pro mutation was identified by denaturing...,62,541,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ing is routinely performed in our laboratory. The p.Leu1077Pro mutation was identified by denaturing...,62,541,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...icilian Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...icilian Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The present study provides evidence that the p.Leu1077Pro is a relatively frequent mutation ass...,87,46,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...irth by sweat test. All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ich resulted pathological. She had a p.Asn1303Lys/p.Leu1077Pro genotype,105,295,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The relatively high prevalence of p.Leu1077Pro associated with the severe clinical c...,118,35,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.I852T,"...three siblings share the same variant c.2555T >C (p.I852T) in the homozygous state. Accordingly, dia...",57,306,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"...nd CRB1 mutations in 7.4 % of them, with the same p.I852T mutation (of our patients) in two patients...",72,188,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"...nd CRB1 mutations in 7.4 % of them, with the same p.I852T mutation (of our patients) in two patients...",72,188,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.Arg528Cys,"...dentified a novel dominant mutation, c.1582C > T (p.Arg528Cys), in CACNA1S that causes hypokalaemic ...",10,55,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...novel missense mutation, c.1582C > T, in CACNA1S (p.Arg528Cys) (Figure 1). In his family, the mutati...",35,394,BMC_Urol_2014_Nov_28_14_96.txt
p.R206H,"...1 causes an arginine-to-histidine substitution at p.R206H in ALK2 within the GS domain in FOP, makin...",29,1735,Bone_Res_2015_Apr_14_3_15005.txt
p.L196P,"...e positions of the mutation in the GS domain are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E....",29,2642,Bone_Res_2015_Apr_14_3_15005.txt
p.Q207E,"...in are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E.70–72 Moreover, several mutations noticed ...",29,2684,Bone_Res_2015_Apr_14_3_15005.txt
p.G328E,"...hreonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 sh...",29,2799,Bone_Res_2015_Apr_14_3_15005.txt
p.V600E,"...ino acid 600 in the kinase domain of the protein (p.V600E, previously known as p.V599E; Smalley and ...",17,441,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...ino acid 600 in the kinase domain of the protein (p.V600E, previously known as p.V599E; Smalley and ...",17,441,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...id 600 within the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the ...",43,385,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...thin the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene...",43,394,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"... cell line HT29 (known to be heterozygous for the p.V600E mutation), several serial dilution studies...",71,60,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...plex g.1798-1799GT>AA changes resulting in a BRAF p.V600K alteration, rather than the more common p....",74,521,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,...is study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutations were detected by ARMS...,74,766,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...med these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A further tumour sample was sh...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...med these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A further tumour sample was sh...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,"...s. A further tumour sample was shown to harbour a p.K601E mutation, which was not detectable by the ...",76,249,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.Gly13Asp,"... KRAS codon 12 (p.Gly12Val, heterozygous) and 13 (p.Gly13Asp, heterozygous), respectively. DNA obtai...",42,238,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...3%. We were able to detect as little as 3% of MUT p.Gly12Val DNA in a WT background,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...tal line indicates WT control, and the p.Gly13Asp p.Gly12Val labelled lines indicate in duplicate th...",83,137,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...pond to HRMA mutated samples (from top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corres...",87,290,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly2891Asp,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identifi...",56,32,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...ells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM associated wit...,68,452,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are shown in Figure 6A...,72,257,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...s expressed with N-terminal tags (Figure 6B). The p.Gly2891Asp mutant protein was autophosphorylated...,72,978,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...d presentation, the two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T213 are bo...",77,668,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ng ATM, the presence of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raise...",89,313,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ng ATM, the presence of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raise...",89,313,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,...nt ATM protein; this could also apply to both the p.Val2424Gly and the p.Val2716Ala ATM mutations,89,1150,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.His2555Gln,...mutation (and also null mutation c.7665delinsGTGA;p.His2555Gln ins*) is slightly truncated (lanes 7 ...,112,564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,Figure 6 The p.Gly2891Asp protein has residual ATM kinase activ...,114,14,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...relative to the wt protein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A, lane 5). No ATM pro...",114,481,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...relative to the wt protein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A, lane 5). No ATM pro...",114,481,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...lation of ATM targets Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein were substantially ...",114,1550,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Q61H, 	KRAS	p.Q61H	 ,130,8,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q546K, 	PIK3CA	p.Q546K	 ,132,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12A,GEO	KRAS	p.G12A	S,139,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT116	KRAS	p.G13D	S,141,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Ile2047Asn,The presence of one novel missense mutation (p.Ile2047Asn) was analysed in 100 control chromoso...,58,46,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.Asn344fsX	NP,76,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr1019Met,ARDM-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,41,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,...0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,68,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1108His,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,...4) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,90,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu2027Phe,ARDM-183	63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser ...,91,47,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg2107His,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1640Gln,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1640Gln,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,70,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr901Ala,ARDM-131	27	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile156Val,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,37,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly88Gly,3	c.264 A>T	p.Gly88Gly	This study,113,13,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Glu433Glu,10	c.1299A>G	p.Glu433Glu	This study,118,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,"...as null mutations: three were nonsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); t...",130,91,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,"...ations: three were nonsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); two splice-s...",130,102,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,"...se mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); two splice-site mutations (IVS22-2A>T...",130,127,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...nges were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but not in the 100 ethni...",130,524,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2142Val,...ntrol chromosomes. We identified the heterozygous p.Ile2142Val change in one out of 100 control chro...,130,640,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"...wo previously described mutations [c.4537delC and p.Trp1724Cys], not included in the array by the ti...",130,870,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...el ABCA4 variants detected in this screening, the p.Arg1129Leu mutation was found to be the most fre...",138,117,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"... not present (false positive). Interestingly, the p.Trp1724Cys mutation was detected by dHPLC in thi...",147,321,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...rm these results by sequencing, a false positive [p.Ala1598Asp] was identified. Altogether, the comb...",150,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...47), double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who presented a CRD phenotyp...",167,641,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...7Tyr alleles, who presented a CRD phenotype. This p.Cys2137Tyr change was located more towards the a...",167,699,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...7Tyr alleles, who presented a CRD phenotype. This p.Cys2137Tyr change was located more towards the a...",167,699,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...7Tyr alleles, who presented a CRD phenotype. This p.Cys2137Tyr change was located more towards the a...",167,699,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower freq...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,"...enotypes respectively, we identified the missense p.Val1433Ile mutation, located in the second trans...",179,104,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Pro149Leu,"...s state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, which is located in exon 2 and g.chr7...",116,371,Brain_2013_Jan_3_136(1)_269-281.txt
p.Tyr226Cys,...xon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier status of t...,123,639,Brain_2013_Jan_3_136(1)_269-281.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,34,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q (P)	5 m	Novel,53,48,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,40,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., ...",58,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., ...",58,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,13	9 y	c.[674G>A] + c.[674G>A]	p.R225H + p.R225H	24 h	Novel,59,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...74G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,74,Brain_2014_May_18_137(5)_1350-1360.txt
p.Leu772*,"...gous frame-shift deletion in CCDC88A (c.2313delT, p.Leu772*ter). Analysis of cDNA extracted from pat...",13,668,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772*,"...gous frame-shift deletion in CCDC88A (c.2313delT, p.Leu772*ter). Analysis of cDNA extracted from pat...",13,668,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,"...ntrol, carrier parent and affected child with the p.Leu772X mutation. (D) Reverse transcriptase poly...",33,642,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.E286Q,TP53	5	(10)	17	GAA>CAA/p.E286Q	X	NA	X	Missense	Transversion	1.00	 	Yes,129,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M3430I, 	 	 	 	ATG>ATA/p.M3430I	NA	X	X	Missense	Transition	0.00	 	ND,136,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E476K,THSD4	2	(4)	15	GAG>AAG/p.E476K	X	X	X	Missense	Transition	1.00	 	Yes,140,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E652K, 	 	 	 	GAG>AAG/p.E652K	NA	X	X	Missense	Transition	0.96	 	ND,141,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.F303L,TRMT5	2	(4)	14	TTT>CTT/p.F303L	X	X	X	Missense	Transition	0.04	 	Yes,142,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E152Q, 	 	 	 	GAG>CAG/p.E152Q	NA	X	X	Missense	Transversion	0.03	 	ND,143,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.L540V,PIK3CA	2	(4)	3	CTC>GTC/p.L540V	NA	NA	X	Missense	Transversion	0.99	 	ND,144,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q546P, 	 	 	 	CAG>CCG/p.Q546P	NA	NA	X	Missense	Transversion	1.00	 	ND,145,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P292S, 	 	 	 	CCT>TCT/p.P292S	NA	NA	X	Missense	Transition	0.34	 	ND,147,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.T468M,HSP90B1	1	(2)	12	ACG>ATG/p.T468M	X	 	X	Missense	Transition	0.98	 	Yes,154,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N167S,PCF11	1	(2)	11	AAT>AGT/p.N167S	X	X	X	Missense	Transition	0.02	 	Yes,156,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R217C,SEC63	1	(2)	6	CGC>TGC/p.R217C	NA	X	X	Missense	Transition	1.00	 	ND,159,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R217C,SEC63	1	(2)	6	CGC>TGC/p.R217C	NA	X	X	Missense	Transition	1.00	 	ND,159,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D339A,ST7L	1	(2)	1	GAT>GCT/p.D339A	X	X	X	Missense	Transversion	1.00	 	Yes,161,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q1582P,ZFYVE26	1	(2)	14	CAA>CCA/p.Q1582P	X	X	X	Missense	Transversion	0.00	 	Yes,164,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.V600E,...otein is the murine counterpart of the human BRAF p.V600E oncogenic variant. V637 is encoded in Braf...,129,92,Cancer_Cell_2013_Jul_8_24(1)_15-29.txt
p.Y657S,...er and activator of transcription 3 (STAT3) gene (p.Y657S) Eur. J. Pediat. 2011 170 661 666 10.1007/...,129,230,Cancers_(Basel)_2014_Mar_6_6(1)_494-525.txt
p.V617F,7 Lange T.  Edelmann A.  Siebolts U.    JAK2 p.V617F allele burden in myelo proliferative neopl...,53,46,Case_Rep_Hematol_2015_Aug_9_2015_703457.txt
p.Trp897Ter,"c.2691G>A, p.Trp897Ter",55,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg277Ter,"c.829C>T, p.Arg277Ter",65,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg630X,"c.2455C>T, p.Arg630X",68,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Trp1689X,"c5067G>A, p.Trp1689X",71,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Glu693X,"c.2076_2077InsT, p.Glu693X",72,18,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Lys1450X,"c.4975A>T, p.Lys1450X",75,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Met899Ile,"c.2697G>A, p.Met899Ile",100,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.L541P,"... in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,670,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...ith complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,690,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.L541P,"... in exons 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous ...",29,599,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.L541P,"... in exons 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous ...",29,599,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant in exon 2 of...",29,619,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.K249N,...ygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of these thr...,29,772,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.K249N,...ygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of these thr...,29,772,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.Ala1038Val,"..., p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p.Ala1038Val, rs61751374), were identified in cis-...",33,241,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.Glu66Gln,...utation in addition to a functional polymorphism (p.Glu66Gln) frequently seen in the Asian populatio...,77,1144,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Glu66Gln,...utation in addition to a functional polymorphism (p.Glu66Gln) frequently seen in the Asian populatio...,77,1144,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"..., further 6 families (19 patients) comprising the p.Arg112His genotype are known. Five of the 6 inde...",79,64,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"..., further 6 families (19 patients) comprising the p.Arg112His genotype are known. Five of the 6 inde...",79,64,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"... a relatively mild phenotype, consistent with the p.Arg112His genotype",82,235,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Pro251Leu,"...wed two polymorphisms, a homozygote polymorphism (p.Pro251Leu), and a heterozygote silent polymorphi...",40,173,Case_Reports_Immunol_2012_Nov_21_2012_196417.txt
p.Pro251Leu,"...wed two polymorphisms, a homozygote polymorphism (p.Pro251Leu), and a heterozygote silent polymorphi...",40,173,Case_Reports_Immunol_2012_Nov_21_2012_196417.txt
p.Pro251Leu,"...wed two polymorphisms, a homozygote polymorphism (p.Pro251Leu), and a heterozygote silent polymorphi...",40,173,Case_Reports_Immunol_2012_Nov_21_2012_196417.txt
p.N306I,"...ffectively than EVER2 N306 (Figure 6d). Thus, the p.N306I polymorphism was sufficient to modulate th...",64,785,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.T172Vfs,(D) The protein change p.T172Vfs*51 is predicted to generate a 223 amino ...,99,24,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.T172Vfs,(D) The protein change p.T172Vfs*51 is predicted to generate a 223 amino ...,99,24,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.T172Vfs,(D) The protein change p.T172Vfs*51 is predicted to generate a 223 amino ...,99,24,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.R1255K,"...R1934X) affect all three isoforms; another three (p.R1255K, p.R1267X and p.N1324fsZ23) affect DSPI a...",70,167,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1775I,"...and p.N1324fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect ...",70,236,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1775I,"...and p.N1324fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect ...",70,236,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.K1583R,"...4fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI ...",70,246,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.K1583R,"...4fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI ...",70,246,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,"...se when inherited with another nonsense mutation, p.Q673X, which affects all isoforms (Asimaki et al...",70,607,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,"...plete ablation of DSP expression from one allele (p.Q673X) and ablation of DSPI only, allowing expre...",70,773,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...ease (Uzumcu et al. 2006). In this case (p.R1267X/p.R1267X), the cutaneous phenotype is relatively m...",70,1120,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...xpression (which is haplo-insufficient in p.Q673X/p.Q1446X and results in more severe cutaneous dise...,70,1293,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...xpression (which is haplo-insufficient in p.Q673X/p.Q1446X and results in more severe cutaneous dise...,70,1293,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...otype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 years compa...,70,1430,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,...mpared with cardiac failure at age 9 years in the p.Q673X/p.Q1446X case and therefore we are tempted...,70,1527,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.S358L,P 13 — Deleterious effects of theTMEM43mutation p.S358L found in a German family with arrhythmogen...,1137,49,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,P 13 — Deleterious effects of theTMEM43mutation p.S358L found in a German family with arrhythmogen...,1137,49,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...r of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Christensen...,1153,399,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...r of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Christensen...,1153,399,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...clearly been demonstrated. The female carriers of p.S358L presented a rather mild arrhythmogenic phe...,1153,574,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...clearly been demonstrated. The female carriers of p.S358L presented a rather mild arrhythmogenic phe...,1153,574,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.M252T,"...). Two missense mutations in TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also proba...",13,383,Cilia_2012_Oct_1_1_18.txt
p.R441C,"...n TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also probable founder mutations. Thes...",13,410,Cilia_2012_Oct_1_1_18.txt
p.R441C,"...n TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also probable founder mutations. Thes...",13,410,Cilia_2012_Oct_1_1_18.txt
p.Q376P,P95	Pakistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,35,Cilia_2012_Oct_1_1_18.txt
p.Q376P,...akistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,56,Cilia_2012_Oct_1_1_18.txt
p.R85X,162 + 163	British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dy...,96,40,Cilia_2012_Oct_1_1_18.txt
p.M252T,186	British	TMEM67	c. 755 T > C p.M252T	c. 653 G > T p.R208X†††	+	+	 	 	 	 	 ,98,33,Cilia_2012_Oct_1_1_18.txt
p.V673A,"... + b	 	TMEM67	c. 1351 C > T p.R451X	c. 2108 T > A p.V673A	 	+	 	+	 	 	mental retardation, retinal co...",101,57,Cilia_2012_Oct_1_1_18.txt
p.Q662X,"...	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abnormal cerebellum, wide nasa...",102,66,Cilia_2012_Oct_1_1_18.txt
p.W1182R,128	British	CC2D2A	c. 3544 T > C p.W1182R	c. 3774_3774insT p.E1259fsX1	 	 	 	 	 	 	...,105,34,Cilia_2012_Oct_1_1_18.txt
p.R156C,36 + 36A	Pakistani/Gujarati	RPGRIP1L	c. 466 C > T p.R156C*N	not detected	+	+	 	 	 	 	 ,106,51,Cilia_2012_Oct_1_1_18.txt
p.V1298D,"... G > A het p.D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 ...",109,229,Cilia_2012_Oct_1_1_18.txt
p.R85X,"....D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 European/Afr...",109,241,Cilia_2012_Oct_1_1_18.txt
p.L63R,...ative pathogenic mutation in TMEM216 c. 188 T > G p.L63R,109,850,Cilia_2012_Oct_1_1_18.txt
p.R649X,...probable founder mutations RPGRIP1L c. 1945 C > T p.R649X and CC2D2A c. 3540delA p.R1180SfsX6 should...,138,957,Cilia_2012_Oct_1_1_18.txt
p.R440Q,"...rthermore, some MKS mutations, such as the TMEM67 p.R440Q missense mutation, are allelic for Joubert...",138,1456,Cilia_2012_Oct_1_1_18.txt
p.D254N,"...on six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for the fir...",33,235,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.R1267X,...ng both isoforms. A homozygous nonsense mutation (p.R1267X) in the DSP-1 specific region of exon 23 ...,72,287,Clin_Res_Cardiol_2011_Dec_26_100(12)_1087-1093.txt
p.N288K,"...of these occurred in a family with a c.846 C > G, p.N288K SMARCB1 mutation that we have previously r...",59,1098,Clin_Sarcoma_Res_2012_Oct_4_2_17.txt
p.Ala944Thr,p.Ala944Thr	One copy	One copy	Zero copies	Missense...,51,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
p.W577R,...ial hypercholesterolaemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin. Transpla...,345,141,Curr_Vasc_Pharmacol_2015_Nov_13(6)_759-770.txt
p.W577R,...ial hypercholesterolaemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin. Transpla...,345,141,Curr_Vasc_Pharmacol_2015_Nov_13(6)_759-770.txt
p.Gly1324Ser,Experimental factors	VWF A1-p.Gly1324Ser was expressed in E. coli as inclusion...,15,29,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...i-NTA and Heparin affinity chromatography. VWF A1-p.Gly1324Ser purity and absence of aggregates were...,15,224,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ed process for expression and purification of the p.Gly1324Ser A1 domain is described,23,61,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...A1 domain harboring the loss-of-function mutation p.Gly1324Ser,27,165,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,2.1 Production of p.Gly1324Ser A1 in Escherichia col,37,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...tical gel filtration and reverse phase HPLC of A1 p.Gly1324Ser. The upper panel shows a chromatogram...,72,63,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...tical gel filtration and reverse phase HPLC of A1 p.Gly1324Ser. The upper panel shows a chromatogram...,72,63,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Fig. 1Fig. 2 Photograph of the VWF A1 p.Gly1324Ser crystals taken with a polarized light...,74,39,Data_Brief_2016_May_10_7_1700-1706.txt
p.M1V,...to conversion of the initiation codon ATG to GTG (p.M1V) (Inhoff et al. in press),66,1136,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
p.M1V,...to conversion of the initiation codon ATG to GTG (p.M1V) (Inhoff et al. in press),66,1136,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
p.Glu248Lys,"....203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R ...",34,177,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.N88S,"...pe caused by heterozygous mutations in BSCL2 gene p.N88S in Austrian and German families, these pati...",88,280,Diagn_Pathol_2013_May_9_8_78.txt
p.N88S,"...pe caused by heterozygous mutations in BSCL2 gene p.N88S in Austrian and German families, these pati...",88,280,Diagn_Pathol_2013_May_9_8_78.txt
p.N88S,...n a large Dutch family with heterozygous mutation p.N88S in the BSCL2 gene and segregating autosomal...,88,590,Diagn_Pathol_2013_May_9_8_78.txt
p.Thr78Ala,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Thr78Ala,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Thr78Ala,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Leu,"2	c.269C>T	p.Ser90Leu	dHMN, CMT2	[18,29,30]",100,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Trp,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Leu91Pro,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg138X,3	c.412C>T	p.Arg138X	CGL2	[5],103,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Q223R,"...i EA  Genelhu VA  Cabello PH  Pimentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene var...",142,78,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.E709A,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes,79,25,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P848L,4	M	exon21 (p.P848L)	–	First scan	E−	Yes	Yes	Yes,82,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.S768I,8	M	exon18 (p.G719S) and exon20 (p.S768I)	SD	First scan	E−	Yes	Yes	Yes,95,34,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L861Q,11	F	exon21 (p.L861Q)	SD	First scan	E−	Yes	Yes	Yes,104,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L858R,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E...,110,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L858R,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E...,110,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L858R,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E...,110,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E−	Yes	Yes	Yes,110,35,EJNMMI_Res_2016_Feb_9_6_10.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.A734E,"...ng-defective, recessive sticky missense mutation (p.A734E) in AARS (alanyl-tRNA synthetase) in a mou...",38,479,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R329H,"...didate genes identified a novel mutation in AARS, p.R329H. The mutant AARS exhibits reduced aminoacy...",38,1180,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D893N,"...ions were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin et al, 2012; ...",38,1407,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D893N,"...ions were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin et al, 2012; ...",38,1407,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.F52L,"...blastic anemia. A pathogenic, recessive mutation (p.F52L) in the YARS2 gene (mitochondrial tyrosyl-t...",100,328,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L155R,...und heterozygous with a second missense mutation (p.L155R). The mutations in AARS2 cause perinatal o...,109,572,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L155R,...und heterozygous with a second missense mutation (p.L155R). The mutations in AARS2 cause perinatal o...,109,572,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.Ser107Leu,"... We identified three FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four unrelated pat...",3,2158,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...ted patients (two males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated femal...,3,2251,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... p.Arg448Trp is a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling act...",3,2544,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... p.Arg448Trp is a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling act...",3,2544,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling activity similar to...",3,2560,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling activity similar to...",3,2560,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...s from previous functional studies indicated that p.Arg85Cys moderately compromises receptor signall...,3,2714,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tation Taster, SIFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be d...",47,343,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a hetero...",50,24,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,... 1). Results of in silico analysis indicated that p.Arg85Cys is damaging according to Mutation Taste...,50,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The PROKR2 variant p.Arg85Cys has been described in the databases of ...,56,20,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,The p.Arg448Trp variant was identified in a 4-year-old...,63,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...milar to the WT FGFR1c curve (Fig. 1A and B). The p.Arg448Trp variant, on the other hand, demonstrat...",81,445,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tients harbouring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two ...",84,528,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...rent FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with PROKR2 variants...",84,557,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...rent FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with PROKR2 variants...",84,557,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"Concerning the p.Pro772Ser variant, due to its finding in five of...",90,16,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"Concerning the p.Pro772Ser variant, due to its finding in five of...",90,16,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"Concerning the p.Pro772Ser variant, due to its finding in five of...",90,16,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ala51Thr,"...us missense variants (p.Leu173Arg, p.Arg85His and p.Ala51Thr). The first two showed deleterious effe...",101,243,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ala51Thr,"...us missense variants (p.Leu173Arg, p.Arg85His and p.Ala51Thr). The first two showed deleterious effe...",101,243,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Leu,"...variants in 11 unrelated patients, three of them (p.Arg85Leu, Leu173Arg and Arg268Cys) proved to be ...",101,558,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...B) variants had normal signalling activity, while p.Arg448Trp had reduced maximal signalling activit...",120,275,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... of total protein and maturation levels of WT and p.Arg448Trp receptors. Plotted are means±s.e.m. of...,120,629,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... of total protein and maturation levels of WT and p.Arg448Trp receptors. Plotted are means±s.e.m. of...,120,629,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,...nts. (G) Cell-surface expression levels of WT and p.Arg448Trp receptors assessed in live transiently...,120,756,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Disease-causing	...,144,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Disease-causing	...,144,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,c.253C>T	p.Arg85Cys	First intracellular loop	Disease-causin...,153,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,c.253C>T	p.Arg85Cys	First intracellular loop	Disease-causin...,153,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro483Ser,p.Pro483Ser	⇊	=				0,222,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu	=	NS	156	2	400	0	Present study,227,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,p.Arg448Trp	↓	NS				0,228,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ile249Thr,...zygous missense mutation of the CTSK gene (exon 6 p.Ile249Thr). Histomorphometry of a transiliac bon...,31,1657,Endocrine_2016_Feb_18_52_414-426.txt
p.Ala386Glu,...evealed two novel genetic alterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg)...,57,973,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,... c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targeted genotypin...,57,1011,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Met918Thy,"...a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted next generat...",4,1189,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
p.Met918Thy,"...a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy), further validated by Sanger sequenci...",31,246,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
p.N148K,...lysis showed that the finger printing of the STAR p.N148K mutant is also different from the WT prote...,5,317,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R188C,"...st common mutation causing this phenotype is STAR p.R188C. Thus, the spectrum of clinical presentati...",23,454,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,"...N1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously described (1). Th...",34,401,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,"...N1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously described (1). Th...",34,401,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...e (A) (dbSNP – rs775130992), resulted in the STAR p.N148K mutation (Fig. 1), which was observed befo...",44,886,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,... Japanese and Korean populations (1) and the STAR p.R182L mutation among Palestinian Arabs (1). The ...,62,455,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R193X,"...the STAR p.N148K mutation, a second mutation STAR p.R193X, a nonsense mutation, was identified",62,974,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...e altered conformation that results from the STAR p.N148K mutation prevents its interaction with VDA...,67,1111,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Lys1385Thr,"...rozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially responsive to dia...",4,573,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Lys1385Thr,...el missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is highly ...,31,394,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Lys1385Thr,...el missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is highly ...,31,394,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Lys1385Thr,...el missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is highly ...,31,394,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Ala561Thr,...n of the Ikr potassium channel showing that KCNH2 p.Ala561Thr mutation is located in the S5 transmem...,36,903,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Val174Ala,... were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP we...,148,197,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Asn130Asp,...ces. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation in Asian...,148,228,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Asn130Asp,...ces. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation in Asian...,148,228,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Asn130Asp,...ces. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation in Asian...,148,228,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"... report that describes association of the c.946A (p.Arg307Gln) LOF SNP with low LS-BMD, and that oth...",3,3048,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.His155Tyr,"... in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the extracellular domain ...",18,1188,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"One LOF P2RX7 polymorphism, the c.1513C allele (p.Glu496Ala) has recently been associated with inc...",20,49,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associat...",50,871,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associat...",50,871,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1.00 (0.02)	...,89,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1.01 (0.06)	...,92,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0.97 (0.02)	...,106,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.R307Q,rs28360457	c.946G>A (p.R307Q)	0.02	0.97 (0.01)	0.84 (0.04)	*	0.002 (0.0...,107,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.T357S,rs2230911	c.1096C>G (p.T357S)	0.07	0.97 (0.01)	0.98 (0.02)	1.00 (0.16)	...,108,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg347Pro, R347P	c.1040G>C	p.Arg347Pro,172,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro67Leu, P67L	c.200C>T	p.Pro67Leu,187,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu92Lys, E92K	c.274G>A	p.Glu92Lys,192,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117Cys, R117C	c.349C>T	p.Arg117Cys,196,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.His199Tyr, H199Y	c.595C>T	p.His199Tyr,205,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347His, R347H	c.1040G>A	p.Arg347His,217,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val520Phe, V520F	c.1558G>T	p.Val520Phe,231,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg560Lys, R560K	c.1679G>A	p.Arg560Lys,241,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu927Pro, L927P	c.2780 T>C	p.Leu927Pro,264,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu927Pro, L927P	c.2780 T>C	p.Leu927Pro,264,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly970Arg, G970R	c.2908G>C	p.Gly970Arg,266,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1066His, R1066H	c.3197G>A	p.Arg1066His,273,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1244Glu, G1244E	c.3731G>A	p.Gly1244Glu,284,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His, R117H	c.350G>A	p.Arg117His,296,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu558Ser, L558S	c.1673 T>C	p.Leu558Ser,299,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe1052Val, F1052V	c.3154 T>G	p.Phe1052Val,304,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe1052Val, F1052V	c.3154 T>G	p.Phe1052Val,304,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1152His, D1152H	c.3454G>C	p.Asp1152His,307,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile1234Val, I1234V	c.3700 A>G	p.Ile1234Val,308,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg75Gln, R75Q	c.224G>A	p.Arg75Gln,314,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Met470Val, M470V	c.1408 A>G	p.Met470Val,316,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Met470Val, M470V	c.1408 A>G	p.Met470Val,316,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly576Ala, G576A	c.1727G>C	p.Gly576Ala,317,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val754Met, V754M	c.2260G>A	p.Val754Met,319,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu997Phe, L997F	c.2991G>C	p.Leu997Phe,320,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Trp, R1070W	c.3208C>T	p.Arg1070Trp,322,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp,"...e508del, p.Gly542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with ...",396,100,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro1013His,"...s of unproven or uncertain CF clinical relevance (p.Pro1013His, p.Arg1162Leu …); A, accepted; R, ref...",396,276,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117H,"Thauvin-Robinet C, Munck A, Huet F et al: CFTR p.Arg117H is associated with CBAVD and other CFTR-...",513,48,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.L997F,"...is variants in population-based screening panels: p.L997F, further genotype/phenotype correlation da...",575,131,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp19His,...orted rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is believed t...,92,780,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Tyr54Cys,...an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>T and rs41...,92,1079,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Tyr54Cys,...an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>T and rs41...,92,1079,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Ala723Asp,"p.Ala723Asp	2,4	2, 4",377,1,Eur_Urol_2014_Oct_66(4)_752-768.txt
p.Ala723Asp,"p.Ala723Asp	2,4	2, 4",377,1,Eur_Urol_2014_Oct_66(4)_752-768.txt
p.L266V,"56,295,441	exon 8	C	G	G	G	G	missense (p.L266V)	rs31110637",297,39,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.V811M,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions cause",314,51,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.Cys1263Ser,"The 2-bp insertion (p.Thr1027fs) and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) i...",51,47,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asp216His,...ustres M  Tuffery-Giraud S  Collod-Beroud G   The p.Asp216His TOR1A allele effect is not found in th...,83,201,F1000_Biol_Rep_2010_Jun_16_2_41.txt
p.Asp216His,...ustres M  Tuffery-Giraud S  Collod-Beroud G   The p.Asp216His TOR1A allele effect is not found in th...,83,201,F1000_Biol_Rep_2010_Jun_16_2_41.txt
p.R496C,"11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[31, 32]",158,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.P1812R,23	c.5435C>G	p.P1812R	1	4.6	7.5	Y	Y/Y	0	ND	ND,162,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.V2908G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[34],168,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"...nst them being deleterious. This is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34]...",189,458,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.E462G,"...is is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,488,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.V2908G,"...6C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,513,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.Arg320X, 9a	F4	0	Exon 10	g.64348C>T	p.Arg320X	Bil	Yes	Enucl	Epithelial	C (49),86,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X," 13a	F8	3 (26, 11, 49)	Exon 14	g.76430C>T	p.Arg445X	Bil	Yes	Enucl	Epithelial	L (65)",90,43,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 16a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(45),93,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg467X, 18a	F23	NA	Exon 15	g.76898C>T	p.Arg467X	Bil	No	RT + CH	Melanoma	(28),95,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg579X, 21a	F10	0	Exon 18	g.150037C>T	p.Arg579X	Ul	Yes	Missing	Other	(59),98,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu737X, 28	F14		Exon 21	g.160832G>T	p.Glu737X	Bil	No	RT	Osteosarcoma	(20),107,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 29a	F27	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT + CH	Sarcoma	LMS (32),108,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Gln444Gln, 32	F7	1 (29)	Exon 13	g.73869G>A	p.Gln444Gl,112,34,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.C121G,"... homozygous for the inactivating missense variant p.C121G (c.T361G) in the UGT3A1 gene, which encode...",165,548,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.P158P,"...008). Two of the frameshift mutations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), gen...",45,579,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158P,"...008). Two of the frameshift mutations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), gen...",45,579,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158H,"...ations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), generate a novel 21 amino acid-lon...",45,610,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.F160X,"...2). The third non-sense mutation, c.479_480delTT (p.F160X), introduces a premature stop codon that r...",45,793,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.Thr226Ala,...xpressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met mutations. Vast differ...,32,647,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Thr226Met,...e mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met mutations. Vast differences in the sev...,32,663,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...damo et al., 1999). By inserting the heterozygous p.Val408Ala mutation in one Kv1.1 allele a mouse m...",84,1137,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...animals similar to EA1 (Herson et al., 2003). The p.Val408Ala is a homozygous lethal mutation that c...",84,1399,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.T312M,"...s in other PAI genes (Table 2); patient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP1...",201,141,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.V126I,"...nt 12 had three variants, p.L361D in CYP17A1, and p.V126I and p.I993V in NNT, patient 15 had two, p....",201,251,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L649R,"...n NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patient 17 had two, p.H24_Y25...",201,322,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L206R,"...e sequencing in ACA-S (14). The somatic mutation, p.L206R/c.617A > G was present in more than one-th...",19,598,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...the synthesis of cortisol and other steroids. The p.L206R and Leu199_Cys200insTrp mutations in the P...,23,638,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.R898W,"... studies suggesting a founder effect: p.R267X and p.R898W (15, 27–32)",30,1965,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.R898W,"... studies suggesting a founder effect: p.R267X and p.R898W (15, 27–32)",30,1965,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L58P,"...entified a homozygous STX11 mutation, c.173T > C (p.L58P), in three patients presenting clinically w...",11,832,Front_Immunol_2014_Jan_14_4_515.txt
p.L58P,"...entified a homozygous STX11 mutation, c.173T > C (p.L58P), in three patients presenting clinically w...",11,832,Front_Immunol_2014_Jan_14_4_515.txt
p.Pro271Ser,UNC13D	c.811C > T p.Pro271Ser htz	None detected	None detected,51,19,Front_Immunol_2014_Jan_14_4_515.txt
p.P271S,... A was heterozygous for a rare UNC13D c.811C > T (p.P271S; frequency 0.001 in a Caucasian population...,83,454,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,"...nd homozygous for an uncommon UNC13D c.2782C > T (p.R928C, frequency 0.01 in a Caucasian population ...",83,611,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,"...nd homozygous for an uncommon UNC13D c.2782C > T (p.R928C, frequency 0.01 in a Caucasian population ...",83,611,Front_Immunol_2014_Jan_14_4_515.txt
p.G67R,52	MLH1	c.199 G > A	p.G67R	2	Causal	ACI	No cancers,43,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R226Q,"8	MLH1	c.677 G > A	p.R226Q	8	Causal	ACI	CRC (38), EC (52)",45,20,Front_Oncol_2016_Aug_24_6_189.txt
p.E56X,"4	MSH2	c.166 G > T	p.E56X	1	Causal	ACI	CRC (44), EC (51)",53,20,Front_Oncol_2016_Aug_24_6_189.txt
p.P349R,DA	MSH2	c.1046C > G	p.P349R	6	Causal	ACI	BC (41),57,21,Front_Oncol_2016_Aug_24_6_189.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cance...,240,172,Front_Pediatr_2014_Sep_9_2_96.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cance...,240,172,Front_Pediatr_2014_Sep_9_2_96.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cancer  (2014 ) 14 :1...,240,188,Front_Pediatr_2014_Sep_9_2_96.txt
p.R270H,"...Subsequent in vitro experiments revealed that the p.R270H mutant, which was significantly associated...",28,2268,Front_Pharmacol_2014_Nov_6_5_236.txt
p.V60L,Figure 1 P2RX2 p.V60L attenuates ATP evoked inward current. HEK29...,50,16,Front_Physiol_2016_May_24_7_186.txt
p.Arg870His,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Likely pathogen...,57,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp896Asn,"NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs606231340	Pathogenic	Rani et al., 2...",61,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Trp1214Ter,NM_000256.3(MYBPC3):c.3641G > A (p.Trp1214Ter) rs730880597	Pathogenic	Bashyam et al...,64,35,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp770Asn,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Likely pathogen...,66,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Ile106Met,NM_001001430.2 (TNNT2):c.318C > G (p.Ile106Met) rs3729547	Uncertain significance	Rani...,72,37,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg141Gln,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397516347	Pathogenic/Likely pathoge...,76,34,Front_Physiol_2016_Oct_28_7_499.txt
p.Ser215Leu,NM_001018005.1 (TPM1):c.644C > T (p.Ser215Leu) rs199476316	Conflicting interpretatio...,79,36,Front_Physiol_2016_Oct_28_7_499.txt
p.R870H,...i G. R. Gopikrishna M. Narasimhan C.   (2007 ). A p.R870H mutation in the beta-cardiac myosin heavy ...,180,72,Front_Physiol_2016_Oct_28_7_499.txt
p.R870H,...i G. R. Gopikrishna M. Narasimhan C.   (2007 ). A p.R870H mutation in the beta-cardiac myosin heavy ...,180,72,Front_Physiol_2016_Oct_28_7_499.txt
p.Pro632Ser,p.Pro632Ser	Stop; Nonsyn	This study,91,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Pro632Ser,p.Pro632Ser	Stop; Nonsyn	This study,91,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg385Ser,c.974T>G*	p.Arg385Ser,94,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg281X,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,40,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Asp532His,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu437Pro,"S6	M	Homozygous	c.1310T>C*	p.Leu437Pro	Nonsyn	Refs. 4,15",112,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu628X,p.Glu628X	Stop; stop	Ref. 18,115,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala456Val,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg332X,"p.Arg332X	Frameshift/stop; stop	Refs. 6,13,15",132,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Pro310Arg,"p.Pro310Arg	Nonsyn; Nonsyn	Refs. 2,15",135,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu99Gln,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val339Met,"S9	M	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Refs. 15,17",140,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gly352Arg,"S17	F	Homozygous	c.1054G>A	p.Gly352Arg	Nonsyn/splicing	Refs. 6,20",142,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser39Phe,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser39Phe,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.E368K,"...NM2 showed the heterozygous mutation c.1102G > A, p.E368K, already known to be pathogenic in dominan...",48,1017,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"The mutation found in Patient 2 (p.E368K, in exon 8) is the second most frequent in...",52,34,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.K483E,"... assays demonstrated that the MAX p.R60Q and BRAF p.K483E mutations were activating mutations, where...",11,454,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"... included missense mutations in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A ...",110,493,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...F (c.1447A > G, p.K483E), and RPTOR (c.2252C > T, p.A751V), and a nonsense mutation in ROS1 (c.1176 ...",110,582,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...tation in ROS1 (c.1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mutations had allelic f...",110,659,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,The identified TP53 (p.R248Q) mutation is a previously described gain-o...,112,22,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...ggested by the high allelic frequencies for TP53 (p.R248Q) and APC (p.R790*) mutations, we confirmed...",117,414,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"... and differentiation (reviewed in [37, 38]). MAX (p.R60Q) is the most common MAX gene mutation repor...",128,362,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... left. e, f Structures of wild-type BRAF and BRAF p.K483E mutant. e Model of the BRAF kinase domain ...",128,3282,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... left. e, f Structures of wild-type BRAF and BRAF p.K483E mutant. e Model of the BRAF kinase domain ...",128,3282,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...s of the H-bond between Arg 60 and DNA in the MAX p.R60Q mutant. Overall, our analysis predicts that...",135,302,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...tant. Overall, our analysis predicts that the MAX p.R60Q mutant could form a stable heterodimer with...",135,361,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...ural and biochemical results suggest that the MAX p.R60Q mutation inhibits MAX homodimerization, but...",135,863,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...f mTOR [47, 48]. Analysis of the identified RPTOR p.A751V mutation by PolyPhen, SIFT, and PROVEAN [4...",138,370,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...R or mTOR substrates [52]. In addition, the RPTOR p.A751V mutation has been reported in The 1000 Gen...",138,901,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...nt within the human population [53]. Hence, RPTOR p.A751V mutation would not be expected to negative...",138,1107,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...nt within the human population [53]. Hence, RPTOR p.A751V mutation would not be expected to negative...",138,1107,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,Functional characterization of BRAF p.K483,140,37,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...RAF mutants with no kinase activity, such as BRAF p.D594A, are able to promote ERK phosphorylation b...",169,231,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... of the dimer [58, 76]. We demonstrated that BRAF p.K483E expression increased ERK1/2 activation des...",169,378,Genome_Med_2016_Oct_31_8_116.txt
p.C634R,"...mutations; 7 families had MEN2A (p.C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1], p.C618R [n = 1])...",45,497,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...d FMTC (p.C618Y [n = 1]), and 1 family had MEN2B (p.M918T [n = 1]). Of the 33 MEN2 patients, 32 (97%...",45,610,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,  F1	2	1/1	28-58	p.C634F	43.0	1/26,66,18,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,  F1	2	1/1	28-58	p.C634F	43.0	1/26,66,18,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F5	3	2/1	19-32	p.C634R	24.7	2/40.5,70,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F6	6	4/2	19-65	p.C634R	33.5	1/21,71,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R, F7	3	1/2	21-36	p.C618R	27.3	1/40,72,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y, F8	8	2/6	24-78	p.C618Y	45.3	-,74,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F, p.C634F/Y/R	21	12	9,106,2,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"... heterozygous missense mutations within exons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y ...",227,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n ...",227,219,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"... = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T...",227,237,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...= 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was sur...",227,258,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...= 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was surprising to find that i...",227,280,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...s in codon 634 and is most commonly identified as p.C634Y, and almost never p.C634R [25]. It has bee...",236,261,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"... commonly identified as p.C634Y, and almost never p.C634R [25]. It has been previously suggested tha...",236,287,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"... In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1), only 2 proband...",238,194,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.R515W,p.R515,239,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R512Q,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R621Q,p.R621Q	No,252,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R563H,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.C641R,p.C641,283,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.C641R,p.C641,283,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R351*,p.R351,302,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,347,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.D719G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.S630P,A1371	2	H	c.1888T>C	p.S630P	Yes,468,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P721S,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,523,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,523,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,534,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L1551P,F871	1	H	c.4652T>C	p.L1551P	Yes,541,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1528H,c.1412delG	p.R1528,556,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L78Pfs,Fam9	1	H	c.233_234del	p.L78Pfs*2	Yes,566,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A966Pfs,p.A966Pfs*8,585,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G115Kfs,p.G115Kfs*,602,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G115Kfs,p.G115Kfs*,613,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q356Pfs,c.1066dupC	p.Q356Pfs*23	Yes,620,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q318Pfs,MTI-131	2	H	c.953_954AGdel	p.Q318Pfs*5	Yes	novel	Emirati	This study,635,29,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,652,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,663,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,p.G2663Afs*4,734,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.M843Efs,ND	1	H	c.2527_2528delAT	p.M843Efs*25	Yes,745,26,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L292P,... impairment. Here we describe a missense variant (p.L292P) within a mutation-rich region of FRMD7 de...,15,192,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.I240T,"...Z, Sun J et al. Identifcation of a novel mutation p.I240T in the FRMD7 gene in a family with congeni...",91,88,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.Arg44Gln,"...ly reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in...",26,938,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg44Gln,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/total	−/−	+/+	−/−	+/+	...,52,38,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg103X,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/total	−/−	+/+	−/−	+/+	...,63,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg103X,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/total	−/−	+/+	−/−	+/+	...,63,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg103X,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/total	−/−	+/+	−/−	+/+	...,63,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg203X,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/partial	−/−	+/+	−/−	...,66,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg203X,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/partial	−/−	+/+	−/−	...,66,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Glu268X,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/total	−/−	−/−	−/−	+/+	...,70,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.D1854N,...ant predicted a missense substitution (c.5560G>A; p.D1854N) at a conserved residue within the cataly...,3,2559,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,...n 48 is predicted to result in a missense change (p.D1854N) in the kinase-binding domain of the prot...,46,1658,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.G608G,"... mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does not result i...",10,332,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.A152T,"...generative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia...",178,208,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.R27Lfs,... form of HSP with cognitive decline (12). Patient p.R27Lfs*3 is a woman in her 80s who initially pre...,81,287,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.L1679Rfs,...her from Syria carries the homozygous c.5036delT (p.L1679Rfs*1687) mutation (10). One SPG11 patient ...,83,284,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.H65R,Heme binding pocket	p.H65R	c.194A>G	22.01	30.30	S	3	PE: 11.5% WT activ...,20,21,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,p.T262R	c.785C>G	0.14	0.20	B	1,21,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,Other locations in active core	p.E144K	c.430G>A	0.10	0.20	B	12	ECE: <1%WT activit...,23,32,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,p.C165Y	c.494G>A	1.85	3.00	B	8	ECE: 0–3%WT activit...,24,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, ...",25,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,p.I278T	c.833T>C	0.00	0.00	B	146	PE: Vmax 0.8–1.4%...,26,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,p.P49L	c.146C>T	35.01	61.90	S	3,27,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,p.K102N	c.306G>C	17.74	43.40	S	1	ECE: 21–34%WT act...,28,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,p.A114V	c.341C>T	8.94	18.07	S	10	ECE: tetramer + a...,34,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,"p.E176K	c.526G>A	16.35	26.60	S	2	ECE: aggregates, ...",35,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [J...,39,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...92]. Seven mutant plasmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), ...",58,159,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"...T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared using the previously descri...",58,299,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...t with the wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have c...",65,246,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...t with the wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have c...",65,246,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...pe CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effect...",65,264,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,"...ontained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant pro...",78,635,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins exp...",78,644,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins expressed at 18°C",78,666,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"... included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D...",88,387,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"... the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. Thi...",88,396,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...14V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was...",88,405,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"...e larger than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to burie...",108,1562,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,"...see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any measurabl...",118,239,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,Active site	B	p.G148R	0.2±0.1	0.2±0.2	0.3±0.3	0.4±0.1	N/A	N/A,127,15,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,Active site	B	p.G148R	0.2±0.1	0.2±0.2	0.3±0.3	0.4±0.1	N/A	N/A,127,15,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,B	p.G305R	n.d.	n.d.	n.d.	0.4±0.02	N/A	N/A,128,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,B	p.G307S	0.3±0.02	0.2±0.1	0.4±0.01	0.5±0.2	N/A	N/A,129,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,B	p.T262R	n.d.	n.d.	n.d.	0.2±0.2	N/A	N/A,131,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,Other locations in active core	B	p.E144K	0.6±0.4	0.9±0.6	0.5±0.5	3.3±2.8	N/A	N/A,133,34,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,Other locations in active core	B	p.E144K	0.6±0.4	0.9±0.6	0.5±0.5	3.3±2.8	N/A	N/A,133,34,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,S	p.K102N	8.8±1.7	25.7±4.3	9.2±0.9	13.6±10.2	58.2±44...,138,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,S	p.K102N	8.8±1.7	25.7±4.3	9.2±0.9	13.6±10.2	58.2±44...,138,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,S	p.R125Q	2.3±0.3	8.1±2.5	2.7±0.3	19.4±8.8	141.8±78....,139,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,S	p.R369C	2.5±0.4	6.4±0.3	2.4±0.1	13.1±0.4	57.5±8.1	...,142,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,S	p.D444N	233.7±39.9	817.9±101.5	313.6±22.6	117.0±27...,151,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,S	p.D444N	233.7±39.9	817.9±101.5	313.6±22.6	117.0±27...,151,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,Regulatory domain – second CBS domain	B	p.L539S	1.2±0.1	1.2±0.1	1.6±0.2	4.1±0.2	N/A	N/A,153,41,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,Regulatory domain – second CBS domain	B	p.L539S	1.2±0.1	1.2±0.1	1.6±0.2	4.1±0.2	N/A	N/A,153,41,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,"... p.E302K was inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibited by bo...",165,461,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,".... In addition, mutations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I27...",165,582,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"... p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated by AdoMet to an extent ...",165,640,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...amers/oligomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p....",168,1066,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...amers/oligomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p....",168,1066,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...gomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. Ho...",168,1075,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...S, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, this folding promot...",168,1101,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...d type at 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exh...",170,208,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...d type at 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exh...",170,208,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...e Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than a...",170,226,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximat...",170,235,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...rroring the increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V...",175,654,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...nts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in...",175,680,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"...etramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in amounts...",175,688,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,...requency and pathogenicity of mutation c.1105C T (p.R369C) in the cystathionine β-synthase gene J Pe...,212,176,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.Ser2Gly,"...d caused by the invariant c.4A>G missense change (p.Ser2Gly) in SHOC2 [Cordeddu et al., 2009], a sca...",12,2282,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Glu26Lys,...ctural variant of normal hemoglobin (HBB c.79G>A; p.Glu26Lys) affecting the production rate of HbA. ...,29,64,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...e opposite domain I. C: Phe215, which harbors the p.Phe215Ser substitution, is a conserved interface...",104,520,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ser193Asn,p.Ser193Asn	9	Ser(100.0%)	0 D	0.754 Poss D	60 D	Li...,116,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly200Ser,p.Gly200Ser	9	Gly(100.0%)	0.02 D	0.252 T	90 D	Like...,117,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asp277Tyr,"p.Asp277Tyr	5	Asp(77.8%), Asn(16.7%), Pro(5.6%)	0 ...",119,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asp277Tyr,"p.Asp277Tyr	5	Asp(77.8%), Asn(16.7%), Pro(5.6%)	0 ...",119,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val	8	Ala(94.4%), Phe(5.6%)	0 D	0.986 D	80...",124,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val	8	Ala(94.4%), Phe(5.6%)	0 D	0.986 D	80...",124,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"p.Gly678Arg	1	Gly(61.1%), Leu(22.2%), Thr, Ser and...",128,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu977Pro,p.Leu977Pro	9	Leu(100.0%)	0 D	1.00 D	92 D	Likely d...,131,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ser193Asn,"p.Ser193Asn, homozygous in FGD patient [Meimaridou...",138,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"p.His365Pro, homozygous in an FGD patient [Meimari...",153,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Pro437Leu,"p.Pro437Leu, found in compound heterozygosity in a...",159,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Pro437Leu,"p.Pro437Leu, found in compound heterozygosity in a...",159,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val, homozygous in an FGD patient [Meimari...",162,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"p.Gly678Arg, found in a patient with FGD in compou...",168,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,...ient with FGD in compound heterozygosity with the p.Gly862Asp change described below [Meimaridou et ...,168,78,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,p.Ala1008Pro and p.Asn1009Lys. Both variations were found in patien...,177,18,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"... Both variations were found in patients with FGD: p.Ala1008Pro was present in homozygosity, whereas ...",177,81,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...p.Ala1008Pro was present in homozygosity, whereas p.Asn1009Lys was in compound heterozygosity with p...",177,131,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val	ENST00000264663.5:c.2977A > G	PASS	Mis...,187,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,p.Arg27His	ENST00000264663.5:c.80G > A	PASS	Missen...,189,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser	ENST00000264663.5:c.1765A > T	PASS	Mis...,190,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser (rs370370846) Thr589 is part of a loop...,198,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val (rs78818665) Ile993 is located within ...,207,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"...e for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that t...",220,266,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Q1028Q,...o patients showed the presence of silent mutation p.Q1028Q present in exon 14. Another silent mutati...,13,253,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...1028Q present in exon 14. Another silent mutation p.T428T was observed in a patient with gonadal dys...,13,306,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,"....999 indicating to be pathogenic mutation. Since, p.D806N mutation was found to be important residue...",13,809,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...n identified. The missense mutation (c.2416 G > A p.D806N; rs702689) was identified in exon 14 [Figu...,40,340,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,...nts (2-4 and 7). The silent mutation (c.3084A > G p.Q1028Q; rs3822625) was also identified in patien...,40,475,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,In-silico analysis of p.D806N missense mutation has been carried out to ...,44,23,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,... sequence alignment and weblogo revealed that the p.D806N was well conserved across species [Figure ...,44,1268,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,"In four of our patients, a missense mutation p.D806N was identified in exon 14 which of caused ...",55,46,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...eletion mutation (p.T942ins) and silent mutation (p.T428T) were identified in patient 10. The clinic...,59,103,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...eletion mutation (p.T942ins) and silent mutation (p.T428T) were identified in patient 10. The clinic...,59,103,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Pro62Arg,"...ct the basic domain. The sixth missense mutation, p.Pro62Arg, alters the PY motif in the transactiva...",47,1167,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
p.Val501Gly,"...87186Clinical StudyA Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid peroxidase Ge...",3,187,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...yses using PolyPhen-2 and SIFT predicted that the p.Val501Gly mutation is functionally “damaging.” T...,17,1339,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... change from valine to glycine at amino acid 501 (p.Val501Gly). In addition, other documented polymo...",42,223,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... change from valine to glycine at amino acid 501 (p.Val501Gly). In addition, other documented polymo...",42,223,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...ide chain, due to Gly-501 lacking a side chain in p.Val501Gly mutant TPO, could alter the hydrophobi...",55,810,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Pro499Leu,"...terestingly, Rivolta et al. in 2003 reported that p.Pro499Leu mutation in the TPO which is also loca...",55,980,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...onstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene which could be associ...",58,72,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...substitution of valine by glycine at residue 501 (p.Val501Gly),66,400,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Q36H,"...ieck L  Chiesa A  Targovnik HM   Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dua...",81,104,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.A348V,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R17Q,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R261H,HARS	chr5:140056309	NM_001289093	Exon7	c.782G>A	p.R261H	Tolerated	Het	0.0010	AD/AR	UHS3B,78,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.V78M,...SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD10/RP35,81,52,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.E4784K,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.E4784K,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.F329I,WFS1	chr4:6302507	NM_001145853	Exon8	c.985T>A	p.F329I	Probably damaging	Het	–	AD/AR	Wolfram synd...,83,48,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.M337V,p.M337V-hTDP-43 mt-TAR5/6	M337V-hTDP-43	Thy 1.2	O	...,183,1,Int_J_Mol_Sci_2013_Oct_9_14(10)_20079-20111.txt
p.Tyr85Cys,"c.254A>G (A374G, p.Tyr85Cys)	Iranian Jewish	Björses et al. (2000) [...",98,18,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Val259Phe,...3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was initiated o...,16,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
p.L33P,"...in GPIIIa gene causes an amino acid substitution (p.L33P), leads to the creation of two distinct for...",27,535,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
p.Gly202Arg,"...cid exchange of glycine to argenine at codon 202 (p.Gly202Arg/G202R). In this way, his healthy paren...",221,260,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
p.Ser2Gly,"...riant mutation in SHOC2, c.4A > G, predicting the p.Ser2Gly change in the encoded protein, underlies...",12,105,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly)",66,174,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly)",66,174,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Val244Leu,...on 23710.1186/s13052-016-0237-8Case ReportA novel p.Val244Leu mutation in MFN2 leads to Charcot-Mari...,3,136,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...with specific clinical features [11]. c.730G > A (p.Val244Met), a mutation occurring at the same pos...",53,942,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"... leucine and may affect protein features. Second, p.Val244Leu in MFN2 was predicted to be disease-ca...",55,338,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.His586Pro,...) predicting the amino acid substitution mutation p.His586Pro in the desmoplakin polypeptide,52,813,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...are consistent with the de novo missense mutation p.His586Pro in DSP being the causative genetic les...,58,659,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ile776Val,DSC2	Desmocollin 2	p.Ile776Val	Het	rs1893963	0.1965,118,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg142His,JUP	Plakoglobin	p.Arg142His	Het	rs41283425	0.0240,120,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gln433Arg,EVPL	Envoplakin	p.Gln433Arg	Het	rs2071192	0.3241,127,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg300Trp,"...erent missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4, 5, 11), p.Ile322Thr (f...",60,542,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"...erent missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4, 5, 11), p.Ile322Thr (f...",60,542,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"(36). The second missense mutation in exon 5, p.Arg300Trp, affects the last amino acid of the LA...",61,47,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also...",67,20,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also predicted to alter TGFB3 func...",67,50,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also predicted to alter TGFB3 func...",67,50,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Cys409Tyr,"...ypothesized that the mutated, inactivated allele (p.Cys409Tyr) leads to a nonfunctional protein, dec...",80,1379,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Cys409Tyr,...and the patient reported by Rienhoff et al. (16) (p.Cys409Tyr) presented with short stature (5th per...,82,235,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,...11; p.Asp263His: Family 3; p.Leu401Pro: Family 8; p.Ile322Thr: Family 10). Previously published muta...,125,389,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"... whereas the mutant side chain is in red. For the p.Arg300Trp mutation, side chains of nearby negati...",129,951,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,... in a Human Subject With TGFB3 Mutation (3-III:1; p.Asp263His,131,141,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Q463X,"...yosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in patient III4...",72,75,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.E334K,"....1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p.E334K)",74,141,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.R332W,"...8), who identified a homozygous missense variant (p.R332W) in all affected members of the Turkish co...",72,755,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.I12T,"...er D1S1661 were obtained. BSND mutation, that is, p.I12T, cosegregated in all extant members of our ...",15,1064,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
p.Thr173Met,"...Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identi...",51,735,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...BM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identified, plus three previous...",51,760,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",51,858,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults fro...",51,908,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults fro...",51,908,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,...onsequent effect on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST ...,51,1552,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...ied two novel missense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as ...",81,61,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...P5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as three previously reported...",81,86,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...V and VII impairment in female aged 21 years with p.Ala242Thr substitution (pedigree 3),352,386,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,...hritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a man aged ...,357,170,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...acking in this region is favored. The site of the p.Ala242Thr mutation is only 10 Å from the SOST pe...,363,153,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,... the mutant arginine side chain can be tolerated. p.Gln89Arg is a reported SNP (rs41494349) with min...,372,90,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"... functional consequences presented here. The LRP5 p.Asn198Ser mutation, seen in our most extreme HBM...",388,191,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...e in LRP5 HBM.43 Our most frequent LRP5 mutation (p.Ala242Thr), associated with BMD Z‐scores +3.1 to...",388,765,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...e in LRP5 HBM.43 Our most frequent LRP5 mutation (p.Ala242Thr), associated with BMD Z‐scores +3.1 to...",388,765,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,... DNA was available from relatives). Interestingly p.Gln89Arg was also identified in one of the first...,393,110,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,... DNA was available from relatives). Interestingly p.Gln89Arg was also identified in one of the first...,393,110,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"LRP5 mutation p.Thr173Met, identified in one isolated HBM case, ...",396,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although without modeling t...",398,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although without modeling t...",398,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,".... Interestingly, two LRP5 HBM cases (p.Arg266Cys; p.Asn198Ser) still had high BMD despite long‐term ...",400,1264,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.L450X,... gene that caused truncation of the Wip1 protein (p.L450,111,56,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.L450X,... gene that caused truncation of the Wip1 protein (p.L450,111,56,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.R458X,"S1). All identified Wip1-truncating mutations (p.R458X, p.L484X",290,48,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.L484X,"...ll identified Wip1-truncating mutations (p.R458X, p.L484X",290,57,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.K535X,"p.K535X, and p.F534X) and showed a striking simila...",291,1,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.F99S,...dysfunctional as well due to a missense mutation (p.F99S) or normal (henceforth designated XPB−/− an...,24,242,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.E1099K,"...nd to harbour somatic mutations in NSD2, with the p.E1099K alteration being most prevalent (15/19 ca...",72,1138,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.E1099K,"...nd to harbour somatic mutations in NSD2, with the p.E1099K alteration being most prevalent (15/19 ca...",72,1138,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.E1099K,"...nd to harbour somatic mutations in NSD2, with the p.E1099K alteration being most prevalent (15/19 ca...",72,1138,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.H1047R,"155	45	OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)...",39,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047R,"...OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H168R,"140	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V272E,"149	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"148	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"...	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"...	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"...	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"...	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245S,"144	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245S,"144	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"...	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G13D,"..., partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M1004V,"198	59	OC	Serous	IVB	G3	NA	PIK3CA p.M1004V, c.3010A>G (1)",60,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G262V,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,32,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G262V,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,32,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R282W,"..., spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,87,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.S37F,"203	55	EC	EC	IA	G1	NA	CTNNB1 p.S37F, c.110C>T (1)",69,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.S37F,"203	55	EC	EC	IA	G1	NA	CTNNB1 p.S37F, c.110C>T (1)",69,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"...infertility, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"193	54	B	Inclusion cysts			—	KRAS p.G12D, c.35G>A (1)",77,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C242F,"...	39	BC	Breast cancer, uterine leiomyoma			NA	TP53 p.C242F, c.725G>T (1)	Germline mutation",78,55,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.N239D,"...ing carcinoma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors...",79,116,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C238R,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C238R,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C238R,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Ala726Thr,"...reported (25) paternally inherited ABCC8 variant (p.Ala726Thr), but current evidence suggests that t...",112,783,J_Clin_Res_Pediatr_Endocrinol_2016_Jun_6_8(2)_197-204.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer ...,183,285,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer ...,183,285,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer 2014 14 13 10.11...,183,301,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.Ser49Cys,...exander BH  Doody MM    The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cance...,287,109,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
p.Ser49Cys,...exander BH  Doody MM    The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cance...,287,109,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
p.Arg63Trp,...19110.1084/jem.20102191Brief Definitive ReportThe p.Arg63Trp polymorphism controls Vav1 functions an...,3,174,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...19110.1084/jem.20102191Brief Definitive ReportThe p.Arg63Trp polymorphism controls Vav1 functions an...,3,174,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...19110.1084/jem.20102191Brief Definitive ReportThe p.Arg63Trp polymorphism controls Vav1 functions an...,3,174,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,... the substitution of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is assoc...,9,588,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is associated with increas...,9,606,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...on of an arginine by a tryptophan at position 63 (p.Arg63Trp or R63W). Associated with this substitu...,15,564,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Thr1356Ala,C3	Ex32/c.4109 A>G	p.Thr1356Ala	G	A	A	A	A	G	A,41,20,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.L1206V,ATM	c.3616T>G	p.L1206V	10	Tolerated	Benign,31,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V849A,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A9G,DDB1	c.26C>G	p.A9G	86	Damaging	Damaging (possibly),37,14,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K471R,EXO1	c.1412A>G	p.K471R	18	Tolerated	Benign,38,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K543R,MSH6	c.1628A>G	p.K543R	29	Damaging	Benign,41,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.F3418L,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably),43,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.F3418L,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably),43,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R273C,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R273H,TP53	c.818G>A	p.R273H	38	Damaging	Damaging (probably),47,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,...ent targeted SOLiD sequencing. In addition to the p.Q336L somatic mutation and the p.E528K germline ...,61,162,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,...ent targeted SOLiD sequencing. In addition to the p.Q336L somatic mutation and the p.E528K germline ...,61,162,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"...of CHEK2 (Table 2). Five rare variants, including p.E528K, were specific for the patient cohort, as ...",61,629,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,"...ing of CHEK2 transcripts, whereas the p.R117G and p.D438Y substitutions were shown to have deleterio...",61,893,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,"...ples derived from healthy blood donors, where the p.R180C and p.I157T substitutions, previously iden...",61,1390,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,"... from healthy blood donors, where the p.R180C and p.I157T substitutions, previously identified by ge...",61,1402,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	Damaging	Da...,68,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R3W,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	Damag...,70,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R3W,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	Damag...,70,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R3W,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	Damag...,70,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,c.349A>G	p.R117G	rs28909982	1/171	ND	Swedish	0	0	Damaging	D...,71,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006	0.001	Da...,76,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,c.1111C>T	p.H371Y	Reported	2/64	Somatic/germline	Chinese	0.0...,78,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I919T,...lytic domain of the PARP1 protein (p.K633X) and a p.I919T substitution located in the catalytic doma...,81,283,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I919T,...lytic domain of the PARP1 protein (p.K633X) and a p.I919T substitution located in the catalytic doma...,81,283,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,...tic domain of PARP1 (Table 3). Two rare variants (p.Y930C and p.L1013M) were also identified in two ...,81,375,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,...tic domain of PARP1 (Table 3). Two rare variants (p.Y930C and p.L1013M) were also identified in two ...,81,375,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1013M,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0.001	Toler...,91,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I169V,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	Tolerated	B...,95,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I169V,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	Tolerated	B...,95,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K122R,c.365A>G	p.K122R	454 amplicon	Novel	ND	Chinese	0	Damaging	D...,102,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1111F,c.3331C>T	p.L1111F	Selector	Novel	Germline	Chinese	0	Damagin...,106,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1111F,c.3331C>T	p.L1111F	Selector	Novel	Germline	Chinese	0	Damagin...,106,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Damaging	...,107,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,...encing. In addition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter appr...,112,158,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,"...ddition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter approach, anothe...",112,170,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R847K,"...e sequencing–presented somatic mutations in PMS1 (p.R847K) and MLH1 (p.A223D), respectively. The DLB...",124,1117,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R847K,"...e sequencing–presented somatic mutations in PMS1 (p.R847K) and MLH1 (p.A223D), respectively. The DLB...",124,1117,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R486X,"...iency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P...",96,274,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.M147V,"...e 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G39...",34,60,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.K369E,"...tions (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A43...",34,78,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A434T,"...97Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S53...",34,123,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A434T,"...97Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S53...",34,123,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T527P,"...92Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S65...",34,150,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.I529S,"...96E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V65...",34,159,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S532I,"...10M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S66...",34,168,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.C565Y,"...34T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T72...",34,177,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S657N,"...48L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p....",34,195,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S666F,"...29S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluat...",34,213,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S666F,"...29S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluat...",34,213,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...are two frequent mutations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent ...",56,306,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...are two frequent mutations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent ...",56,306,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ns in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent in the Japanese and Kore...",56,330,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ients homozygous for the most prevalent mutation, p.H723R, hearing level at low frequency varied fro...",60,739,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu183Pro,"...veral yeast models with NARP-MILS mutations (atp6-p.Leu183Pro (Kucharczyk et al. 2009a, b, c), atp6-...",99,2154,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Tyr12Cys,"Recently, a homozygous missense mutation c.35A>G (p.Tyr12Cys) has been described in exon 2 of the AT...",121,51,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Arg386Cys,"... are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T...",164,736,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Arg386Cys,"... are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T...",164,736,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"... population-dependent. For example, the c.337A>T (p.Ile113Phe) mutation was actually found to be muc...",164,1060,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"... population-dependent. For example, the c.337A>T (p.Ile113Phe) mutation was actually found to be muc...",164,1060,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.R152W,"M	5.0	0.7	7.6	454 C > T (p.R152W), exon 2	454 C > T (p.R152W), exon 2	Slow	...",55,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"3	M	.6	1.9	2.3	971 G > T (p.G324V), exon 5	971 G > T (p.G324V), exon 5	Rapid...",57,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.V323G,"...1.2	2.8	3.0	995 T > G (p.V323G), exon5	995 T > G (p.V323G), exon5	Rapid	554 (194)	Y	Y	N	4	4	Y	N",58,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"6	M	.8	5.1	5.9	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	207 (145)...",60,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"M	3.0	5.8	6.2	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	158 (145)...",62,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"9	F	2.0	7.8	8.3	454C > T (p.R152W), exon 2	454C > T (p.R152W), exon 2	Slow	2...",64,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"10	M	7.0	10.1	18.3	454 C > T (p.R152W), exon2	454 C > T (p.R152W), exon2	Slow	10...",65,31,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,...	M	9.0	10.2	10.7	629 A > G (p.Y210C)	937 (C > G) (p.P313A)	Slow	193 (107)	N	N	Y	6	5	N	N,66,53,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...consisted of patients who were homozygous for the p.R152W mutation (n = 3, all of Turkish Ancestry)....",108,132,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"... p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry). The third ...",108,255,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"... p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry). The third ...",108,255,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"...tion, we note that the group of patients with the p.Y210C mutation performed best (Karageorgos et al...",159,101,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"...tion, we note that the group of patients with the p.Y210C mutation performed best (Karageorgos et al...",159,101,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,...t was reported by Swiedler et al. (2005) that the p.Y210C mutation was associated with low GAG excre...,159,430,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...e of the four children, p.Y210C was combined with p.R327X, a nonsense mutation leading to no product...",159,561,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G12S,...0.1038/jid.2013.430nihpa529559ArticleSomatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal N...,3,166,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,...0.1038/jid.2013.430nihpa529559ArticleSomatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal N...,3,166,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...from affected individual WHN101, finding the HRAS p.G12S mutation in curly hair only (Figure 2d, Sup...",15,813,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...m germline heterozygous HRAS mutations, including p.G12S (Gripp and Lin, 2012; Siegel et al., 2012)....",17,564,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...ts, 64 additional samples were screened, and HRAS p.G12S mutations were not found (Levinsohn et al.,...",21,307,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"... al., 2013). In one report, 3 specimens with HRAS p.G12S mutations were identified; in 2 there was a...",21,420,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G13R,"...were identified; in 2 there was a concurrent HRAS p.G13R mutation, and in one, the lesion was on the...",21,487,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...d tissue of WHN100 and WHN101 confirmed this HRAS p.G12S mutation. (c) In WHN100, there is a small m...",50,726,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.S200N,"...se determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulation of NF-κB,...",16,1180,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L228R,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolerated	Pathol...",45,40,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathological	Neutr...",47,37,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.Pro534Leu,"...67X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missen...",36,137,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
p.Pro534Leu,...oded by one of 47 CpGs in the PHEX gene (15). The p.Pro534Leu mutation seems to affect the local hyd...,43,211,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
p.Gly303Arg,... of the nine predicted transmembrane domains. The p.Gly303Arg mutation was previously reported in Ja...,29,231,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Gln224Lys,...d previously described mutations in this loop are p.Gln224Lys and p. Arg228Trp (18). Three mutations...,29,540,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Q79X,"...nd, compound heterozygous mutations (p.M515fsX563/p.Q79X) have been identified. In the present study...",53,213,J_Lipid_Res_2015_Nov_56(11)_2172-2182.txt
p.Ala52Ser,"...68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser) [13]. The functional analysis performe...",35,963,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Trp68Cys,...reported missense mutations in this region (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) a...,35,1604,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...at this novel missense sequence change (c.211A/T, p.Ile71Phe) identified in the index patient is a d...",37,205,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...at this novel missense sequence change (c.211A/T, p.Ile71Phe) identified in the index patient is a d...",37,205,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Asp180Gly,...nt 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probably damaging	Possibly damaging	94...,119,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Lys259Glu,...0	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0.00	C55	...,160,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ser189Leu,...25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 806	VUS3...,165,59,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ser189Leu,...25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 806	VUS3...,165,59,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.R386C,"...ingle de novo known pathogenic mutation in GALNS (p.R386C), suggesting the presence of a second muta...",183,76,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.R386C,"...ingle de novo known pathogenic mutation in GALNS (p.R386C), suggesting the presence of a second muta...",183,76,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.E197X,"...mozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Figure 2). Th...",30,352,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys300Gly,3	c.898T>G (p.Cys300Gly)	Pathogeni,102,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys148Tyr,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys126Arg,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys126Arg,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys126Arg,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys126Arg,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys77Tyr,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.R1441C,...ytemans K Rademakers R Theuns J  Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,68,53,J_Mol_Neurosci_2011_Nov_26_45(3)_516-521.txt
p.Q61K,"...fied missense mutations included MAP3K5 and NRAS (p.Q61K; Figure 3; see also supplementary material,...",116,865,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.Q61K,"...fied missense mutations included MAP3K5 and NRAS (p.Q61K; Figure 3; see also supplementary material,...",116,865,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G12C,"...changing KRAS mutations; MAP polyp 1B4S carried a p.G12C, while FAP polyps 12A11S and 9A5S carried p...",116,1186,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G12C,"...changing KRAS mutations; MAP polyp 1B4S carried a p.G12C, while FAP polyps 12A11S and 9A5S carried p...",116,1186,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.A146T,"... p.G12C, while FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of t...",116,1235,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.A146T,"... p.G12C, while FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of t...",116,1235,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.E411X,...ed truncating somatic WTX mutations (at positions p.E411X and p.E558X,130,883,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.C1139Wfs,"...gous gene deletion. Patients with mild TBS due to p.C1139Wfs*14 mutation, which partially undergo NM...",68,1502,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.Cys157Tyr,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,11,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Ser1008Leu,c.3023C>T; p.Ser1008Leu	1.15,195,13,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Glu936Asp,"...S15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs2796267),...",220,299,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Glu936Asp,"...S15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs2796267),...",220,299,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,The CFB variant p.Asp371Gly (patient 8) has not previously been de...,250,17,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.L858R,"...n 21 that changes the leucine 858 in an arginine (p.L858R). Concerning rare alterations, about 3% of...",23,201,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...n 21 that changes the leucine 858 in an arginine (p.L858R). Concerning rare alterations, about 3% of...",23,201,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...nce: -i- is EGFR mutation distribution, including p.T790M, heterogeneous within the primary tumor?; ...",39,123,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P21	p.G719A	5	0	2	0	7	7	0	 ,102,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P32	p.L858R	0	3	0	1	4	4	0	 ,113,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	3	3	0	 ,117,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	3	3	0	 ,118,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P39	p.L858R	3	0	0	0	3	3	0	 ,120,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...tions (DEL19), exon 20 insertions (INS20) and the p.L858R mutation along with KRAS and HER2 exon 20 ...",130,135,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...EGFR codons 719, 861 and mutated samples for EGFR p.T790M. The 153 fragments generated from mutated ...",130,297,J_Transl_Med_2014_May_16_12_131.txt
p.G719X,"...utation panel (DEL19, INS20, p.L858R, p.L861Q and p.G719X)",130,537,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...ic TaqMan PCR technology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p....",132,534,J_Transl_Med_2014_May_16_12_131.txt
p.G719S,"...AST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using s...",132,561,J_Transl_Med_2014_May_16_12_131.txt
p.G719S,"...AST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using s...",132,561,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...en patients had an exon 19 deletion (DEL19), 12 a p.L858R point mutation, 6 an exon 20 insertion (IN...",143,294,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 patients, ...",143,387,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 patients, ...",143,387,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...here was no discordance for samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Tab...",144,102,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...here was no discordance for samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Tab...",144,102,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"...samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Table",144,130,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P20	p.G719A	1	0	4	0	1	2	2,202,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	 	3	 ,213,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	 	6	 ,217,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	 	2	1,218,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	 	2	1,219,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P38	p.L858R	3	0	0	0	1	2	 ,220,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...at were EGFR-TKI naïve. In untreated patient, the p.T790M mutation is usually described as a subclon...",243,135,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,...teration is a driver mutation altogether with the p.L861Q. Routine EGFR testing gives a qualitative ...,244,248,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...esistance. Issues are either the development of a p.T790M or a wild type subclon,314,213,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...esistance. Issues are either the development of a p.T790M or a wild type subclon,314,213,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...wild type this might not have been sufficient for p.T790M subclone detectio,315,234,J_Transl_Med_2014_May_16_12_131.txt
p.P660L,...hese data support the potential conserved role of p.P660L in human TMC1 function,14,157,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,19,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...vel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1030,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,...n; and the green arrow/yellow star represents the p.P660L mutation located within a predicted third ...,83,852,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"... to confer channel function [18]. TMC1 c.1979C>T, p.P660L is located in a predicted third extracellu...",91,739,J_Transl_Med_2016_Jan_28_14_29.txt
p.Tyr657X,...n itself. Cells studied from one patient with the p.Tyr657X PIK3R1 mutation expressed abundant trunc...,3,4180,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"...of whom had an additional rare missense mutation, p.Asp231Ala, in the ADIPOQ gene and severely suppr...",20,192,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,"...latory subunits of PI3K, stood out. The mutation, p.Tyr657X (Y657X) when numbered according to the p...",33,160,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,...ssion of WT p85α or one of two p85α mutants — the p.Tyr657X mutation studied in primary cells and th...,50,271,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...Tyr657X mutation studied in primary cells and the p.Arg649Trp mutation, which accounts for around 50...",50,323,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...null murine fibroblasts stably overexpressing the p.Arg649Trp mutant PIK3R1 (24); however, recruitme...",66,871,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...ared, a knockin mouse heterozygous for the Pik3r1 p.Arg649Trp mutation was reported. While this exhi...",66,1882,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"... of adiponectin, with the approximate site of the p.Asp231Ala (D231A) substitution indicated. SP, si...",149,71,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"... of adiponectin, with the approximate site of the p.Asp231Ala (D231A) substitution indicated. SP, si...",149,71,JCI_Insight_1(17)_e88766.txt
p.L560P,...zygous missense mutations on SLC12A1 (p.C436Y and p.L560P) and atypical clinical and laboratory feat...,3,1906,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,...nificant residual transport activity of the NKCC2 p.F177Y mutant construct in contrast to no activit...,30,1548,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,... intrinsic partial transport defect caused by the p.F177Y mutation. The partial function of NKCC2-F1...,30,1975,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.C436Y,...lso has compound heterozygous missense mutations (p.C436Y and p.L560P). These findings suggested tha...,30,2402,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.H186D,We report a case of PNDM caused by a novel p.H186D heterozygous mutation in the KCNJ11 gene w...,12,44,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.His186Asp,"...chromosome 11p15.1 and encoding Kir6.2, c.556C>G (p.His186Asp), was found (Fig. 1). Genetic study fo...",17,236,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.G13D,...nker DJ  Di Nicolantonio F   Association of KRAS  p.G13D mutation with outcome in patients with chem...,275,68,Lancet_2011_Jun_18_377(9783)_2103-2114.txt
p.Leu279Arg,...a). Pedigree analysis shown that the c.836 T > G (p.Leu279Arg) mutation was from his father and the ...,44,1015,Lipids_Health_Dis_2016_May_6_15_88.txt
p.G1151R,...edigrees (Figure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted ...,43,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...nt alleles by chance. Therefore, we inferred that p.R1604S was causally related to SNHI in family DE...",43,1214,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data are shown on either the ...",47,195,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,Three cases were homozygous for the DFNB59 p.G292R (c.874G > A) variant. This variant was pre...,49,44,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...cordingly, from a statistical perspective, DFNB59 p.G292R might be associated with poor CI performan...",49,641,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...r of 1 patient (DE3039) homozygous for the DFNB59 p.G292R variant, whereas imaging findings were nor...",59,366,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...r of 1 patient (DE3039) homozygous for the DFNB59 p.G292R variant, whereas imaging findings were nor...",59,366,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...15 mutations and 3 were homozygous for the DFNB59 p.G292R variant. The allele frequencies of PCDH15 ...,64,179,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ausative mutation in these 3 patients, the DFNB59 p.G292R variant still might serve as a predictor f...",68,1407,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G3658E,... amino acid change from glycine to glutamic acid (p.G3658E) at a highly conserved residue (Fig. 2) w...,40,676,Meta_Gene_2016_May_18_9_124-127.txt
p.Cys255Tyr,"...9Argfs*10) and would be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of c...",48,354,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys255Tyr,"...9Argfs*10) and would be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of c...",48,354,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,"...ould be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of cysteine in the l...",48,370,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,"...ould be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of cysteine in the l...",48,370,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...demonstrated co-segregation of the novel mutation p.Thr621Arg with the FH phenotype. We also describ...,62,152,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...demonstrated co-segregation of the novel mutation p.Thr621Arg with the FH phenotype. We also describ...,62,152,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,...henotype. We also described the novel mutation of p.Cys329Phe in a previous report [17]. In our stud...,62,227,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,...henotype. We also described the novel mutation of p.Cys329Phe in a previous report [17]. In our stud...,62,227,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...1 Family co-segregation of the novel c.1862C > G (p.Thr621Arg) LDLR mutation. (A) A family pedigree ...,92,56,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...1 Family co-segregation of the novel c.1862C > G (p.Thr621Arg) LDLR mutation. (A) A family pedigree ...,92,56,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys34Gly, c.100T > G	p.Cys34Gly	3	2	Probably damaging	Not tolerated	Dis...,137,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys255Tyr, c.764G > A	p.Cys255Tyr	1	51	Probably damaging	Not tolerated	D...,145,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp266Glu, c.798T > A	p.Asp266Glu	1	5	Probably damaging	Not tolerated	Di...,146,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val523Met, c.1567G > A	p.Val523Met	1	10	benign	Not tolerated	Disease caus...,152,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg574Cys, c.1720C > T	p.Arg574Cys	1	12	Probably damaging	Not tolerated	D...,153,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg, c.1862C > G	p.Thr621Arg	1	131	Probably damaging	Not tolerated	...,157,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly676Arg, c.2026G > C	p.Gly676Arg	1	14	Probably damaging	Not tolerated	D...,159,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro685Leu, c.2054C > T	p.Pro685Leu	1	14	Probably damaging	Not tolerated	D...,161,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro685Leu, c.2054C > T	p.Pro685Leu	1	14	Probably damaging	Not tolerated	D...,161,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala391Thr, c.1171G > A	p.Ala391Thr	3	8	Benign	Tolerated	Polymorphism	No,177,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn640Asn, c.1920C > T	p.Asn640Asn	1	13	n/a	n/a	Polymorphism	No,179,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn640Asn, c.1920C > T	p.Asn640Asn	1	13	n/a	n/a	Polymorphism	No,179,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg744Gln, c.2231G > A	p.Arg744Gln	1	15	Benign	Tolerated	Polymorphism	No,183,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln, c.10580G > A	p.Arg3527Gln	13	APOB ex26	Probably damaging	Not to...,189,15,Metabolism_2016_Mar_65(3)_48-53.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.G320V,"...olaou et al. showed that 80% of HJV mutations are p.G320V, however until now more than 25 different ...",62,1012,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...t cases III-9 and III-7 were homozygotes for HJV (p.C89R,180,118,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...he proband, case III-9 was a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p....",317,122,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...V mutation found in the proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorph...",317,375,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...V mutation found in the proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorph...",317,375,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,The HJV c.265T>C (p.C89R) mutation is a novel mutation and there is ...,336,19,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...m Iran which is reported as a novel HJV mutation (p.C89R),340,447,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.Arg1715His,"...us system, including the cerebellum. The mutation p.Arg1715His, identified in this study, was found ...",8,589,Mol_Brain_2015_Dec_29_8_89.txt
p.Arg1715His,...ocal images of HeLa cells expressing wild-type or p.Arg1715His mutant CaV3.1. HeLa cells were transi...,116,85,Mol_Brain_2015_Dec_29_8_89.txt
p.D620N,...altered by the Parkinson’s disease VPS35 mutation p.D620N Hum Mol Genet 2015 24 6 1691 703 10.1093/h...,169,208,Mol_Brain_2015_Oct_31_8_70.txt
p.Arg226X,(p.Arg226X),86,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Glu470Gln,"We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsense mutatio...",12,43,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Y1945X,"...5A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an affected individual carrying conge...",11,619,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,The p.L1291F model was constructed from the wild-type ...,50,5,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,The p.L1291F model was constructed from the wild-type ...,50,5,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.R1113Vfs,"...r studies in which mutations in exon 2 (p.E1105*, p.R1113Vfs*12 and p.Y289* homozygote), which encod...",66,1192,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,.... (C) Sanger sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozy...,79,490,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,.... (C) Sanger sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozy...,79,490,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Asp1451Asn,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to profound	N...,109,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Lys1557Glu,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to profound	N...,111,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2124Gln,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to profound...,123,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2124Gln,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to profound...,123,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2124Gln,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to profound...,123,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly2244Glu,c.6731G>A	p.Gly2244Glu		Homozygous	Severe to profound	Nal et...,126,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln2716His,"c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd et al., 2...",131,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2792Ala,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to profound	Gao ...,134,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu3160Phe,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to profound...,139,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu3160Phe,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to profound...,139,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu3160Phe,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to profound...,139,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu3160Phe,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to profound...,139,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro221Leu,...CG; p.Val19fs*24) and a point mutation (c.662C>T; p.Pro221Leu). The consanguineous parents carry the...,3,1465,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,...es both the exon 1 (p.Val19fs*24) and the exon 5 (p.Pro221Leu) mutations (Fig. 1b). As the parents a...,16,130,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,...ble. It is difficult to predict the effect of the p.Pro221Leu change by itself: the pathogenicity pr...,38,258,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Arg288Met,...s in the SMN1  gene in Chinese patients with SMA: p.Arg288Met mutations causing SMN1  transcript exc...,68,122,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Arg288Met,...s in the SMN1  gene in Chinese patients with SMA: p.Arg288Met mutations causing SMN1  transcript exc...,68,122,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Q201Rfs,IVS9	c.729+5G>A	p.Q201Rfs*23	f	Novel	44,39,17,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G389Efs,13	c.1166delG	p.G389Efs*5	f	Novel	71,46,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G389Efs,13	c.1166delG	p.G389Efs*5	f	Novel	71,46,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y419Ffs,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (2002)	31,48,19,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D511Mfs,15	c.1531delG	p.D511Mfs*2	i	Novel	23,54,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D511Mfs,15	c.1531delG	p.D511Mfs*2	i	Novel	23,54,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.K654Sfs,18	c.1961_1962delAA	p.K654Sfs*21	f	Novel	43,62,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y69Vfs,IVS2	c.205-2_205-1delAGinsT	p.Y69Vfs*33	f	Stahl et al. (2008)	43,68,29,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.E359Pfs,10	c.1071_1074dupCCCT	p.E359Pfs*2	f	Novel	47,69,23,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D419Gfs,10	c.1255dupG	p.D419Gfs*2	f	Novel	33,70,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L22Pfs,CCM3	4	c.63_64dupCC	p.L22Pfs*13	f	Novel	42,71,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L76P,"... mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other frequent mutations ...",82,1079,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Glu102Gly,"...c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The distribution o...",82,1232,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Asp106Gly,"...ted as pathogenic for a given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1250,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.Y356X,"...tients with PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,637,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...tients with PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,637,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,"...nd previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,655,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...on database). In this study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 ca...",55,209,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...3V) from the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previousl...",55,292,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,Phe/Tyr - 10.97	p.Y356,79,17,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,Phe/Tyr - 10.97	p.Y356,79,17,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,Phe/Tyr - 10.97	p.Y356,79,17,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,Phe/Tyr - 10.97	p.Y356,79,17,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Met1093Ile,"... the identification of a novel missense mutation, p.Met1093Ile QIAO SHU-KAI 12REN HAN-YUN 1REN JIN-H...",3,241,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...und heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this female patient, wi...",3,1830,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...und heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this female patient, wi...",3,1830,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...e, F8 compound heterozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were iden...",12,210,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using multiplex PCR ...",12,237,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using multiplex PCR ...",12,237,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... have often been reported in HA patients (31,32). p.Met1093Ile is a novel missense mutation unreport...",44,1502,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...tructure of the B domain. (C and D) Comparison of p.Val502Asp mutation structural images in A2 domai...,53,609,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R541H,... protein function has revealed that the lamin A/C p.R541H mutation causes the highly conserved seque...,51,442,Mol_Med_Rep_2015_Oct_8_12(4)_5065-5071.txt
p.T528R,... 3. Chromatograms of the heterozygous c.1583 C→G (p.T528R) mutation in exon 9 of LMNA,65,100,Mol_Med_Rep_2015_Oct_8_12(4)_5065-5071.txt
p.N410H,...W  Rademakers R   Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration Acta Neu...,223,229,Mol_Neurodegener_2014_Oct_29_9_43.txt
p.N410H,...W  Rademakers R   Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration Acta Neu...,223,229,Mol_Neurodegener_2014_Oct_29_9_43.txt
p.Tyr402His,...n AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 2006 27 921 5 1686569,223,167,Mol_Vis_2007_Feb_7_13_196-205.txt
p.Tyr402His,...n AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 2006 27 921 5 1686569,223,167,Mol_Vis_2007_Feb_7_13_196-205.txt
p.I459K,"... in compound heterozygosity with p.E402X and with p.I459K	 [2,11]",45,112,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R400W,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.A496T,Exon 14	c.1522 G>A	p.A496T	RP	Found in heterozygosity; second mutant ...,62,20,Mol_Vis_2008_Apr_21_14_675-682.txt
p.Gly140Arg,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Pro192Leu,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,21,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.R733X,... A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2,17,501,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,...G in family F1 and a nonsense mutation c.2197C>T (p.R733X) in family F2 (Figure 3). Using SSCP analy...,111,166,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.Glu150Lys,...sion 2712008MOLVIS307Research ArticleA homozygous p.Glu150Lys mutation in the opsin gene of two Paki...,3,97,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...sion 2712008MOLVIS307Research ArticleA homozygous p.Glu150Lys mutation in the opsin gene of two Paki...,3,97,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...d a homozygous c.448G>A mutation resulting in the p.Glu150Lys amino acid change. This variant was fi...,13,290,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...two Pakistani families studied here share the RHO p.Glu150Lys mutation due to a common ancestry,16,318,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu249Ter,...C3) loops [23]. The first reported null mutation (p.Glu249Ter) associated with arRP was shown to abo...,171,456,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu249Ter,...C3) loops [23]. The first reported null mutation (p.Glu249Ter) associated with arRP was shown to abo...,171,456,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.S138X,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a seven-ye...,31,33,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.S138X,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a seven-ye...,31,33,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],53,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg89Gly,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg89Gly,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr179X,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, retinal d...",68,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr179X,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, retinal d...",68,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Pro133Thr,c.397C>A	p.Pro133Thr	bilateral microphthalmia	[11],71,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.R240X,... c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected members o...,13,430,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.R240X,".... In Family 3, the previously described c.718C>T (p.R240X) nonsense mutation in exon 9 [2,18,19] was...",86,799,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr265Ile, 	c.794C>T	p.Thr265Ile	-	N	Y (hetero) Score=2**	N	Y (hetero),83,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Asp282Asp, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2*	Y (hete...,84,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val116Gly,PTMAP3 (NG_001180)	c.347T>G	p.Val116Gly	-	N*	N*	Y (hetero)	Y (hetero),85,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr121Arg, 	c.362C>G	p.Thr121Arg	-	N*	N*	Y (homo)	Y (homo),87,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys185Arg, 	c.553T>C	p.Cys185Arg	rs3748493	N*	N*	Y (hetero)	Y (homo),89,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys281Cys, 	c.843C>T	p.Cys281Cys	rs3748492	N*	Y (homo) Score=4**	Y (het...,90,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr109Thr,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17	N	Y (het...,92,28,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val400Gly,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y (homo) S...,95,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val400Gly,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y (homo) S...,95,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val400Gly,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y (homo) S...,95,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro46Ala,RPS19P1 (NG_001295)	c.136C>G	p.Pro46Ala	rs2009092	Y (hetero) Score=12	Y (hetero...,109,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.His489Gln, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score=27	N	Y(he...,114,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.His489Gln, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score=27	N	Y(he...,114,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ala, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (homo),118,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro58Ser,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N	Y (het...,131,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro58Ser,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N	Y (het...,131,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gly181Gly,c.543G>T	p.Gly181Gly	rs7262320	Y (hetero) Score=26	N	Y (het...,132,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gly181Gly,c.543G>T	p.Gly181Gly	rs7262320	Y (hetero) Score=26	N	Y (het...,132,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr85Thr,C20orf79 (NM_178483)	c.255C>T	p.Thr85Thr	rs1053834	Y (hetero) Score=25	N	Y (hete...,137,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro99Ser,c.295C>T	p.Pro99Ser	rs1053839	Y (hetero) Score=20	N	Y (hete...,138,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ala123Ala,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26	Y (homo)...,141,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg514Pro,"Two novel mutations, c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) in TGFBI were identifie...",13,46,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"Two novel mutations, c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) in TGFBI were identifie...",13,46,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"...utations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2 and Family...",13,180,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...ctural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,13,598,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...ctural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,13,598,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p. Arg124Cy...",16,45,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...ly 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of TGFBI (F...",61,148,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Family 1, a...",63,79,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... results of the heterozygote mutations c.1876A>G (p.His572Arg) of TGFBI in Family 3, and their corre...",67,70,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...quences of TGFBI displayed a high conservation of p.Arg514Pro and Phe515Leu in the chimpanzee, cow, ...",69,475,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...tion could be detected. In Family 1, the mutation p.Arg514Pro is predicted to shorten the helix and ...",74,257,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,... more phenotypic effects. The mutation c.1876A>G (p.His572Arg) is also identified in Family 3. The p...,77,348,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,... more phenotypic effects. The mutation c.1876A>G (p.His572Arg) is also identified in Family 3. The p...,77,348,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg124Leu,...e. Dighiero and colleagues [10] suggest that both p.Arg124Leu and p.Thr125_Glu126del compound hetero...,79,769,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Ala546Asp,"...rance. The third compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in...",79,1438,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Pro551Gln,"... compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in two non-consang...",79,1454,Mol_Vis_2010_Feb_15_16_224-230.txt
p.K1370E,"...d only in the RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in pri...",15,135,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K663N,"...ly a few missense variants, such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1...",25,1234,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A669T,"...nse variants, such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], hav...",25,1248,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R872H,"...iants were identified (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, an...",46,72,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A1670T,"...ied (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were c...",46,90,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,"... them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registere...",46,110,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,"...R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registered in the SNP d...",46,124,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,"...R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registered in the SNP d...",46,124,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,20,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,Exon 4	c.4955G>T	p.R1652L	Novel	20090	0/190,60,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A1670T,Exon 4	c.5008G>A	p.A1670T	rs446227	44/55	106/190,61,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S1691P,Exon 4	c.5071T>C	p.S1691P	rs414352	44/55	106/190,62,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,Exon 4	c.6098G>A	p.C2033Y	rs61739567	20149	27/190,65,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,...jects from different areas of China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to...,69,258,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...lead to amino acid change, while the other three (p.I408L, p.K1370E, and p.R1652L) were missense cha...",69,351,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,The impact of variant p.I408L was predicted to be “Borderline” by PolyPh...,71,23,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...Grantham score was 5. Based on these assessments, p.I408L is less likely to be a disease-causing mut...",71,224,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...Grantham score was 5. Based on these assessments, p.I408L is less likely to be a disease-causing mut...",71,224,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...was 56, being moderately conservative. Therefore, p.K1370E is potentially disease causing. For the p...",71,572,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... p.K1370E is potentially disease causing. For the p.R1652L variant, the predictions were “Possibly d...",71,621,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...Determination of the evolutionary conservation of p.K1370E and p.R1652L by multiple amino acid seque...,71,1190,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,Exon 4	c.1222A>C	p.I408L	adRP	F	56	0/552	Borderline	1.234	Tolerant	...,76,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... RP1 wild type protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based ...",81,134,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...due 1370. B. Difference between wild type and the p.R1652L variant, at position around residue 1652....",90,129,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...-be-identified mutation. In contrast, the variant p.R1652L was likely to be a deleterious substituti...",95,1689,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ypeptide where many mutations occur. Furthermore, p.R1652L was predicted to abolish one possible pro...",95,2109,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...he truncation mutation carrier [29]. Notably, the p.R1652L and p.K1370E carriers were classified as ...",95,2784,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...sentations of the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear ...,97,83,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ographs and automated visual field reports of the p.R1652L carrier, showing much milder clinical man...",97,365,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ographs and automated visual field reports of the p.R1652L carrier, showing much milder clinical man...",97,365,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,"...ies, we identified two RP1 mutations, p.R677X and p.D984G, in two out of 173 Hong Kong Chinese RP pa...",99,71,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...mited. Recently, Sheng et al. [30] identified the p.N985Y variant as the disease-causing mutation fo...",99,596,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P63I,"...eng et al., [30] another three missense variants (p.P63I, p.G79E, and p.P903L) were also found to oc...",99,1174,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G79E,"...l., [30] another three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at h...",99,1182,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,"...her populations, with the most frequent mutation, p.R677X, presenting in approximately 3% of adRP pa...",101,475,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,"...her populations, with the most frequent mutation, p.R677X, presenting in approximately 3% of adRP pa...",101,475,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.T373I,p.T373I*	c.1118C>T	Pakistan	ARRP	[18],105,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.T373I,p.T373I*	c.1118C>T	Pakistan	ARRP	[18],105,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,... we have identified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predi...,119,62,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...tified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predicted to have ...,119,75,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.V107I,...ution of a highly conserved Valine by Isoleucine (p.V107I).The mutation was confirmed by DHPLC,15,423,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"....1). We found that codon 107, where the mutation (p.V107I) occurred, was phylogenetically conserved ...",56,444,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...n the substitution of a Valine for an Isoleucine (p.V107I), in loopC of AQP0 (Figure 5). The high co...",75,570,Mol_Vis_2010_Mar_25_16_534-539.txt
p.I576T, 	m.14063T>C (p.I576T)	MT-ND5	Yes	Yes	No	12/15859	0.25	0.582,45,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T, 	m.14063T>C (p.I576T)	MT-ND5	Yes	Yes	No	12/15859	0.25	0.582,45,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I164T, 	m.15237T>C (p.I164T)	MT-CYB	Yes	No	No	2/15859	1	0.508,47,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L, 	m.9071C>T (p.S182L)	MT-ATP6	Yes	Yes	Yes (H16c)	5/15859	0.65	0...,51,14,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.T8A," 	m.12358A>G (p.T8A)	MT-ND5	Yes	Yes	Yes (B4e, P4a, N1a1b, M7d, N...",52,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.T8A," 	m.12358A>G (p.T8A)	MT-ND5	Yes	Yes	Yes (B4e, P4a, N1a1b, M7d, N...",52,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,...(m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237...,56,690,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H,"...m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 ...",56,720,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,"... (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5: p.T8A]), and FJ96...",56,893,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.V39I,"...-ND5: p.T8A]), and FJ969383.1 (m.3421G>A [MT-ND1: p.V39I]; Table 1). Employing standard database and...",56,970,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,...gion of the MT-CYB protein. C: Variant m.9071C>T (p.S182L) changed the structure of the membrane-spa...,58,447,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.C637Y,"... family. Two novel mutations of FBN1, p.C271* and p.C637Y, were identified in the MF1 and MF2 famili...",12,551,Mol_Vis_2013_Apr_5_19_751-758.txt
p.Val234Ile,CA4	p.Val234Ile	44	280	48	222	0*	-	0*	-	0*	-,81,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Val234Ile,CA4	p.Val234Ile	44	280	48	222	0*	-	0*	-	0*	-,81,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Cys214Tyr,PRPH2	p.Cys214Tyr	40	48	67	27	0*	-	0*	-	0*	-,86,7,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Gln304Glu,p.Gln304Glu	0*	-	0*	-	96	27	28	25	100	32,88,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,p.Ser1691Pro	0*	-	100	122	0*	-	0*	-	49	53,94,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,p.Ser1691Pro	0*	-	100	122	0*	-	0*	-	49	53,94,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ala1670Thr,"...a heterozygous form and two polymorphisms in RP1, p.Ala1670Thr and p.Ser1691Pro [21], in a heterozyg...",97,522,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,"...rm and two polymorphisms in RP1, p.Ala1670Thr and p.Ser1691Pro [21], in a heterozygous and homozygos...",97,539,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,"...rm and two polymorphisms in RP1, p.Ala1670Thr and p.Ser1691Pro [21], in a heterozygous and homozygos...",97,539,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Gln304Glu,"... or <30% total variation (i.e., the polymorphisms p.Gln304Glu and p.Asp338Gly in PRPH2) that proved ...",132,941,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Asp338Gly,"...ariation (i.e., the polymorphisms p.Gln304Glu and p.Asp338Gly in PRPH2) that proved to be positive v...",132,957,Mol_Vis_2013_Mar_21_19_654-664.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,338,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.N105H,"...—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene...",82,92,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.Cys134Trp,...losa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 2009...,106,260,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.L5063R,"...s mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectivel...",10,108,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,...nylalanine for a serine at protein position 1442 (p.F1442S) and a leucine for an arginine at protein...,77,106,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,...nylalanine for a serine at protein position 1442 (p.F1442S) and a leucine for an arginine at protein...,77,106,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...as found for these mutations. The missense mutant p.F1442S residue, buried in a fibronectin type III...",82,314,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...cting protein(s). The second identified mutation, p.L5063R, represents the most downstream pathogeni...",87,495,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,... change affects long and short isoforms while the p.L5063R variant affects only the long isoform of ...,87,984,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.Q11X,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,44,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,44,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,44,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.W244X,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.P396L,9	c.1187C>T	p.P396L	0/2	ND	2/184	Reported,80,13,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,"...ozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C: The homoz...",88,137,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...utations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated with the BCD phenotypes and w...",103,209,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...ion of CYP4V2. Second, a novel nonsense mutation (p.Gln11X) in exon 1 causes premature termination a...",103,657,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"...a deleterious homozygous novel nonsense mutation (p.Q11X), did not exhibit earlier disorder symptom ...",105,493,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.G2186E,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0.68)	DE (...",68,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,...eine to the hydrophobic tyrosine at residue 2139 (p.C2139Y). Our previous work revealed the generati...,78,829,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,...variation that might generate a truncated protein p.S1653Kfs*2 or cause NMD. The two novel variation...,80,626,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"...t also carries a novel heterozygous EYS mutation, p.G3083D, which has been found to induce the elong...",118,581,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"...t also carries a novel heterozygous EYS mutation, p.G3083D, which has been found to induce the elong...",118,581,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"...same allele with the reported pathogenic mutation p.C2139Y. Another recurrent mutation, the frameshi...",118,763,Mol_Vis_2016_Jun_16_22_646-657.txt
p.His50Asp,"...ons were novel, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two ...",68,456,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"...ons were novel, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two ...",68,456,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...el, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base p...",68,468,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...el, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base p...",68,468,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...ee missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base pair frame shift d...",68,485,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,...letions (p.Asp23GlufsX9 and p.Ile48ValfsX55). The p.His50Asp mutation was observed in three familial...,68,586,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,... in three sporadic cases (Figure 1). Although the p.His50Asp change segregated with the disease phen...,68,771,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,c.148C>G (p.His50Asp)	Damagin,80,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damaging (0.997)	...,89,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damaging (0.997)	...,89,11,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...n at the positions of the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evo...",96,129,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...d in the NDP gene. A: Patient ID: family 33-II:2 (p.H50D); the right eye of the patient shows straig...,101,202,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...cular dragging. C, D: Patient ID: family 72-IV:1 (p.H50D); the right (C) and left (D) eyes show drag...",101,549,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...n ectopic macula. E: Patient ID: family 139-II:2 (p.H50D); the right eye of the patient shows an ava...,101,687,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"... present study, the three novel missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were loc...",110,57,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...el missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the highly conserved ...",110,86,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"..., and a missense change at cysteine 126 position (p.Cys126Arg) in four unrelated patients with FEVR....",114,396,Mol_Vis_2016_May_16_22_491-502.txt
p.Asn102Asp,c.304A>G; p.Asn102Asp	 	Benign	Tolerated	No effect	1	 ,169,11,Nat_Commun_2014_Aug_7_5_4398.txt
p.Glu443Asp,c.1329G>T; p.Glu443Asp	 	Benign	Tolerated	No effect	2	 ,173,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly966Ala,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	No effect...,186,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg985Cys,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect protein fun...,187,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly1071Ser,c.3211G>A; p.Gly1071Ser	rs35766432	Benign	Tolerated	No effect...,192,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1082Asn,c.3244G>A; p.Asp1082Asn	rs138871050	Benign	Tolerated	No effec...,193,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Glu1150Gly,c.3449A>G; p.Glu1150Gly	rs35023148	Benign	Tolerated	No effect...,197,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1171Gly,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effect	1	 ,198,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1171Gly,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effect	1	 ,198,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,We here describe a NaV1.9 mutation (p.V1184A) that causes early onset cold-aggravated ...,14,37,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"To analyse the consequences of mutation p.V1184A for the function of NaV1.9, we performed ...",23,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...rger current densities of cells expressing mutant p.V1184A were accompanied by three major effects: ...,25,627,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...aV1.9 at 30 and 20 °C; 9.8±1.0 and 9.8±0.7 mV for p.V1184A at 30 and 20 °C, respectively; both P>0.0...",25,1612,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Influence of p.V1184A on DRG neuron excitabilit,31,14,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Influence of p.V1184A on DRG neuron excitabilit,31,14,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ing their RMP3. To analyse the impact of mutation p.V1184A on the excitability of primary nociceptiv...,32,181,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Comparison of mutation p.V1184A with p.L811,38,24,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The phenotypes associated with mutation p.V1184A in NaV1.9 as well as those with mutations...,39,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The phenotypes associated with mutation p.V1184A in NaV1.9 as well as those with mutations...,39,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...t to that of the NaV1.9 gain-of-function mutation p.L811P, which results in pain insensitivity1516. ...",39,215,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...t to that of the NaV1.9 gain-of-function mutation p.L811P, which results in pain insensitivity1516. ...",39,215,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...citability of neurons transfected with p.L811P or p.V1184A. However, longer trains of action potenti...",39,1152,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...eurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels increase the probability of cumul...",39,1714,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...tudy identified a heterozygous missense mutation (p.V1184A) in NaV1.9 as a cause for early onset col...,42,56,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,... temperature. We further showed that the mutation p.V1184A did not affect the Q10 values of the gati...,46,906,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nario would be in line with our data showing that p.V1184A does not affect the intrinsic temperature...,48,1083,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nario would be in line with our data showing that p.V1184A does not affect the intrinsic temperature...,48,1083,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The clinical symptoms caused by mutation p.V1184A in NaV1.9 are reminiscent of primary eryt...,50,42,Nat_Commun_2015_Dec_8_6_10049.txt
p.R225C,"...d body areas in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 describe...",50,1704,Nat_Commun_2015_Dec_8_6_10049.txt
p.A808G,"...s in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 described mutation ...",50,1715,Nat_Commun_2015_Dec_8_6_10049.txt
p.G699R,"...p.A808G. Notably, Han et al.36 described mutation p.G699R, located in the S4/S5 linker in domain II ...",50,1765,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... contrast to the NaV1.9 gain-of-function mutation p.L811P that results in pain insensitivity1516. Th...,52,176,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...d elusive. To infer potential differences between p.V1184A and p.L811P we assessed the functions of ...,52,346,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...d elusive. To infer potential differences between p.V1184A and p.L811P we assessed the functions of ...,52,346,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... infer potential differences between p.V1184A and p.L811P we assessed the functions of both mutation...,52,359,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... infer potential differences between p.V1184A and p.L811P we assessed the functions of both mutation...,52,359,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... infer potential differences between p.V1184A and p.L811P we assessed the functions of both mutation...,52,359,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...tes opening of NaV1.9 more strongly than mutation p.V1184A (Fig. 7b). As a result, the window curren...",52,1583,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...cator of channel activity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 ...,52,1773,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...cator of channel activity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 ...,52,1773,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...cator of channel activity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 ...,52,1773,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...cator of channel activity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 ...,52,1773,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcitable under th...",54,294,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f repetitive firing revealed that, in contrast to p.V1184A, mutation p.L811P leads to a substantial ...",54,467,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... revealed that, in contrast to p.V1184A, mutation p.L811P leads to a substantial instability of DRG ...",54,486,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... may be caused by increased influx of Na+ through p.L811P as it is predicted by the larger window cu...,54,792,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...(Fig. 7b) and the slower inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9...,54,898,Nat_Commun_2015_Dec_8_6_10049.txt
p.Val1184Ala,...n pcDNA3.1 was used as template15. The c.3551T>C (p.Val1184Ala) mutation was introduced by PCR-based...,67,84,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...of the family with episodic pain. Genotype of the p.V1184A mutation is indicated. V/A=heterozygous m...,130,64,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ins (DI-DIV) are indicated; position of mutations p.L811P (blue) causing pain insensitivity and p.V1...,130,437,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ons p.L811P (blue) causing pain insensitivity and p.V1184A (red) causing cold-aggravated peripheral ...,130,483,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Figure 2 Mutation p.V1184A enhances activation of NaV1.9,132,19,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... not affected by mutation p.V1184A while mutation p.L811P slows down channel inactivation, thus prol...",148,246,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... not affected by mutation p.V1184A while mutation p.L811P slows down channel inactivation, thus prol...",148,246,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...rent; this window current is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9....,148,681,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ltage steps. Notably, fast inactivation of mutant p.L811P (n=11) is impaired in the entire voltage r...",148,953,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ltage steps. Notably, fast inactivation of mutant p.L811P (n=11) is impaired in the entire voltage r...",148,953,Nat_Commun_2015_Dec_8_6_10049.txt
p.Leu117Val,...a point mutation causing the predicted amino acid p.Leu117Val substitution. This missense mutation o...,20,521,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,"...993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these mutations like...",20,1388,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,p.Leu117Val	Exon 6	3.63	deleterious	probably damag...,150,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,p.Trp124Ter	Exon 6	4.46			26.5,154,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.I772T, p.I772T	2315T>C	17	1/159 UK FALS	0/897 UK controls...,126,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.E624K, p.E624K	1870G>A	16	1/49 US SALS trios	0/801 AU San...,132,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.R179X,"...predicted protein-truncating variant (rs36095412, p.R179X, genotyped in 11,148 ulcerative colitis pa...",5,1017,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,... (P=0.02); and (3) a premature stop gain variant (p.R179X) in RNF186 with signal of association (P=0...,16,1407,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"...rong support that the premature stop-gain allele, p.R179X, confers protection against UC (P=0.0028, ...",19,238,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...w-frequency coding variant in RNF186 (rs41264113, p.A64T, MAF=0.8%) was found to confer increased ri...",27,390,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...ith rs3806308 or the low-frequency coding variant p.A64T (Supplementary Fig. 3). Naturally, the prot...",27,719,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...ith rs3806308 or the low-frequency coding variant p.A64T (Supplementary Fig. 3). Naturally, the prot...",27,719,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...d two individual carriers containing ASE data for p.R179X in transverse colon and sigmoid colon. The...,33,183,Nat_Commun_2016_Aug_9_7_12342.txt
p.G149R,"...ariants (p.V362I, MAF=1.27%, OR=0.72 (0.63–0.83); p.G149R, MAF=0.45%, OR=0.60 (0.45–.0.79)) and the ...",42,718,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,Table 1 Association of p.R179X in RNF186 with ulcerative colitis,147,24,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,Table 1 Association of p.R179X in RNF186 with ulcerative colitis,147,24,Nat_Commun_2016_Aug_9_7_12342.txt
p.Trp977X,"...Table 1) revealed a nonsense mutation, c.2931G>A (p.Trp977X), also in IGSF1 (Fig. 1c). B-III.7 and B...",42,1226,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Ser863Phe,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [8.5-18.3],233,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Trp1173X,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [8-16.5],248,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Ile123Thr,"... 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARNSHI in ...",24,785,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile129Ser,"...170 and rs1841958, encoding KLRC4 p.Asn104Ser and p.Ile129Ser. In a meta-analysis, we combined the T...",15,804,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile129Ser,"...170 and rs1841958, encoding KLRC4 p.Asn104Ser and p.Ile129Ser. In a meta-analysis, we combined the T...",15,804,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...nd revealed a large effect size of the homozygous p.Arg725Gln genotype on BD with uveitis (odds rati...,17,991,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...n psoriasis21, 22 and AS12. ERAP1 p.Asp575Asn and p.Arg725Gln, which are in strong LD, confer protec...",21,239,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...n-uveitis) samples (Figure 3). Furthermore, ERAP1 p.Arg725Gln homozygosity was associated with an od...",23,471,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...asis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in B,70,65,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...asis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in B,70,65,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...asis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in B,70,65,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,ERAP1 rs17482078 (ERAP1 p.Arg725Gln)	Turkish Discovery	TOF-MS	Uveitis BD	4...,121,25,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asn279Ser,"...9, coding for an amino-acid substitution in EXO1 (p.Asn279Ser; CADD score 3331), suggesting that thi...",29,561,Nat_Genet_2015_Apr_9_47(4)_373-380.txt
p.Q185X,"...sing TRIB3 and HOIL1, and the nonsense c.553 C>T, p.Q185X mutant allele in HOIL1. Pedigree of kindre...",103,189,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
p.L1872P,"...ygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) ha...",29,221,Nature_2011_Jan_27_469(7331)_539-542.txt
p.S13F,...s: the cardiac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31...,3,245,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...s: the cardiac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31...,3,245,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31-50-3617229...,3,256,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studie...,7,54,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using ge...,7,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is simil...",10,506,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...rs, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and...",10,570,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...rs, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and...",10,570,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,....S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haploty...,10,621,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...e cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac co...,13,117,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...e cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac co...,13,117,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...e cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac co...,13,117,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ematic representation of desmin with locations of p.S13F (‘head’ structure) and p. N342D (2B domain)...,22,997,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ematic representation of desmin with locations of p.S13F (‘head’ structure) and p. N342D (2B domain)...,22,997,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in severa...",28,40,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in several index pat...",28,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ms were (1) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigat...",28,394,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ms were (1) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigat...",28,394,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...luated known and obligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data ha...,35,192,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data have been described p...,35,211,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed the published cardiological data on p.S13F and p.N342D carriers of other origin,35,680,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ikely carriers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting...,44,148,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting the posta...,44,158,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...e following changes at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). ...",48,150,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...s at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). Previously, we pub...",48,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nd p.T453I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other ...",48,228,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...3I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutation...",48,236,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,"... Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutations (p.T442I an...",48,249,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342N,"...evel: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intronic and 3...",48,661,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"p.S13F	6,8	5 families	Dutch	Founder",51,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"p.S13F	6,8	5 families	Dutch	Founder",51,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...se mutation in the head domain (Fig. 1). Mutation p.N342D (c.1024A > G) is a missense mutation in th...,65,173,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... index patients. Twelve proven and seven obligate p.N342D carriers were identified by family cascade...,65,611,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... index patients. Twelve proven and seven obligate p.N342D carriers were identified by family cascade...,65,611,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"D-II-7 8	F	p.S13F	collapse (55)	RBBB, cAVB, LAHB (55)	normal ...",71,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"E-I-2 8	F	p.S13F	MW (54)	incomplete RBBB (62), incomplete RB...",74,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"H-IV-2	M	p.S13F	screening (9)	PVCs, LBBB (9)	NA (pending)	n...",79,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"H-IV-2	M	p.S13F	screening (9)	PVCs, LBBB (9)	NA (pending)	n...",79,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"H-IV-2	M	p.S13F	screening (9)	PVCs, LBBB (9)	NA (pending)	n...",79,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Genealogy and haplotype analysis of families with p.S13,92,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"... cardiopathy” were reported [13]. We identified a p.N342D mutation in these families, thereby provin...",96,149,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... 3 Clinical characteristics of known and obligate p.N342D carriers and relatives likely to be carrie...,98,56,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"U-III-17	F	p.N342D	MW (16)	PACs, PVCs, ventricular bigeminy, ...",120,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-IV-9	F	p.N342D	MW (27)	normal (29)	normal (29)	scapulo-il...,125,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-IV-9	F	p.N342D	MW (27)	normal (29)	normal (29)	scapulo-il...,125,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"D-I-4 1,14	M	p.N342D	MW (23)	normal	NA	mild distal (23), CK 963...",129,14,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Geographical distribution of carriers of p.S13F or p.N342,139,42,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...bligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherlands (Fig. 5a, b), ...",140,107,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...bligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherlands (Fig. 5a, b), ...",140,107,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ig. 4 Pedigrees of families O and U with mutation p.N342D. Updated pedigrees of the two families (O ...,140,555,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...phical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distribution of know...,142,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... all carriers of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index pat...",147,89,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...p.N342D), including three new index patients with p.S13F and two new large families with p.N342D. Th...",147,150,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ients with p.S13F and two new large families with p.N342D. This is the largest series to date of car...,147,189,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ients with p.S13F and two new large families with p.N342D. This is the largest series to date of car...,147,189,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...of p.N342D is in accordance with the phenotype of p.S13F. However, the neuromuscular phenotype is mo...",151,73,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...of p.N342D is in accordance with the phenotype of p.S13F. However, the neuromuscular phenotype is mo...",151,73,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...inent in carriers with p.N342D than in those with p.S13F, because all p.N342D carriers presented wit...",151,180,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...th p.N342D than in those with p.S13F, because all p.N342D carriers presented with a neuromuscular ph...",151,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...here are many unidentified carriers of p.S13F and p.N342D founder mutations in the Netherlands. Our ...,159,74,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.V394L,"...1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P)...",342,659,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.Val726Ala,"...680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg7...",22,695,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Lys695Arg,"...(p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2084A>G, rs104895094) in exon 10; P...",22,788,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.N478D,The homozygous p.N478D missense mutation in MTPAP causes spastic ...,16,16,Nucleic_Acids_Res_2015_Oct_15_43(18)_9065-9075.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"L (desc)	2,5 cm	T3	Not tested	KRAS c.35G>A (p.G12D)",37,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & metachr Lu...",38,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,"...3	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,54,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,49,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,49,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"R (transv)	1,6 cm	T1	MSH2/MSH6	KRAS c.38G>A (p.G13D)",47,46,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,7	63	F	R (asc)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V)	liver (clinicaly)	None,48,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,7	63	F	R (asc)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V)	liver (clinicaly)	None,48,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon...",57,312,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon...",57,312,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,"...(p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G...",57,390,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"...A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a NRAS mut...",57,437,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"...ations respond to EGFR inhibitors [24], specially p.G13D, RAS-mutated tumors generally fail to respo...",66,207,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"...osequencing. The CAA to CTA transition leads to a p.Q61L amino acid substitution, comprising constit...",69,793,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...osequencing. The CAA to CTA transition leads to a p.Q61L amino acid substitution, comprising constit...",69,793,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...sition in codon 61 of the NRAS gene, leading to a p.Q61L amino acid substitution (Fig. 1C). After in...",72,229,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.V600E,† 4 p.V600E and 2 p.D594G mutations,65,5,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.T319Ter, 48	p.T319Ter (c.954_957del)	delTACT of (TACT)2	8,78,5,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.L325R, 218	p.L325R (c.974T > G)		8,80,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.L325R, 218	p.L325R (c.974T > G)		8,80,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.L325R, 218	p.L325R (c.974T > G)		8,80,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R234W, 240	p.R234W (c.700C > T)		7,82,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.S10I, 273	p.S10I (c.29G > T)		1,86,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.K267Rfs,MSIH22	p.K267Rfs*9 (c.800delA)	delA of (A)6	7,88,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.G13D,... JR  Simes J  Karapetis CS    Association of KRAS p.G13D mutation with outcome in patients with chem...,95,229,Oncotarget_2015_Oct_26_6(38)_40815-40821.txt
p.G13D,...ng YF  Yang ZY  Zheng DY  Chen JZ  Tang JL   KRAS p.G13D mutation and codon 12 mutations are not cre...,96,64,Oncotarget_2015_Oct_26_6(38)_40815-40821.txt
p.R764H,"...utations in HRAS p.G13C, CASP8 p.R127* and PDGFRA p.R764H at all sub-sites in primary and metastatic...",25,320,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...geal tumor), a substitution at amino acid residue p.I251N in the TP53 gene was observed in two sub-s...",30,276,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...geal tumor), a substitution at amino acid residue p.I251N in the TP53 gene was observed in two sub-s...",30,276,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...m TP53 fragments spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed ...,30,611,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...ents spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed 21.86% alter...,30,623,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"... the tumor sub-site B, there was no alteration at p.Y236C and 59.23% alteration (A replaced by T) at...",30,857,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...alteration (A replaced by T) at p.I251N. Thus the p.I251N alteration at sub-site A developed indepen...,30,926,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,Figure 2 TP53 mutations p.I251N and p.Y236C within the primary laryngeal tumor sub-sit...,32,37,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...tions in the p.I251N residue and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C re...",33,430,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"... and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently...",33,458,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.A934P,"...tinguishable from acrocallosal syndrome who has a p.A934P GLI3 mutation [21]. Second, patients with ...",57,949,Orphanet_J_Rare_Dis_2008_Apr_24_3_10.txt
p.E191K,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.A176T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.N417S,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,23,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.Lys62X,...lly always double heterozygous mutations) and the p.Lys62X/p.Cys84fs mutation is present in two-thir...,260,453,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
p.Lys62X,...lly always double heterozygous mutations) and the p.Lys62X/p.Cys84fs mutation is present in two-thir...,260,453,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
p.V382M,"...I restriction sites for the variants p.E2496E and p.V382M, respectively, using T4 DNA ligase (Invitr...",60,366,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,c.820C > T	5	p.R274X	+	2	Present study,70,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,c.820C > T	5	p.R274X	+	2	Present study,70,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2618X,c.7854G > C	41	p.W2618X	+	1	Present study,80,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2618X,c.7854G > C	41	p.W2618X	+	1	Present study,80,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2618X,c.7854G > C	41	p.W2618X	+	1	Present study,80,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,"c.2276G > T	13	p.C759F	+	3	Dreyer et al., 2000",162,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L1572F,"c.4714C > T	22	p.L1572F	-	7	Dreyer et al., 2008",168,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2106T,"c.6317T > C	32	p.I2106T	-	117	Aller et al., 2006",174,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2169T,"c.6506T > C	34	p.I2169T	-	85	Aller et al., 2006",176,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2169T,"c.6506T > C	34	p.I2169T	-	85	Aller et al., 2006",176,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,c.7130A > G	38	p.N2377S	UV2	1	Present Study,184,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,c.7130A > G	38	p.N2377S	UV2	1	Present Study,184,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,c.7182C > A	38	p.N2394K	UV2	1	Present Study,186,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,c.7182C > A	38	p.N2394K	UV2	1	Present Study,186,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V2562A,"c.7685T > C	41	p.V2562A	-	1	Dreyer et al., 2008",190,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2639P,"c.7915T > C	41	p.S2639P	UV2	3	McGee et al., 2010",192,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2639P,"c.7915T > C	41	p.S2639P	UV2	3	McGee et al., 2010",192,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R2875Q,"c.8624G > A	43	p.R2875Q	-	9	Aller et al., 2006",194,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3088K,"c.9262G > A	47	p.E3088K	-	1	Dreyer et al., 2008",198,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3115A,"c.9343A > G	47	p.T3115A	-	9	Dreyer et al., 2008",202,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3199D,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"c.9799T > C	50	p.C3267R	+	5	Aller et al., 2006",208,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"c.10073G > A	51	p.C3358Y	+	1	McGee et al., 2010",210,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G4838E,"c.14513G > A	66	p.G4838E	-	1	McGee et al., 2010",230,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4848Q,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"c.15076A > G	70	p.K5026E	UV2	1	McGee et al., 2010",236,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,e p.R303H and p.Y1992C were initially described as being pathoge...,247,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,e p.R303H and p.Y1992C were initially described as being pathoge...,247,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S1457S,"c.4371G > A	20	p.S1457S	-	1	Dreyer et al., 2000",266,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G1671G,"c.5031C > A	25	p.G1671G	-	22	Aller et al., 2006",268,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3912E,"c.11736G > A	61	p.E3912E	-	2	Dreyer et al., 2008",276,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3969P,"c.11907A > T	61	p.P3969P	-	2	Dreyer et al., 2008",278,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L3982L,"c.11946A > T	61	p.L3982L	-	29	Dreyer et al., 2008",280,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4222T,"c.12666A > G	63	p.T4222T	-	58	Dreyer et al., 2008",286,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4397E,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and stable	Nor...,308,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and stable	Nor...,308,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	Norma...,312,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	Norma...,312,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,RP1703*	p.C3267R/p.C3358Y	1936	USHA	50	Since 64 years		50	...,332,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"RP1759	p.C3267R/p.Y1992C#	1945	USH2	62	Congenital, modera...",334,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,RP1631	c.1841-2A > G/p.R274X	1976	USH2		Since infancy	NormalA	28	28	Con...,338,22,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,RP1631	c.1841-2A > G/p.R274X	1976	USH2		Since infancy	NormalA	28	28	Con...,338,22,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1295X,"RP1539*	p.R1295X/p.N3894D#	1987	USH2	20	Congenital, modera...",344,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressi...,348,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W4725X,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressive	Centr...,348,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,"RP690M*	p.P4818L/p.Q3368X + c.5278delG	1972	USH2	22	Congenital, mod...",352,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,"RP690M*	p.P4818L/p.Q3368X + c.5278delG	1972	USH2	22	Congenital, mod...",352,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,RP1613	c.9260delT/p.G44R	1971	USH2	30	Severe	NormalA	20	20	Marked co...,358,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2196T,"... possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have alr...",426,93,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,"...umc.nl/LOVD2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been desc...",426,317,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,"...umc.nl/LOVD2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been desc...",426,317,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,p.G44R	Affect (Score 0.01)	Probably damaging	Patho...,431,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,p.E4921K	Tolerated (Score 0.85)	Benign	Neutral (NN...,441,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,p.E4921K	Tolerated (Score 0.85)	Benign	Neutral (NN...,441,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,...ssibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [https://grenad...,448,95,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...d it as clearly pathogenic (See Table 6). The new p.V382M change, which affects the first base of ex...",448,411,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,...igure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresis shows the d...,450,52,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,...missense mutations were considered as pathogenic. p.C759F and p.C3267R were already described by oth...,452,64,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,...missense mutations were considered as pathogenic. p.C759F and p.C3267R were already described by oth...,452,64,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,...missense mutations were considered as pathogenic. p.C759F and p.C3267R were already described by oth...,452,64,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...c.nl/LOVD2/Usher_montpellier, [35]]. p.C3358Y and p.P4818L were classified by McGee et al. (2010) [3...",452,208,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...gregation analyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them ...",452,900,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...gregation analyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them ...",452,900,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...lyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them as pathogenic...",452,913,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...riant p.G44R was detected in a single patient and p.G3546R in three cases (one homozygous and two co...,452,1103,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.A258T,"II.1, II.2, II.3	Ho He	c.772 G > A	p.A258T	5	LDLRA2	Vyse et al. 1996 [18]",73,36,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.A258T,"II.1, II.2, II.3	Ho He	c.772 G > A	p.A258T	5	LDLRA2	Vyse et al. 1996 [18]",73,36,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.A258T,"II.1, II.2, II.3	Ho He	c.772 G > A	p.A258T	5	LDLRA2	Vyse et al. 1996 [18]",73,36,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.W393Yfs,"I.1, I.2	He	c.1176_1177dupAT	p.W393Yfs*5	11	SP	Baracho et al. 2003 [19]",74,30,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.W393Yfs,"I.1, I.2	He	c.1176_1177dupAT	p.W393Yfs*5	11	SP	Baracho et al. 2003 [19]",74,30,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.W393Yfs,"I.1, I.2	He	c.1176_1177dupAT	p.W393Yfs*5	11	SP	Baracho et al. 2003 [19]",74,30,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.R474X,"III.1, III.3, III.4	He	c.1420 C > T	p.R474X	11	SP	Fremaux-Bacchi et al. 2004 [20]",75,37,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.Cys4Ser,"...ne patient had a missense variant (g.35295505G>C; p.Cys4Ser) in exon 1, three patients had the same ...",124,209,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"... found in five MA patients. A) The g.35295505G>C (p.Cys4Ser) variant in control and patient 223, B) ...",126,147,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"... found in five MA patients. A) The g.35295505G>C (p.Cys4Ser) variant in control and patient 223, B) ...",126,147,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,p.Pro312His	 	 	CA: 3 (2.7%)	CA: 0 (0%),136,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.V1165M,... NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was approved by the...,44,462,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
p.Leu105X,...g mutation in our cohort was c.312_321del10insAT (p.Leu105X) (16 homozygous and 11 compound heterozy...,160,450,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.Arg371Cys,...nt. A missense mutation [NM_006517.4:c.1111C > T; p.Arg371Cys] in exon 4 of the SLC16A2 gene was ide...,62,672,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg371Cys,...nt. A missense mutation [NM_006517.4:c.1111C > T; p.Arg371Cys] in exon 4 of the SLC16A2 gene was ide...,62,672,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.R450Q,...p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplication of GRIA3	Partial dupli...,118,149,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...IA3	Partial duplication of GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant ...,118,232,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...p.G630R	Missense variant p.G630R	Missense variant p.G630R,118,282,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,...novel missense mutation [NM_000828.4:c.1888G > C; p.Gly630Arg] in exon 12 of the GRIA3 gene that seg...,146,108,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,The wild type residue glycine of the p.Gly630Arg is neutral and the mutant residue argi...,149,38,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...n exon 6 of the SYP gene [NM_003179.2:c.877G > A; p.Gly293Ser]. This missense variant was found in a...,231,139,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...n exon 6 of the SYP gene [NM_003179.2:c.877G > A; p.Gly293Ser]. This missense variant was found in a...,231,139,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg371Cys,...9 is located in the seventh TMD and the recurrent p.Arg371Cys amino acid substitution present in fam...,243,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,We identified a missense mutation c.1888G > C (p.Gly630Arg) (RefSeq NM_000828.4) in the glutamate...,248,48,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg631Ser,...d in GRIA3[34-38]. One of the missense mutations (p.Arg631Ser,252,161,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...features. The missense benign variant c.877G > A (p.Gly293Ser) (RefSeq NM_003179.2) has been reporte...,271,151,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg2068His,...tions have been found in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are theref...,268,1112,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...ound in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are therefore very likely t...,268,1129,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.G205S,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.Arg506Gly,...he chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has been annotated...,115,243,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg401Pro,...e region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evolutionarily n...,117,131,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,"...ls of the family (II:5, III:10, IV:13). Moreover, p.Ser96*SLC17A9 was also present in heterozygous s...",119,445,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Pro97Ser,...9C>T heterozygous de novo (both parents wildtype)	p.Pro97Ser	Missense,36,66,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu321*,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu321*,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",78,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg2419*,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg2419*,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val455Met,... caused by a spontaneous GCK activating mutation (p.Val455Met) suffered from epilepsy and showed neu...,8,97,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Val455Met,... caused by a spontaneous GCK activating mutation (p.Val455Met) suffered from epilepsy and showed neu...,8,97,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Val455Met,"...as referred to our hospital, and the heterozygous p.Val455Met mutation was found at GCK gene sequenc...",23,888,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Arg329His,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg373Cys,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Glu208Lys,(NM_000166.5)	1	c.622G>A	p.Glu208Lys,180,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg7Ser,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu78Pro,(NM_022489.3)	1	c.233T>C	p.Leu78Pro,201,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg94Trp,(NM_014874.3)	1	c.280 C>T	p.Arg94Trp,210,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg280His,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.His361Tyr,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg329His,Mutation p.Arg329His (c.986G>A) was found in three families...,290,10,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly514Ser,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg297Leu,(NM_001005360)	c.890G>T	p.Arg297Leu	SIFT:,338,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg297Leu,(NM_001005360)	c.890G>T	p.Arg297Leu	SIFT:,338,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly694Glu,...r was heterozygous for the p.Thr330 deletion. The p.Gly694Glu variant was not present in the mother;...,33,1125,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...wo of the variants reported here (p.Asp608del and p.Gly694Glu) are located at the subunit interface ...,49,400,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...wo of the variants reported here (p.Asp608del and p.Gly694Glu) are located at the subunit interface ...,49,400,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...wo of the variants reported here (p.Asp608del and p.Gly694Glu) are located at the subunit interface ...,49,400,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.R150C,...cci syndrome) is not caused by the PTHR1 mutation p.R150C Hum Mutat 2004 24 466 73 15523647,55,141,Orthop_Rev_(Pavia)_2012_May_29_4(2)_e16.txt
p.R150C,...cci syndrome) is not caused by the PTHR1 mutation p.R150C Hum Mutat 2004 24 466 73 15523647,55,141,Orthop_Rev_(Pavia)_2012_May_29_4(2)_e16.txt
p.Gly230Val,We screened the c.689G > T (p.Gly230Val) mutation in exon 7 of ELOVL5 by Sange...,58,29,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.C78W,...date variants that remained for consideration are p.C78W (TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP...,15,536,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.C78W,...27X (TNFAIP3;A20). Haplotype analysis showed that p.C78W occurred de novo on the haplotype inherited...,15,625,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.L227X,...the haplotype inherited from the grandmother. The p.L227X mutation-associated haplotype was found on...,15,702,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.V1316A,...e genesis of resurgent currents. We show that the p.V1316A mutation chiefly accelerates the I to O t...,40,708,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858F,"...n each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations...",48,916,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858H,"...main, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Ac...",48,925,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.P1308L,"...h as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly...",48,934,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...hannel. The activation and inactivation curves of p.V1316A mutant channel are negatively and positiv...,67,136,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the open state) or both. Fig 4E shows that in the p.V1316A mutant channel, the decay of transient cu...",67,1228,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...oscopic inactivation rates are ~50% slowed by the p.V1316A mutation. In other words, the Navβ4 pepti...",67,1518,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...an accelerates decay of transient currents in the p.V1316A mutant channel, and the p.V1316A mutation...",67,1636,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...g 4 The activation and inactivation curves of the p.V1316A mutant channel in the presence of the Nav...,69,86,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nnels (n = 15 for the WT channels; n = 12 for the p.V1316A mutant channels). The ratio between the s...,70,1372,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...in the same sweep) is significantly larger in the p.V1316A mutant channel with depolarization potent...,70,1510,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...zation voltage is significantly lengthened by the p.V1316A mutation only in the presence but not in ...,70,2160,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...olarization of +40 mV but not 0 mV in both WT and p.V1316A mutant channels, again demonstrating the ...",73,422,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...t currents indeed are significantly larger in the p.V1316A mutant channel than in the WT channel in ...,73,871,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...61.g005Fig 5 Larger resurgent Na+ currents in the p.V1316A mutant than that in the WT channels,75,77,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ion curve of resurgent Na+ currents in the WT and p.V1316A mutant channels,78,101,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... Single Boltzmann fits to the mean values are for p.V1316A mutant channel: Vh = ~59.5 mV and k = ~21...,79,2037,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...resurgent currents is significantly longer in the p.V1316A mutant than in the WT channel (Fig 7B and...,85,360,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...increased sustained and resurgent currents in the p.V1316A mutant channel, which may be chiefly and ...",85,500,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rents by membrane hyperpolarization in the WT and p.V1316A mutant channels,87,141,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rents by membrane hyperpolarization in the WT and p.V1316A mutant channels,87,141,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...~+160 mV for ~10 ms in 20 mV increment for WT and p.V1316A mutant channels. Note that the inverse de...,88,259,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e decay time constants are very similar in WT and p.V1316A mutant channels. (B) Cumulative results w...,88,355,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...voltage in semi-logarithmic scales for the WT and p.V1316A mutant channels. The lines are linear reg...,88,1405,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...voltage in semi-logarithmic scales for the WT and p.V1316A mutant channels. The lines are linear reg...,88,1405,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...resurgent currents are very similar in the WT and p.V1316A mutant channels. (E) The cells were held ...,88,1762,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 1.25×exp(–0.71V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,2599,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 1.25×exp(–0.71V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,2599,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the tail currents are very similar in the WT and p.V1316A mutant channels. Individual data is shown...,88,2796,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ntials (e.g., +20, +40, and +60 mV) in the WT and p.V1316A mutant channels. Note that there is no si...",94,1622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e is no significant difference between the WT and p.V1316A mutant channels at each voltage (n = 7; N...,94,1712,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...addition of Navβ4 peptide (Fig 2B and 2C). In the p.V1316A mutant channel, the addition of Navβ4 pep...",98,622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and L1610, and p.V1316A and R1611 are ~11...",101,4310,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...(tip to tip) distances between residues V1316 (or p.V1316A) and L1610, R1611, V1722, and G1723 in th...",101,4505,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...mulations of resurgent Na+ currents in the WT and p.V1316A mutant channels,103,107,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"..., and 1/tau(V) = 0.17×exp(–1.03V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",104,1894,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...thout Navβ4 peptide	WT channel with Navβ4 peptide	p.V1316A mutant channel with Navβ4 peptide,107,65,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...se in Sustained and Resurgent Na+ Currents by the p.V1316A Mutatio,128,60,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rease the inter-residue distances between residue p.V1316A of the S4–S5 linker/D3 and the nearby res...,129,2409,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... [40–42]. In this study, we demonstrated that the p.V1316A mutation, which causes very prominent and...",132,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...r fluorescent microscope (Nikon, Inc. Japan). The p.V1316A mutation was made using Quikchange site-d...",139,263,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...vation curve of resurgent currents of both WT and p.V1316A mutant channels. The ionic currents are a...,154,546,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...een the sustained and peak currents in the WT and p.V1316A mutant channels are obtained with the sam...,166,70,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...een the sustained and peak currents in the WT and p.V1316A mutant channels are obtained with the sam...,166,70,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...gs, simulated sustained currents are increased in p.V1316A mutant channels. (B) The kinetics of the ...",166,239,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ack symbols and line), and ~62.1 mV and ~17.2 for p.V1316A mutant resurgent currents (red symbols an...",166,2434,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...G1723 are ~6.4 Å, and ~6.9 Å, respectively in the p.V1316A mutant channel. Individual data is shown ...",173,696,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...G1723 are ~6.4 Å, and ~6.9 Å, respectively in the p.V1316A mutant channel. Individual data is shown ...",173,696,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.Ser1012Pro,"...und to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved residue (GERP ...",131,286,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.Gly1890Glu,"...es unavailable) harbored variant (T2587c.5669G>A, p.Gly1890Glu) a rare missense variant. Both mutati...",131,511,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.R216H,"...276C>T), and the non-synonymous (ns) substitution p.R216H in exon8 were genotyped in the entire stud...",47,282,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...t001Table 1 Distribution of COLEC11—rs7567833G/A (p.R216H) genotypes and allele(s),67,80,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,The minor allele of exon8 variant rs7567833A (p.R216H) was significantly associated with increas...,140,47,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tic models for the contribution of the respective p.R216H genotypes. It has been hypothesized that t...,154,603,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...216H genotypes. It has been hypothesized that the p.R216H substitution increases the alpha helical p...,154,656,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...216H genotypes. It has been hypothesized that the p.R216H substitution increases the alpha helical p...,154,656,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tability and protein folding properties [41]. The p.R216H substitution is located in the carbohydrat...,154,799,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.Phe31Ile,...sense substitutions in STK15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) we...,15,1777,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.K45E,The rs679620 A MMP3 p.K45E polymorphism in the matrix metalloproteinas...,93,21,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.K45E,The rs679620 A MMP3 p.K45E polymorphism in the matrix metalloproteinas...,93,21,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,...ing evidence for an association between the STK15 p.Phe31Ile variant and RCC was less secure a lower...,97,459,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.A145S,"... have been identified, the benign and polymorphic p.A145S variant (rs29281) and the p.I304N mutation...",81,100,PLoS_One_2010_Mar_5_5(3)_e9476.txt
p.T348M,3 p.T348M allele specific primer,97,3,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135L,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G ...",110,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.D170D,"...N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dup...",110,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S329N,"...69-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX1...",110,158,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S329N,"...69-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX1...",110,158,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R388X,"...G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N = 1)	Chr12q24....",110,185,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R168Q,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*...",111,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.V198M,"...(N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)...",111,59,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T219T,"...78−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L...",111,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A242A,"... p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A4...",111,83,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A242A,"... p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A4...",111,83,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P340P,"...R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(...",111,99,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P340P,"...R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(...",111,99,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P340P,"...R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(...",111,99,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A439P,"...1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2),...",111,129,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.H463H,"...1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),...",111,141,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y859C,"....A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3)...",111,180,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...7I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)	...",111,208,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P46L,"...(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup		...",112,76,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C70R,"...37S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference p...",152,443,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C70R,"...37S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference p...",152,443,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Arg554X,"...n recorded in CAPS. However, a nonsense mutation (p.Arg554X) was identified in NLRP3 putatively resu...",164,1045,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Q2980X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,2,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.Q2980X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,2,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.S1142X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,11,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.S1142X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,11,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.Arg274Trp,...ather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three individuals...,20,221,PLoS_One_2011_Dec_14_6(12)_e29248.txt
p.Arg274Trp,...ather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three individuals...,20,221,PLoS_One_2011_Dec_14_6(12)_e29248.txt
p.G1069R,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our proband and i...,24,24,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.Q1069R,"...bols, unaffected individuals; Mut/Mut, homozygous p.Q1069R mutation; Mut/WT, heterozygous Q1069R mut...",24,387,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.R2065S,3	Atypical	c.6193C>A	p.R2065S	Missense			Novel,62,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,3	Atypical	c.6193C>A	p.R2065S	Missense			Novel,62,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Thr7Ile,"...non-synonymous amino acid change in cytochrome b (p.Thr7Ile). On the other hand, the m. 10398G allel...",138,431,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Ile283Val,...Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) confer resist...,147,1340,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Ile283Val,...Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) confer resist...,147,1340,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Pro253Arg,"...755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert syndrome) and a mu...",26,450,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Met918Thr,"...drome) and a mutation in RET (c.2943T>C, encoding p.Met918Thr and causing multiple endocrine neoplas...",26,535,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Gly380Arg,"...FGFR3 c.1138G>A achondroplasia mutation (encoding p.Gly380Arg) obtained broadly comparable results, ...",26,1690,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...rlin cDNA or missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treate...,21,123,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treated with TAT-...,21,134,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...ed. (H) Peptide B2 (10-mer) corresponding to DYSF p.L1341P supports reallocation of dysferlin to the...,21,902,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...y human myotubes harboring the dysferlin mutation p.L1341P. Experiment performed 7x. (D) No peptides...,42,724,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...y human myotubes harboring the dysferlin mutation p.L1341P. Experiment performed 7x. (D) No peptides...,42,724,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...) Peptide B2 (10-mer) added corresponding to DYSF p.L1341P. (F) Sarcolemmal dysferlin localization i...,42,834,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"... membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R,...",48,319,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R, corresponding mutant peptide A2 added. (D...",48,361,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... normal and dysferlin-mutant human myotubes. DYSF p.L1341P myotubes, untreated and treated with TAT-...",50,209,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... hardly detectable and closes rapidly. (D–F) DYSF p.L1341P primary human myotube 6, 20 and 90 sec af...",53,355,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Peptide B2 corresponding to DYSF p.L1341P was labeled with ATTO-495-ME fluorescent ...,59,34,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... stress sensor BiP in myotubes harboring the DYSF p.G299R mutation compared to normal controls (Fig....,62,229,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... stress sensor BiP in myotubes harboring the DYSF p.G299R mutation compared to normal controls (Fig....,62,229,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P. Muscle specimens were placed in 30.2 mM ...,91,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...lin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides were synthesized an...,94,83,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...o DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into the vector by site-direc...,97,261,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...orresponding to DYSF p.G299R in the C2B (red) and p.L1431P in the C2E domain (green) [53],125,329,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... with either missense-mutated dysferlin cDNA DYSF p.G299R (upper lane) or p.L1341P (lower lane). Tra...,131,183,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...and immortalized human myotubes carrying the DYSF p.L1341P mutation in (B) were treated with the dys...,137,193,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...analyte the recombinant C2E domain harboring DYSF p.L1341P expressed in E.coli was used. The kinetic...,143,212,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Video S6 Sarcolemmal injury in DYSF p.L1341P primary human myotubes induced by atomic ...,191,38,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Video S6 Sarcolemmal injury in DYSF p.L1341P primary human myotubes induced by atomic ...,191,38,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.A350V,"...s Disease, Is a Gain-of-Function Mutation SLC41A1 p.A350V Is a Gain-of-Function MutationKolisek Mart...",3,608,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...tasis. Here, we demonstrate that the substitution p.A350V potentially associated with PD is a gain-o...",7,894,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ve mainly examined the effect of the substitution p.A350V potentially related to PD on the performan...,23,71,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ve mainly examined the effect of the substitution p.A350V potentially related to PD on the performan...,23,71,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... SLC41A1. Our findings show that the substitution p.A350V in SLC41A1 is a gain-of-function mutation ...,23,199,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) were constructed in co-operation with Dua...,27,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) were constructed in co-operation with Dua...,27,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...or tet-inducible expression of the wt or mutated (p.A350V) HA-strep-tagged SLC41A1. Protein expressi...,27,782,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) cells were cultured in Dulbecco's modifie...,29,56,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,HEK293 cells inducibly over-expressing wt or the p.A350V variant were grown to approximately 80% co...,34,50,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...for the HA-strep-tagged wild-type variant and the p.A350V mutant, 30 µg total protein were run on a ...",40,452,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he Qproteome cell compartment kit (Qiagen). Wt or p.A350V cells were induced or left untreated. Cell...,46,135,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he Qproteome cell compartment kit (Qiagen). Wt or p.A350V cells were induced or left untreated. Cell...,46,135,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rmination of the phosphorylation status of wt and p.A350V varian,48,55,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... goat serum. For detection of strep-tagged wt and p.A350V, we used a primary anti-strep antibody (di...",55,224,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"The -tet and +tet wt and p.A350V cells were rinsed twice with ice-cold, com...",58,26,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... of tet-induced over-expression of SLC41A1 wt and p.A350V variants in HEK293 cell,70,67,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ssion of SLC41A1 wt (further only wt) and SLC41A1 p.A350V (further only p.A350V) variants would be t...,73,258,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V. Viability of uninduced (-tet) wt or -tet p.A350V cells ranged after 24 h between 95% and 10...,73,532,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V. Viability of uninduced (-tet) wt or -tet p.A350V cells ranged after 24 h between 95% and 10...,73,532,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V. Viability of uninduced (-tet) wt or -tet p.A350V cells ranged after 24 h between 95% and 10...,73,532,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V. Viability of uninduced (-tet) wt or -tet p.A350V cells ranged after 24 h between 95% and 10...,73,532,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in soluble and membrane-protein-enriched f...,75,1064,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...m -tet and +tet (24 h) cells. Strep-tagged wt and p.A350V were detected almost exclusively in tet-in...,75,1185,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in subcellular protein fractions isolated ...,75,1623,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in subcellular protein fractions isolated ...,75,1623,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...of SLC41A2 and/or SLC41A3 in +tet and -tet wt and p.A350V cells, respectively. Indeed, we did not de...",76,805,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s [27], [37]. Therefore, we tested whether wt and p.A350V over-expressing cell lines exhibited consi...",78,130,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s [27], [37]. Therefore, we tested whether wt and p.A350V over-expressing cell lines exhibited consi...",78,130,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... p.A350V cells, we calculated that the density of p.A350V-specific bands was ∼1% lower compared with...",78,941,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,SLC41A1 p.A350V localizes within the cytoplasmic membran,80,9,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...almost exclusive detection of both the wt and the p.A350V variants in the fraction enriched in plasm...,81,1106,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...exa-488- and Alexa-647-specific signals in wt and p.A350V variants revealed a 94.5±1.8% (N = 6) and ...,81,1945,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...exa-488- and Alexa-647-specific signals in wt and p.A350V variants revealed a 94.5±1.8% (N = 6) and ...,81,1945,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...mbrane localization of the potentially PD-related p.A350V variant of SLC41A1. Thus, we conclude that...",81,2255,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,p.A350V exhibits identical complex-forming abiliti...,87,1,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"[27]. Therefore, we wondered whether the mutation p.A350V could affect the complex-forming character...",89,51,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...18%) and Western blot analysis of SLC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variant...,92,54,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...LC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variants form identical complexes (two; la...,92,89,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 induces increased Mg2+ ef...,94,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 induces increased Mg2+ ef...,94,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 induces increased Mg2+ ef...,94,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...riod are shown in Table 1. Uninduced wt cells and p.A350V cells regulate their [Mg2+]i at stable lev...,95,385,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...-(HA-strep-SLC41A1), and HEK293-(HA-strep-SLC41A1-p.A350V) cells",97,150,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...93-(HA-strep-SLC41A1) or HEK293-(HA-strep-SLC41A1-p.A350V) cells,102,362,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...93-(HA-strep-SLC41A1) or HEK293-(HA-strep-SLC41A1-p.A350V) cells,102,362,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...rusion occurred from Mg2+-loaded +tet wt and +tet p.A350V cells. Instead, as can be seen in figure 4...",109,194,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...es, cell adhesion, and cell proliferation in +tet p.A350V cells and wt cells",114,188,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...]i changes after resuspension of Mg2+-loaded +tet p.A350V cells and wt cells in completely Mg2+-free...,115,464,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on; **P = 0.01. C: Original growth curves of +tet p.A350V cells and wt cells under control condition...,115,801,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on; **P = 0.01. C: Original growth curves of +tet p.A350V cells and wt cells under control condition...,115,801,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...es that the ∼56 kDa bands corresponding to wt and p.A350V were detected in the P fractions. The spec...,117,463,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he SLC41A1-dependent Mg2+ efflux from +tet wt and p.A350V cells could be further stimulated by the a...,122,75,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...20]. No additional effects on Mg2+ extrusion from p.A350V cells were observed after the application ...,122,312,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...reased by 69±10% (P<0.001) after the induction of p.A350V over-expression compared with cells over-e...,132,693,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ctivity, we found a reduced proliferation rate in p.A350V compared to wt cells. As the growth experi...",132,854,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... with wt cells. The inability further to increase p.A350V-related NME function via cAMP also suggest...,137,841,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ty [53], is similar (0.44±0.01 mM) between wt and p.A350V cells. Therefore, one can speculate that t...",137,1143,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...350V cells. Therefore, one can speculate that the p.A350V mutation augments the affinity of the tran...",137,1196,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...350V cells. Therefore, one can speculate that the p.A350V mutation augments the affinity of the tran...",137,1196,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... PD-associated coding variant of the NME SLC41A1, p.A350V. We have demonstrated that p.A350V is able...",145,423,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... PD-associated coding variant of the NME SLC41A1, p.A350V. We have demonstrated that p.A350V is able...",145,423,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on and have found a reduced proliferation rate in p.A350V compared with wt cells. Our data therefore...,145,620,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.Tyr1957Ter,"... This mutation introduced a premature stop codon (p.Tyr1957Ter, NP_001120693.1 ) and caused either l...",56,492,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...eration sequencing to identify nonsense mutation (p.Tyr1957Ter) in CACNA1A. SNP, single nucleotide p...",59,125,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...mutations to cause EA2, the truncated mutation of p.Tyr1957Ter in this study becomes interesting bec...",66,124,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Lys2950Asn,...2 DBD wild-type and BRCA2 DBD carrying a variant (p.Lys2950Asn) classified as clinically neutral [7]...,144,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly1366Asp,... were intronic and 3 introduced missense changes (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro30...,183,88,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,"...dence from previous studies. In particular, BRCA1 p.Asp1778Gly located in the C-terminus transcripti...",183,549,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,"...dence from previous studies. In particular, BRCA1 p.Asp1778Gly located in the C-terminus transcripti...",183,549,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,"...the proband’s affected mother. Finally, the BRCA2 p.Pro3039Leu has been classified as neutral using ...",183,1085,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.I2285V,...led by a comprehensive analysis of the c.6853A>G (p.I2285V) variant . Hum Mutat 30 : 1543 –50 197954...,293,169,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Glu388X,"...ions including four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B...",7,1339,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...utations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were identified in ou...",7,1366,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...utations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were identified in ou...",7,1366,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...revealed that founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala12...",7,1497,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser137Ser,"...6 polymorphisms (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (...",73,92,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Phe763Phe,"...polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (...",73,117,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1325Leu,"...p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>...",73,167,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ng 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion mutation (c.2659delG), on...",73,425,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp765Gly,"... 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg...",73,560,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala874Pro,"...Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu...",73,612,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr888Pro,"...Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Va...",73,625,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr935Met,"...Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148T...",73,638,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp1047Val,"...Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala129...",73,664,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...hr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg...",73,678,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...hr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg...",73,678,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Glu1173Lys,"...r935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were ...",73,692,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by ...",73,706,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg1320Ser,"...Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by further analysis ...",73,723,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"... (Families M1279, M1524, M1841, M2621 and M4056), p.Pro992Leu (Families M1031, M1038, M1623, M1841, ...",76,166,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...38, M1623, M1841, M1856, M4061, M4062 and M4174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1...",76,248,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...ong the novel mutations identified in this study, p.Val145Phe was present in two compound heterozygo...",101,1591,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...ted founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val mutations, suggestin...",101,4123,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Y83Y,"... of the family (Table 1). These SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a global Minor...",67,255,PLoS_One_2013_Jun_26_8(6)_e66631.txt
p.Y83Y,"... of the family (Table 1). These SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a global Minor...",67,255,PLoS_One_2013_Jun_26_8(6)_e66631.txt
p.G1481E,"...V linker (Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1...",158,864,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.G1481E,"...V linker (Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1...",158,864,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.G1481E,"...V linker (Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1...",158,864,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.M1498T,"...Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1507delKPQ,...",158,874,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.M1498T,"...Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1507delKPQ,...",158,874,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.Y1494N,"... current [33] or to BrS (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W...",158,1064,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.L1501V,"...S (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44]...",158,1086,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.E338X,ESCO1	T79	Serous	Stable	c.G1012T	p.E338X	Nonsense	n/a	n/a	n/a,95,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D359N,T113	Clear cell	Stable	c.G1075A	p.D359N	Missense	Low	Tolerated	Benign,96,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D359N,T113	Clear cell	Stable	c.G1075A	p.D359N	Missense	Low	Tolerated	Benign,96,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.S532L,T77	Clear cell	Unstable	c.C1595T	p.S532L	Missense	Low	Tolerated	Probably damaging,97,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D692Y,MRE11A	T68	Serous	Stable	c.G2074T	p.D692Y	Missense	Low	Affects function	Probably dam...,101,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R483Q,T3†	Serous	Stable	c.G1448A	p.R483Q	Missense	Low	Tolerated	Benign,102,29,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.H731D,rs4934281	10	88692330	MMRN2	NM_024756	c.C2191G	p.H731D	0.62	neutral	NA	NA,122,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.H731D,rs4934281	10	88692330	MMRN2	NM_024756	c.C2191G	p.H731D	0.62	neutral	NA	NA,122,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.V910L,rs34587013	10	88686602	MMRN2	NM_024756	c.G2728C	p.V910L	0.91	neutral	NA	NA,123,49,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.S3588P,...99. SIFT prediction output denotes that bfb Fras1 p.S3588P amino acid change is ‘not tolerated’. A t...,69,484,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.Ala461Val,"... p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel with 11 age...",99,443,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala461Val,"... p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel with 11 age...",99,443,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala461Val,"...st, variants in RGS6 predicting missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not s...",104,789,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...nsistent with the clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect...",106,487,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Cys356Gly,I-2	57	M	5.20	0.93	1.09	3.10	p.Cys356Gly (c.1129T>G),107,30,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Arg52Cys,"...in the exon1 of the human MBL2 gene at codons 52 (p.Arg52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and ...",30,160,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Dly54Asp,"... MBL2 gene at codons 52 (p.Arg52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), ...",30,185,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Gly57Glu,"...g52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), interfere with the formation ...",30,214,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Gly57Glu,"...g52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), interfere with the formation ...",30,214,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Gly57Glu,"...g52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), interfere with the formation ...",30,214,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Gln170X,"MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis causing	Yes, ...",87,22,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln170X,"MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis causing	Yes, ...",87,22,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Arg265Cys,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Normal	Lost	Yes...",110,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,"136	MLH1/Exon 14, c.1657delACCAAGCTTAG, p.Thr553X	Novel Pathogenic	Lost	Normal	Normal	Lost...",113,41,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,"136	MLH1/Exon 14, c.1657delACCAAGCTTAG, p.Thr553X	Novel Pathogenic	Lost	Normal	Normal	Lost...",113,41,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Leu390Phe,"68	MSH2/Exon 7, c.1168C>T, p.Leu390Phe	Probably dis causing by HGMD criteria ...",131,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ile240Phe,"409	PMS2/Exon 7, C.718 A>T, p.Ile240Phe	Novel VUS	Normal	Normal	Normal	Normal	...",133,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.R93H,"...ther one carrying a missense variation in PLCXD3 (p.R93H), both supporting a role of the phosphatidy...",7,1508,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...und in these patients, and one amino acid change (p.R93H) was identified in one subject with early-o...",94,1127,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...und in these patients, and one amino acid change (p.R93H) was identified in one subject with early-o...",94,1127,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R268Q,"... mutation on the protein. According to AGGRESCAN, p.R268Q is located in protein aggregation-prone se...",78,370,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"...death [23]. Taken together, we postulate that the p.R268Q mutation in PMCA4 identified in this famil...",86,1035,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.G13D,"...nchi A , Tu D , et al (2010 ) Association of KRAS p.G13D mutation with outcome in patients with chem...",169,109,PLoS_One_2014_Aug_4_9(8)_e103551.txt
p.A94P,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A291V,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,c.1334A>G	p.Y445C	35	—	—	—	—	—,56,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,c.1331A>G	p.Q444R	34	—	0.2	0.14	—	rs147258453,63,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A388A,exon 6	c.1164G>A	p.A388A	315	M	—	0.03	—-	rs55968178,76,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,exon 2	c.364A>G	p.I122V	31	M	0.2	—	—	—,90,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,...t in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that ...,98,228,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,...t in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that ...,98,228,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,...t in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that ...,98,228,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...CC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient carried GATA...",98,1197,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...CC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient carried GATA...",98,1197,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,"...ransactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",101,124,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",101,139,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",101,139,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...ptional activities of HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC...",101,653,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...activities of HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC1 p.G378...",101,661,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...f HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC1 p.G378_G380delGGG ...",101,673,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...n-synonymous FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional act...",110,181,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional activity as meas...",110,194,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional activity as meas...",110,194,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional activity as meas...",110,194,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,...constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical to the w...,119,71,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,...constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical to the w...,119,71,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...er transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",124,403,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...ion capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP ...",124,418,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I121M,"...ied as a change in the adjacent amino acid (TBX20 p.I121M), identified in a patient with an ostium s...",125,93,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,34	FOXC2	p.Q444R	Tetralogy of Fallot with moderate valvar p...,133,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,66	FOXC1	p.P297S	Tetralogy of Fallot with moderate to sever...,134,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G149V,"...main and its high conservation through evolution, p.G149V mutation could be a potential pathogenic c...",7,1663,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"... of glycine within the C-loop of EGF-like domain, p.G149V mutation could be a potential pathogenic c...",95,178,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.V44A,...(c.131T>C) in exon 2. E: Conservation analysis of p.V44A of the Cx50 gene,73,617,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...e residue for alanine at codon 44 of connexin 50 (p.V44A), which is located in the first extracellul...",76,412,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.R355Q,...AAAACTCAAATGCAGAACC	Site-directed mutagenesis for p.R355Q,54,62,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.R355Q,...AAAACTCAAATGCAGAACC	Site-directed mutagenesis for p.R355Q,54,62,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Gln904Gln,...8	C	C/T	0.140**	0.158	0.49	0.153	0.69	G	c.2712G>A	p.Gln904Gln	synonymous	13,103,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.T41A,"...nd in about 64–85% of all sporadic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to p...",14,799,PLoS_One_2014_May_1_9(5)_e96391.txt
p.T41A,"...nd in about 64–85% of all sporadic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to p...",14,799,PLoS_One_2014_May_1_9(5)_e96391.txt
p.T41A,"...nd in about 64–85% of all sporadic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to p...",14,799,PLoS_One_2014_May_1_9(5)_e96391.txt
p.S196G,"...ction of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193delAGCGGC)...",122,530,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...th wt. (p.P140S vs. wt-type 80% (t test, p<0.01), p.S183L vs. wt-type 85% (t test, p<0.01), p.Ser192...",132,540,PLoS_One_2014_May_21_9(5)_e98157.txt
p.K433K,"... P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glaucoma patients ....",152,140,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.L160H,"...with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N = 66,380...",176,516,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.P174T,"c.521C>G, p.P174T	c.949_950insC	-",18,11,PLoS_One_2015_Jul_29_10(7)_e0134748.txt
p.D150H,"...served aspartic acid with histidine at codon 150 (p.D150H). By linkage and haplotype analysis, we ob...",7,1097,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...structure and function of AQP0. The wild type and p.D150H mutant AQP0 were expressed in HeLa cells s...,7,1505,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,16,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,To investigate whether the p.D150H mutation impacts the normal trafficking of...,91,28,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,To investigate whether the p.D150H mutation impacts the normal trafficking of...,91,28,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.E134G,"...in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C ...",97,1274,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.E134G,"...in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C ...",97,1274,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.Y177C,"...X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213V...",97,1316,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R187C,"...G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p....",97,1330,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R187C,"...G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p....",97,1330,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"..., p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22]). As the presence of...",97,1378,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"..., p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22]). As the presence of...",97,1378,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R233K,"....V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22]). As the presence of clinical heterog...",97,1395,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"...ne domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeability due to im...",99,821,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"... Moreover, this study presented the evidence that p.D150H damages the trafficking of AQP0 and causes...",105,361,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.L4115F,"...tions p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p....",31,390,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Thr399Ile,... rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are in linkage disequilibrium (LD) (r...,20,970,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,"... testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P < 0.0001) appeared in Hardy-Weinber...",33,634,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"TLR1	4	p.His305Leu (rs3923647)	GOF [24,25] LOF [26]	T/a	9...",71,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,"TLR3	4	p.Leu412Phe (rs3775291)	LOF [31,32] GOF [33]	C/t	4...",74,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"TLR4	9	p.Asp299Gly (rs4986790)	LOF [34,35]	A/g	89.3	10.1	...",75,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	4	p.Ser249Pro (rs5743810)	GOF [24]	G/a	35.8	46.7	17....,79,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"TLR8	X	p.Met1Val(rs3764880)	GOF [44,45]	A/g	66.4	15.0	18....",81,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"TLR8	X	p.Met1Val(rs3764880)	GOF [44,45]	A/g	66.4	15.0	18....",81,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.37, 95% CI = 1.83–10.43, P = 0.003). TLR1 p.Asn248Ser and TLR8 p.Met1Val showed some specifi...",86,1280,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	9.6	5.1	0.73	0.22–2.43	1,92,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	5.8	5.4	1.27	0.52–3.12	1,93,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	8.2	7.1	2.93	1.03–8.33	0.4,95,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	44.6	42.6	0.92	0.82–1.04	1,96,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	21.7	21.1	1.05	0.85–1.30	1,98,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	Congenital	216	10.4	2.6	4.94	2.26–10.8...,108,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	Congenital	216	10.4	2.6	4.94	2.26–10.8...,108,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	0.69	0.34–1.30	1	1.12	0.75–1.67	1,132,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	1.30	0.86–1.94	1	0.82	0.53–1.24	1,138,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.28	0.85–1.90	1	0.85	0.56–1.28	1,140,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.88	0.63–1.23	1	0.83	0.57–1.19	1,148,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	0.91	0.65–1.27	1	0.94	0.68–1.30	1,172,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	1.25	0.98–1.61	1	1.07	0.81–1.41	1,182,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	1.13	0.84–1.52	1	1.11	0.82–1.50	1,198,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	1.13	0.72–1.77	1	1.29	0.93–1.80	1,200,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	1.13	0.72–1.77	1	1.29	0.93–1.80	1,200,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.31	0.90–1.90	1	0.84	0.55–1.27	1,206,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...at 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly associated with the preval...",223,534,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,...d a higher frequency of the minor allele for TLR1 p.Asn248Ser in pediatric patients with IgA nephrop...,225,455,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...n line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage disequilibrium, on...",225,1293,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,...f the minor allele frequency for the TLR4 variant p.Asp299Gly with pyelonephritis (both with and wit...,225,1531,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...]. The residual TLR variants, which includes TLR8 p.Met1Val that showed an association with end-stag...",225,1890,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...]. The residual TLR variants, which includes TLR8 p.Met1Val that showed an association with end-stag...",225,1890,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	-	-	-	-	-	-	-,229,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	-	-	-	-	-	-	-,276,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	-	-	-	-	-	-	-,278,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,... al. [58] did not identify an association of TLR2 p.Arg753Gln with renal transplant outcomes. In the...,286,519,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...es. In the context of renal transplantation, TLR4 p.Asp299Gly and p.Thr399Ile are also among the mos...",286,609,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"...th our study, did not find an association of TLR5 p.Arg392Ter with renal transplant outcomes. Even t...",286,2198,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His723Arg,"...sly known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 (pendrin, M...",44,537,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,Nucleotide change (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>...,63,50,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,"... is marked by grey symbols. M—mutation c.5254G>A (p.Gly1752Arg), wt—wild type",82,428,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two siblings (54-...,93,38,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene and the c.2...,95,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...with related family F24) with mutation c.1111C>G (p.Gly371Arg) in the OTOF gene denoted as M. (B) Va...,96,105,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...ee of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which is denoted ...,96,259,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found in the only...,101,32,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found in the only...,101,32,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1389R,"...ein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S...",116,1326,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...enign: (i) strong segregation of homozygosity for p.Gly1752Arg with recessive HL in multiple affecte...,118,160,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...se issues and prove presumed pathogenicity of the p.Gly1752Arg variant in further experimental studi...,118,1342,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...s differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F53 is one of...,128,421,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...s differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F53 is one of...,128,421,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2 (protein code: NP_001734.1:p.A...,37,1845,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...as p.Asn98Ser in CALM2 (protein code: NP_001734.1:p.Asn98Ser; genomic code: NC_000002.11:g.47388990T...,37,1892,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...0.1371/journal.pone.0153851.g002Fig 2 View of the p.Asn98Ser mutation,45,52,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...ound in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in public databases nor h...,54,119,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...ow frequency, that pAsn98Ser is a mutation. CALM2 p.Asn98Ser has been described recently by Makita e...",54,415,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...ry small, this study provide novel information on p.Asn98Ser mutation in CALM2 as a cause of UCA in ...",57,900,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asp96Val,...a variant affecting the immediate upstream codon (p.Asp96Val) to our case was also described in a ch...,63,66,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.I236N,"... conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p...",57,391,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.M239K,"...A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p...",57,409,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.Q318X,"...(p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p.Arg483fs or the IVS2-13 A/C>G ...",57,440,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P30L,"...idual enzymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in...",57,624,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P30L,"...idual enzymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in...",57,624,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V281L,"...zymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60...",57,632,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V281L,"...zymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60...",57,632,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P453S,"...ivity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60% residual ...",57,643,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.A467T,...cleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,543,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Ala467Thr,...f the common homozygous polymerase-gamma mutation p.Ala467Thr?,226,86,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Ala467Thr,...f the common homozygous polymerase-gamma mutation p.Ala467Thr?,226,86,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Trp152Arg,"...XC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease in a Mexi...",14,396,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...racteristics. A novel missense variant (c.454T>C; p.Trp152Arg) was identified in the FOXC1 gene (Fig...,54,464,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...gregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Systemic and ...,57,70,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...gregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Systemic and ...,57,70,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.L22F,1 p.L22F,220,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.A142T,3 p.A142T,224,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.M63X,1 p.M63X,260,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.Gly316Ser,"...nalyzed with the Swiss PDV Viewer, SPDBV 4.1. The p.Gly316Ser mutation was introduced into human ATP...",25,258,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Thr458Asn,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/C",63,33,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e crystal structure in the K+-bound conformation, p.Gly316Ser is directly apposed to a residue in th...",67,367,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Phe780Leu,"...he 5th transmembrane span that is mutated in RDP (p.Phe780Leu) (Fig 2, top) [8]. The glycine is <3.7...",67,466,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Phe780Leu,"...he 5th transmembrane span that is mutated in RDP (p.Phe780Leu) (Fig 2, top) [8]. The glycine is <3.7...",67,466,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ed to be viable (not shown). Cells expressing the p.Gly316Ser mutation survived for 2–3 weeks in sta...,73,839,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ed to be viable (not shown). Cells expressing the p.Gly316Ser mutation survived for 2–3 weeks in sta...,73,839,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...le those with pGly316Ser were more rounded. Other p.Gly316Ser-transfected wells were trypsinized at ...,73,1125,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...nd no detectable division of the remaining living p.Gly316Ser cells. (D) Na,K-ATPase α3 western blot...",76,697,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly358Val,...[17]. In an infant with catastrophic epilepsy and p.Gly358Val ATP1A3 mutation that severely inhibite...,82,422,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.R47H,TREM2 variant p.R47H as a risk factor for sporadic amyotrophic l...,127,15,PLoS_One_2016_Mar_7_11(3)_e0150211.txt
p.His558Arg,"... RYR2 (rs3765097). Of these, the SCN5A rs1805124 (p.His558Arg) was the only non-synonymous variant. ...",77,205,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Gly232Val,...ected) identified a novel LMNA missense mutation (p.Gly232Val) in a Chinese family [18]. In these th...,142,659,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ly penetrant, primary mutations. We excluded TMPO p.Arg690Cys as the primary mutation in our family ...",148,208,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ad the variant; therefore, we concluded that TMPO p.Arg690Cys variant was not the primary mutation i...",148,884,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...lished HCN4 mutation and two subjects had the HCN p.M1113V variant [25]. In our family, we found the...",152,336,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...ily, we found the lack of segregation for the HCN p.M1113V and heart disease; only one affected sibl...",152,419,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg795Lys,"...k for arrhythmia [52]. In addition, we found PKP4 p.Arg795Lys in all four affected members and in on...",174,383,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg795Lys,"...k for arrhythmia [52]. In addition, we found PKP4 p.Arg795Lys in all four affected members and in on...",174,383,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg321Ter,"...li A , Hansen J , et al (2013 ) The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy...",277,114,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.R222H,"...sis performed individuals. The genotype of SCN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222...",35,484,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.R444Q,"p.R444Q[69, 76, 78, 79]	Homo	-	-		274.15 ± 5.80	25...",113,1,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Glu22Glu,ER23/23EK	c.66G>A (p.Glu22Glu)	rs6189	2.19%	2.98% (ss1317539291)	2.93...,129,20,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.Glu376Asp,...> A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu376Asp). The allelic frequency of these polym...,28,496,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Glu342Lys,"... p. Glu264Val) and PI*Z (rs28929474; c.1096G > A; p.Glu342Lys), with a PI*S prevalence in Caucasians...",28,923,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Glu342Lys,"... p. Glu264Val) and PI*Z (rs28929474; c.1096G > A; p.Glu342Lys), with a PI*S prevalence in Caucasians...",28,923,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Leu79Arg,...in a missense amino acid variant p.Leu79Arg. This p.Leu79Arg variant is listed in the Leiden Open Va...,44,481,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.Leu79Arg,... at the Leiden Open Variation Database. Since the p.Leu79Arg variant had been identified in only one...,44,1341,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.Q734X,... a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents. This mutat...,3,1961,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.P753S," 	EGFR c.2257C > T, p.P753S	Yes	98%	Yes	99%",170,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—	Homozyg...,85,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V71F,AIPL1	c.211G>T	p.V71F	8*10−6	arLCA	Mix Jew	MOL0113	—	Homozygous	 ...,86,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.R160Q,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—	Homozygo...,87,15,Sci_Rep_2015_Aug_26_5_13187.txt
p.R160Q,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—	Homozygo...,87,15,Sci_Rep_2015_Aug_26_5_13187.txt
p.R762C,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Homozygous	 ,91,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.R762C,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Homozygous	 ,91,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.T452Sfs,FAM161A	c.1355_6delCA	p.T452Sfs	4*10−5	arRP	Moroccan Jew	MOL0228	26	Homo...,97,23,Sci_Rep_2015_Aug_26_5_13187.txt
p.T452Sfs,FAM161A	c.1355_6delCA	p.T452Sfs	4*10−5	arRP	Moroccan Jew	MOL0228	26	Homo...,97,23,Sci_Rep_2015_Aug_26_5_13187.txt
p.T452Sfs,FAM161A	c.1355_6delCA	p.T452Sfs	4*10−5	arRP	Moroccan Jew	MOL0228	26	Homo...,97,23,Sci_Rep_2015_Aug_26_5_13187.txt
p.L99I,RDH12	c.295C>A	p.L99I	7*10−5	arRP	Moroccan Jew Moroccan Jew Turki...,105,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.H241L,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Homozygous	...,107,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.M1L,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,14,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	Disease causing	1	0.00 Damaging	0	0	0,131,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	0	0	0,134,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerated	0	0	0...,136,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.V200M,"...e is the NLRP3 variant V198M (or, more precisely, p.V200M, rs121908147), detected in the control pop...",11,1017,Sci_Rep_2015_May_19_5_10200.txt
p.F425Y,"...tients O1 (p.I591T, rs11466045, MAF 0.07) and R1 (p.F425Y, rs11466045, MAF 0.001). None of these wer...",27,420,Sci_Rep_2015_May_19_5_10200.txt
p.F425Y,"...tients O1 (p.I591T, rs11466045, MAF 0.07) and R1 (p.F425Y, rs11466045, MAF 0.001). None of these wer...",27,420,Sci_Rep_2015_May_19_5_10200.txt
p.G504D,"...p.L607P (rs182098487, MAF 0.001). A novel change, p.G504D, was found in this same gene in patient B7...",33,580,Sci_Rep_2015_May_19_5_10200.txt
p.S1025L,"...0.01) although only in patient O1, and the change p.S1025L (rs11671248, MAF 0.08) in NLRP11 in patie...",33,1290,Sci_Rep_2015_May_19_5_10200.txt
p.S1025L,"...0.01) although only in patient O1, and the change p.S1025L (rs11671248, MAF 0.08) in NLRP11 in patie...",33,1290,Sci_Rep_2015_May_19_5_10200.txt
p.V939M,"... of the NLRP1 gene, with the only exception being p.V939M (rs61754791, MAF 0.01), found only in pati...",33,1458,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,"...AF 0.03) in patient 2941; a novel change in NOD1 (p.C241G) in patient 2942, again in the NACHT domai...",33,2304,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,"...AF 0.03) in patient 2941; a novel change in NOD1 (p.C241G) in patient 2942, again in the NACHT domai...",33,2304,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,...for example observed for the NLRP3 variant V198M (p.V200M). This change has been reported in several...,42,1052,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,"...gues. Altogether, these data indicate that V198M (p.V200M) is likely a neutral human polymorphism an...",42,2350,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... the novel change found in patient R1, the NLRP12 p.R211C, which is present in a well-conserved doma...",44,69,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...ctional effect on the protein. In particular, for p.Q703K, functional impairment of NLRP3 has been c...",44,1139,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,IPAF (NLRC4)	149451729	2941	p.G786V	0.004	LRR6,123,29,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,IPAF (NLRC4)	149451729	2941	p.G786V	0.004	LRR6,123,29,Sci_Rep_2015_May_19_5_10200.txt
p.A161T,NAIP	61757629	B7	p.A161T	0.02	BIR2,124,18,Sci_Rep_2015_May_19_5_10200.txt
p.L607P, 	182098487	2940	p.L607P	0.005	between NACHT and LRR1,128,18,Sci_Rep_2015_May_19_5_10200.txt
p.N255S,NLRP5	novel	F1	p.N255S	0.001	between DAPIN and NACHT,132,16,Sci_Rep_2015_May_19_5_10200.txt
p.R274Q, 	novel	2940	p.R274Q	0.001	between DAPIN and NACHT,133,14,Sci_Rep_2015_May_19_5_10200.txt
p.R1005Q,NOD3 (NLRC3)	novel	2940	p.R1005Q	0	LRR15,138,25,Sci_Rep_2015_May_19_5_10200.txt
p.S210L,"NOD4	16965150	2941, F1	p.S210L	0.03	before NACHT domain",139,24,Sci_Rep_2015_May_19_5_10200.txt
p.Val345Met,rs10911390	1q25.3	183616884	C/T	0.08	APOBEC4	p.Val345Met	exon 2	B	D,123,46,Sci_Rep_2015_Oct_13_5_14969.txt
p.Arg18Leu,rs139293	22q13.1	39496336	G/T	0.17	APOBEC3H	p.Arg18Leu	exon 2	D	T,124,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.Lys121Asn,rs139299	22q13.1	39497454	G/C	0.31	APOBEC3H	p.Lys121Asn	exon 3	B	D,125,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.L1491X,BCOR	stopgain SNV	NM_001123384:c.T4472A:p.L1491X	36	0.92	T66,130,41,Sci_Rep_2016_Apr_29_6_25264.txt
p.E1001Q,BCOR	nonsynonymous SNV	NM_001123383:c.G3001C:p.E1001Q	71	0.46	T63,131,46,Sci_Rep_2016_Apr_29_6_25264.txt
p.A2808T,"...rs of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A ...",36,1681,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,"....A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The inheritan...",36,1732,Sci_Rep_2016_Jan_20_6_19432.txt
p.D904Qfs,"...Thus far, the mutations identified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, ...",48,89,Sci_Rep_2016_Jan_20_6_19432.txt
p.S754Afs,"...mutations identified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and o...",48,103,Sci_Rep_2016_Jan_20_6_19432.txt
p.T657Afs,"...ntified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Mo...",48,116,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,...ARRP-49. The novel homozygous mutation c.1871G>A (p.S624L) in EYS is likely the causative mutation f...,48,1291,Sci_Rep_2016_Jan_20_6_19432.txt
p.Q1536E,"...10, the compound heterozygous mutations c.C4060G (p.Q1536E) and c.A5038G (p.N1680D) were found, and ...",50,296,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,"...18, the compound heterozygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and th...",50,504,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,"...in mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutations resul...",52,130,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,"...in mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutations resul...",52,130,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging (0.009)/Delet...,105,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging (0.009)/Delet...,105,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (0.541)/Neutr...,112,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.G244S,...with various tumors. A TP53 mutation (c.730G > A; p.G244S) co-segregated with the tumor phenotype wi...,5,1084,Sci_Rep_2016_Jan_28_6_20221.txt
p.W318S,... and compound heterozygous mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)] was ident...,7,1268,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...cing validated the c.279 + 1G > C and c.572C > T (p.A191V) variants in two siblings, which were tran...",19,603,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...pound heterozygous SLC12A5 mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)], who was ...",21,474,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...V), and the large extracellular loop (p.W318S and p.S323P) adjacent to four conserved cysteines (C28...",23,622,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,...extrusion function especially between p.A191V and p.S323P mutants and WT KCC2. The surface expressio...,45,397,Sci_Rep_2016_Jul_20_6_30072.txt
p.L311H,...sessed a homozygous missense mutation c.932T > A (p.L311H). Functional analysis concluded that the C...,49,312,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...ncluding c.148_279del (p.E50_Q93del), c.572C > T (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p....",64,278,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"... (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p.M415V). All variant cDNAs were verified by seque...",64,326,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ala191Val,"...Val	c.279 + 1G > C, p.Glu50_Gln93del; c.572C > T, p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, ...",109,115,Sci_Rep_2016_Jul_20_6_30072.txt
p.Trp318Ser,"...p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244del, p.Ser748del",109,189,Sci_Rep_2016_Jul_20_6_30072.txt
p.Arg2345Trp,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,14,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg175His,"...n GOF mutations; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln...",7,1221,Sci_Rep_2016_May_18_6_26191.txt
p.Arg175His,"...n GOF mutations; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln...",7,1221,Sci_Rep_2016_May_18_6_26191.txt
p.Gly245Ser,"...ns; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273...",7,1234,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"...ts such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273His have been shown to act...",7,1260,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,"...e missense mutation occurring outside of the DBD, p.Leu344Gln, was located in exon 10 of TP53. All m...",19,727,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"... acid, with approximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this cod...",21,110,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Trp,"...oximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this codon, followed by ...",21,126,Sci_Rep_2016_May_18_6_26191.txt
p.Ser267Phe,. The p.Ser267Phe variant in SLC10A1 is associated with ...,201,7,Sci_Rep_2016_May_23_6_26465.txt
p.Y856X,"...two heterozygous nonsense mutations (c.2568C > A, p.Y856X; c.1714C > T, p.R572×16). To the best of o...",31,531,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,"...two heterozygous nonsense mutations (c.2568C > A, p.Y856X; c.1714C > T, p.R572×16). To the best of o...",31,531,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...troduction of a premature stop codon (p.R572X and p.Y856X). In silico predictions supported a pathog...,34,265,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,"...nse mutations found in family 2 and family 3, the p.A2064T mutation had not been reported previously...",39,72,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,...with the residue ALA-2064 located at chain B. The p.A2064T mutation would induce an additional hydro...,39,1185,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,"...anish people. As the Danish founder mutation, the p.N965S mutation was found to account for 16.2% of...",39,1645,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,...d as null mutations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutatio...,41,95,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,...d as null mutations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutatio...,41,95,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,F1:III:1	9	0.15/0.15	12	c.1714C > T	p.R572X	Het	Nonsense	—	—	—	Rare	12,73,37,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.D38A,Exon 4	rs5035	c.113A > C for eAE1	p.D38A for eAE1	1 incomplete dRTA,152,35,Sci_Rep_2016_Oct_21_6_35841.txt
p.Ile157Thr,... DNA damage3435. The missense variant rs17879961 (p.Ile157Thr) changes Isoleucine to Threonine at po...,28,367,Sci_Rep_2016_Sep_16_6_33542.txt
p.Ile157Thr,...ng of principal substrates. The rs17879961 (CHEK2 p.Ile157Thr) substitution may alter its ability to...,28,593,Sci_Rep_2016_Sep_16_6_33542.txt
p.Lys3326X,"...way for DNA repair394041. The variant rs11571833 (p.Lys3326X) leads to a stop codon, which results i...",28,1024,Sci_Rep_2016_Sep_16_6_33542.txt
p.Ile157Thr,...ing the CHEK2 activity as a result of rs17879961 (p.Ile157Thr)173234,30,1635,Sci_Rep_2016_Sep_16_6_33542.txt
p.Arg516His,"...ollowing substitutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), respectively. (B) CCT2 gene...",91,303,Sci_Rep_2016_Sep_20_6_33742.txt
p.Q1063K,p.Q1063K	c.3187C > A	NR	1 (1.1)	-	T	C0	-,168,1,Springerplus_2012_Sep_25_1_20.txt
p.R270X,...s in the transcription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter M...,45,1425,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R168X,"...d by RTT-specific mutations in MeCP2 (p.T158M and p.R168X) that impact the methyl-binding domain, bu...",45,1689,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R257X,...x different AIRE gene mutations were detected and p.R257X mutation was present in 63.3 % of patholog...,10,421,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257X,...x different AIRE gene mutations were detected and p.R257X mutation was present in 63.3 % of patholog...,10,421,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257X,...x different AIRE gene mutations were detected and p.R257X mutation was present in 63.3 % of patholog...,10,421,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
